Synthesis of novel benzotriazole substates suitable for screening hydrolytic enzymes by Watt, Alan
Synthesis of novel benzotriazole substrates suitable for screening 
hydrolytic enzymes 
Alan Watt 
The University of Edinburgh 
A thesis submitted for the degree of Doctor of Philosophy July 2002 
Acknowledgements 
Firstly, I wish to thank my supervisors, Professors Sabine Flitsch and Nicholas J Turner, 
for their encouragement, advice and guidance throughout this PhD project. I am 
especially grateful to Nick for proof-reading this thesis and for his helpful comments and 
suggestions. I would also like to thank John Millar, Wesley Kerr and Dr Ian Sadler for 
providing me with excellent NMR support during my time at Edinburgh. In addition 
Alan Taylor is gratefully acknowledged for operating the Mass Spectrometry service and 
Dr Andy Parkin for some crystal structure determinations. 
I am grateful to my collaborators at the University of Strathclyde, Dr Barrie Moore, Dr 
Duncan Graham and Lorna Stevenson for the SERRS analysis and numerous helpful 
discussions about the azo dyes and SERRS in general. 
I would also like to thank Astra Zeneca for funding and my industrial supervisor Neil 
Barnwell for support, encouragement and helpful suggestions. 
To all past and present students and post-docs of Labs 34, 38 and 120, a big thank you. 
The last three years have, at times, been the most downright frustrating years I can 
remember but I wouldn't change them for anything! Thanks also to all the insect life of 
Lab 34— you know who you are. 
To my Mum and Adam, this thesis would have been impossible without your support 
both financially and emotionally, hope you enjoy it! 
Finally, I wish to thank Denise for all the help, support, encouragement and love she has 
given me over the last two years. Hopefully I can help her as much as she needs. 
It 
Abstract 
1-(benzotriazol-1-yl) alkyl esters (94a-e, 105 and 112) and amides (117-118) have 
been investigated as substrates suitable for screening hydrolytic enzymes. Following 
enzymatic hydrolysis, in aqueous media, the reaction products fragment to release 
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Scheme 1: Enzymatic hydrolysis of 1-(benzotriazol-1-yl)alkyl esters and amides 
The synthesis of novel surface enhanced resonance raman spectroscopy (SERRS) 
inactive mono-azo benzotriazole dyes (5) 1(R) 141-144 A, B and C and their application 
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CE: capillary electrophoresis 
CBz carboxybenzyl 





DCC 1 ,3-dicyclohexylcarbodiimide 
DCM: dichioromethane 
DIPEA: di-iso-propylamine 
DMAP: N'N '-dimethyl-4-aminopyridine 
DMF: dimethyl formamide 
DMSO: dimethyl suiphoxide 
DBU: 1, 8-diazobicyclo[5 .4.O]undecane-7 
e.e.: enantiomeric excess 
EDCI: 1 -(3-dimethylaminopropyl)-ethylcarbodiimide 
ELISA: enzyme linked immunosorbant assay 
ESi: electrospray ionisation 
Et: ethyl 
Et3N: triethylamine 
Et20: diethyl ether 
EtOAc: ethyl acetate 
EtOH: ethanol 
FAB: fast atom bombardment 
GC: gas chromatography 
HOBt: 1 -hydroxybenzotriazole 
HPLC: high performance liquid chromatography 
Hz: hertz 
IPA: iso-propyl alcohol 
m: multiplet 
Me: methyl 
Mp: melting point 
MeOH: methanol 
NMR: nuclear magnetic resonance 
nOe: nuclear overhauser effect 
ph: phenyl 




SERRS: surface enhanced resonance raman spectrometry 
 triplet 
TFA: trifluoroacetic acid 
THF: tetrahydrofuran 
TLC: thin layer chromatography 
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1. Introduction 
1.0 	Opening Remarks 
Biocatalysis is now widely recognized as a practical alternative to traditional 
(non-enzymatic) organic synthesis and is increasingly implemented to solve industrially 
relevant problems'. One area, which has arguably received the most attention, is the 
application of hydrolytic enzymes to the preparation of enantiopure organic compounds. 
The importance of which, is perhaps best reflected in the pharmaceutical industry where 
the Food and Drug administration (FDA) require all newly registered drugs to be 
produced and characterised in enantiomerically pure form. This requirement has sound 
reasoning; since biological activity is often restricted to one of the two enantiomers and, 
in extreme cases, the 'wrong' enantiomer may exhibit undesirable side effects. Enzymes, 
in particular esterases and lipases, have been widely applied to the preparation of pure 
enantiomers from racemic mixtures, prochiral or meso compounds, or diastereomeric 
mixtures. This resolution can be achieved by hydrolysis in aqueous media or by the 
reverse reaction, transesterificationlesterification, in organic solvents. 
Many of the synthetic problems encountered can be solved, by choosing the 
correct enzyme and simply adding it to the reaction much like any other chemical 
reagent. Indeed, for some enzymes, simple rules exist to help predict which enantiomer 
will react quickest2. Unfortunately, most enzymes have evolved to contribute to the 
survival of an organism and will not perform well under the conditions required by the 
process chemist. However, several techniques have been developed to circumvent this: 
e.g. new enzymes can be identified by screening from a range of sources3, the properties 
of existing enzymes can be manipulated by choosing the appropriate reaction conditions 
(medium engineering)4 or mode of implementation (e.g. immobilization, cross-linking 
etc5' 6)  Ultimately, many problems are best solved by engineering the biocatalyst itself, 
either by: directed evolution (combinatorial approach)715, site-directed mutagenesis 
(rational approach) 16-18  or a combination of both techniques to generate libraries of 
1 
'mutant' enzymes which may comply with the chemists wishes. A schematic of the 
numerous manipulation options available is shown - Figure 1. 
Unfortunately, the testing of a number of commercially available enzymes or 
mutated enzyme libraries presents a significant scientific challenge in itself, primarily 
due to the time and labour involved. This is in part due to the vast number of potential 
'mutants' which can be generated by directed evolution and in the length of time 
required to analyse the enzymatic reaction by traditional techniques e.g. NIVIR, GC and 
HPLC. Scientific progress to circumvent this, has led to the development of a range of 
new high-throughput techniques to determine if the mutated enzymes have the desired 
property. 1922 
In this thesis, the focus shall primarily be on the development of novel substrates 
suitable for screening lipolytic enzymes, although reference to other hydrolytic enzymes 
and enzyme classes will be made. 
2 
Medium engineering: 
alter solvent, pH etc. 
Screen for new enzyme: 
commercial sources, clone banks, 
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1.1 	Lipolytic enzymes 
1.1.1 Role and action of lipases and esterases. 
Lipases (triacyiglycerol ester hydrolase's, BC 3.1.1.3) and carboxylesterases 
(BC 3.1.1.1) are enzymes widely distributed among animals, plants and micro-
organisms. These two classes of enzymes catalyse the hydrolysis and synthesis of water 
insoluble long chain triglycerides and small partially water soluble esters, respectively. 
The mechanism of activity is the same for both classes and is based on a 'catalytic triad', 
made up of nucleophiic serine, histidine and aspartame/glutamate? This 'catalytic 
triad' is similar to that found in serine proteases - Scheme 2. 
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Scheme 2: Catalytic mechanism of lipases 
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In contrast to esterases, lipases do not obey normal Michaelis-Menten kinetics 
displaying little or no catalytic activity at low substrate concentrations. Instead, a sharp 
increase in hydrolytic activity occurs when the triglyceride substrate concentration is 
increased beyond its critical micellular concentration to form an emulsion. This 
phenomenon was termed 'interfacial activation'24 and the effect is displayed - 
Figure 3. 
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IS] 
CMC: Critical miceflar concentration 
Figure 3: Interfacial activation of lipases2  
Most lipases also contain a 'lid',2526 which is a surface loop of the protein 
covering the active site of the enzyme. The 'lid' moves away on contact with the 
interface thus allowing the substrate access to the active site. However, not all lipases 
have a lid present or show interfacial activation.23  
1.1.2 The use of lypolytic enzymes in organic synthesis 
Both lipases and esterases have been widely used in synthetic organic 
chemistry," 2, 27, 28 catalyzing the chemio-, regio- and/or stereoselective hydrolysis (a) of 
carboxylic acid esters in aqueous media or the reverse reaction i.e. esterification (b) or 
transesterification (c) in organic solvents - Scheme 3. 
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RCO2R' + H20 	 RCOH + R'OH 
RCO2H + R'OH 	 RCO2R' 
C) 	RCO2R' + R"OH 	 RCO2R" + R'OH 
Scheme 3: Reactions catalysed by lipases/esterases 
In any kinetic resolution the enzyme only utilises one enantiomer of the racemic 
starting material, limiting the maximum yield to 50%. In the majority of cases, this 
theoretical 50% is never achieved because the reactions are stopped at low conversion 
(20-30%) if optically pure product is required or 70-80% conversion if the substrate is 
required. The yield can be improved through a variety of techniques, which include: the 
desymmetrisation of meso or prochiral substrates2931 (Scheme 4) or dynamic kinetic 
resolution. Dynamic kinetic resolution comprises a kinetic resolution with in-situ 
substrate racemization32' 33 - Scheme 5. For dynamic kinetic resolution to be effective 
two criteria must be fulfilled; firstly the rate of racemisation k (rae) must be greater than 
(or at least equal to) the rate of the enzymatic reaction k(s) for the faster reaction, and the 
kinetic resolution must be selective i.e. k(s) >> k(R). A number of suitable racemisation 
catalysts have been reported, including organic bases ,34 transition metal catalysts 
containing rhodium35' 36 and palladium on charcoal .37 
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Scheme 5: Dynamic kinetic resolution 
In addition, lipases and esterases have also been pioneered 38  as reagents for 
selective removal of protecting groups from a range of polyfunctional compounds e.g. 
peptides and carbohydrates. This method of de-protection is particularly attractive 
with sensitive substrates, because enzymes generally operate under mild conditions. 
In all these transformations manipulation of the reaction medium - termed 
medium engineering, can dramatically alter the selectivity of the enzyme. Some factors 
which can be manipulated include pH, organic solvent, 39  water activity, addition of 
metal ions  ,40 surfactants, 41  enzyme memory42 and substrate concentration. These 
concepts have been reviewed recently. 4' ' However, as mentioned previously, 
sometimes an enzyme displaying the appropriate function cannot be found either 
because the function was never developed - due to evolutionary pressure or an 
appropriate enzyme has not been found despite a comprehensive screening procedure. In 
either case, a range of modification techniques, both chemical and genetic, can be 
applied to generate an appropriate biocatalyst. 
1.2 	Modification of lipolytic enzymes 
1.2.1 Chemical modification 
Chemical modification processes have been extremely successful at improving 
the activity and enantioselectivity of enzymes, particularly in the application of 
lipases/esterases in organic solvents. One of the main drawbacks involved in the use of 
7 
enzymes in organic solvents is that they exhibit lower catalytic activity, primarily due to 
denaturation. 
In 1984, KIibanov 44  encapsulated hog liver esterase and lipase from Candida 
cylindracea inside Sepharose or Chromosorb, respectively. The porous beads were 
suspended in organic solvents and the encapsulated enzymes exhibited high 
transesterification activity and stereoselectivity towards primary or secondary alcohols - 
Scheme 6. In these studies the organic solvent acted as both the reaction medium and 
the enzyme substrate. 
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Scheme 6: Application of enzymes in organic solvents 
Following on from these initial experiments, a range of novel methods of 
chemical modification have been developed and reported. These include the 
immobilization of enzymes onto solid supports e.g. Lipozyme® (Rhizomucor miehei 
lipase immobilised on an anionic exchange resin), Novozyme® (Candida antarctica 
lipase B immobilised on acrylic resin) and more recently the introduction of cross-linked 
enzyme crystals, CLECs.45 CLECs are prepared by cross-linking the enzyme with 
glyceraldehydes to provide biocatalysts with much increased stability and activity in 
organic media. Further developments include the pre-treatment of enzymes with organic 
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solvents '46  entrapment in sol-gel matrices 47  and various other membranes. These 
chemical modifications have been discussed in a recent informative review article.5  
If altering the mode of implementation of an enzyme is unsuccessful (in 
improving the enantioselectivity) then rational chemical modification of the primary 
structure of the biocatalyst may prove fruitful. The lipase from Pseudomonas cepacia 
has been successfully modified 48 by chemical modification. This example and other 
examples of rational design will be discussed further - Section 1.2.2. 
1.2.2 Rational design of enzymes 
To embark on rational design of an enzyme the relationship between protein 
sequence and function must be known. This relationship requires a detailed 
understanding of the three-dimensional structure and mode of action of the biocatalyst. 
For the vast majority of enzymes this information is unavailable and even if the target 
enzyme is well characterized, the molecular basis for the desired function may not be. 
Nevertheless, the introduction of computer modelling and the exponential growth of 
databases of protein structure and sequences have facilitated elegant advances in the 
rational design of enzymes 
Kazlauskas et al.48 used a combination of molecular modelling of transition state 
analogues and kinetic measurements to identify the molecular basis of the 
enantioselectivity of a lipase from Pseudomonas cepacia (PCL). The enantioselectivity 
of PCL towards the acetates of 2-methyl-3 -phenyl- 1 -prop anol 1 and 2-phenoxy-1-
propanol 2 was studied - Scheme 7. Although PCL favours the (S)-enantiomer of both 
substrates, the (S)-enantiomers have different shapes due to changes in substituent 
priority. 
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Scheme 7: Enantioselectivity of PCL towards primary alcohols 1 and 2 
The enantioselectivity towards 1-acetate was due to binding of the methyl group 
(at the stereocentre) for the fast-reacting enantiomer but not the slow-reacting 
enantiomer. In contrast, the enantioselectivity towards 2-acetate was due to an extra 
hydrogen bond between the phenoxy oxygen of the substrate with the phenolic OH of 
Tyr 29. Acetylation of Tyr 29 eliminated the hydrogen bonding toward 2-acetate and 
resulted in a decrease in E from 16 to 8. Nitration with tetranitromethane, which 
increases the hydrogen bond strength of Tyr 29, increased the E value from 16 to 36 for 
2-acetate. The same research group have applied similar molecular molecular modeling 
techniques to rationalise the selectivity of chromobacterium viscosum lipase 50 and 
chymotrypsin.5' 
Inversion of enantioselectivity of lipase PS from Pseudomonas cepacia, by site-
directed mutagenesis, was reported by Hirose and co-workers 17  in 1995. Comparison of 
the sequences of lipase AR (Pseudomonas sp.) and lipase PS indicated that they differed 
in only 16 amino acids but there enantioselectivity towards 1,4 dihydropyridines 3a was 
complimentary i.e. lipase PS gave (R)-3 while lipase AH gave (S)-3 in IPE/H20 - 
Scheme 8. Site-directed mutagenesis of lipase PS was performed, replacing Va1266, 
Leu287 and Phe22' for Leu, Be and Leu respectively. The modified lipase PS (mutant 
FVL) now gave (S)-3 (54%, >99.0% e.e. where R=CH2000C2H5) in IPE/HO, a 
complete reversal of enantioselectivity. 
10 
In addition, mutant FYL also showed reversal of enantioselectivity when the 
reaction solvent was changed from water-saturated WE (product (S)-3) to water 
saturated cyclohexane (product (R)-3). An identical solvent effect had previously been 
observed for lipase AR. 
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Scheme 8: Reversal of enantioselectivily by site-directed mutagenesis 
In a more recent study, Holmquist and Berglund 52  utilised rational recombination 
and site-directed mutagenesis to modify the lipase from (Jeotrichum candidum. 
Geotrichum candidum produces two lipase isozymes (GCL I and II) which display 
different abilities to discriminate between the two enantiomers of ethyl 2-
methyldecanote 4 - Scheme 9. By swapping homologous regions between the two 
isozymes, a hybrid enzyme (1348-11-406-1) with improved enatioselectivity over the two 
wild types was created. In addition, site-directed mutagenesis of two residues (I 
lle357AlaILeu358Phe) gave a mutant enzyme with similar activity to wild type I but an 
increased E value from 32 to 54. These mutations were found to be located at the 
entrance to a tunnel, at the bottom of which lies the enzyme's active site. The presence 
of a tunnel was also found to be important in determining the selectivity of Candida 
rugosa lipase.4' 53  
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Scheme 9: Rational recombination and site-directed mutagenesis of GCL land II 
Candida antarctica lipase B (CAL-B) displays poor enatioselectivity towards 1-
halo-2-octanols 5 and 6 which is in sharp contrast to its high enantioselectivity towards 
3-nonanol 7 - Scheme 10. 54 and refs therein To investigate this phenomenon, molecular 
modelling of Candida antarctica lipase B (CAL-B) was used to 'virtually' mutate the 
lipase. The poor selectivity towards S and 6 was attributed to unfavourable interactions 
between the fast reacting (S)-enantiomer and a region situated at the bottom of the active 
site (termed the stereos electivity pocket). These unfavourable interactions were 
'virtually' removed, the mutants modelled, and then selected variants were generated by 
site-directed mutagenesis. The mutation Ser47Ala effectively doubled the enantiomeric 
ratio (at 60% specific activity) observed for 5 and 6, while the mutation Trpl04His 
annihilated the enantio selectivity towards 5 and 6 - Table 1. These results were 
attributed to changes in electrostatic potential and an increased volume of the 
stereoselectivity pocket, respectively. 
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Scheme 10: Esterification of 1-halo-octanols using CAL-B 
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CAL-B E 
5 	 6 	 7 
Activity 
(tributyrin) [s-i] 
Wild type 6.5+/- 0.4 14 +/- 2 200 253+/- 12 
Ser47AJa 12.4 +/- 0.4 28 +/- 3 - 144 +/- 14 
Trpl04His 1.7 +1- 0.1 2.0 +1- 0.1 - 102 +/- 13 
Table 1: Enantiomeric ratios and activity for CALB mutants towards 5, 6 and 7 
Further CAL-B mutants were prepared by Patkar and co workers55. These studies 
focussed on modifications to the consensus sequence. Thr-X-Ser-X-Gly was modified to 
Gly-X-Ser-X-Gly the latter of which is the more usual sequence present in lip ases. A 
T103G mutant showed increased thermostability but only half the specific activity. The 
specificity and enautioselectivity towards the acylation of a range of secondary alcohols 
remained unchanged. A W104H mutant displayed dramatically changed properties: with 
altered substrate specificity but lower thermostabiity, specific activity and 
enantioselectivity. The properties of the W104H mutant highlight the difficulty in 
predicting which amino acids are important for which function. 
Again using CAL-B, the first example of an enantioselective hydrolase by 
engineered substrate-assisted catalysis (SAC) was reported .56 The premise of this 
research was that the hydroxyl group of the substrate, in this case 2 or 3-hydroxy esters, 
8 and 9, could substitute for an active site residue. The active site residue had previously 
been removed by site-directed mutagenesis - Figure 4. CAL-13 consists of the standard 
Ser-His-Asp catalytic triad and the transition state of the catalysed ester hydrolysis is an 
oxyanion. This oxyanion is stabilized by hydrogen bonding with two backbone amide 
linkages and the hydroxyl group of Thr 40. Two mutants Thr4OVal and Thr4OAla were 
created and both showed 3 orders of magnitude lower kcat/Km values for ethyl 
propanoate and ethyl butanoate with respect to the wild type, thus indicating the 
importance of Thr4O. The wild type lipase showed very low substrate specificity for 
either enantiomer of ethyl 2-hydroxypropanoate 8 compared to ethyl propanoate. In 
contrast, the mutants showed improved (S)-2-hydroxypropanoate/pmpanoate specificity 
indicating that the hydroxyl group with (S)-configuration is oriented to allow for 
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improved transition-state stabilisation. As expected, the mutants were unable to perform 
substrate-assisted catalysis with the (R)-enantiomer of 8. The wild type lipase showed 
very low enantioselectivity toward 8 (Es=1.6), whereas the Thr4OAla and Thr4OVal 
mutants gave much improved values of E5=9.8 and E=22, respectively. An increase in 
(S) specificity was also determined with ethyl 3-hydroxybutanoate 9 where the mutants 
displayed lowered ER values (from ER--31 in the wild type to ER-7.9 and ER=2.0  in 
Thr4OAla and Thr4OVal, respectively. The significance of this development is clear 
when we consider that a large range of enzymes including subtilisin, papain and some 
lipases contain side-chain contributions to oxy-anion stabilization and could potentially 
be mutated in a similar manner. 
HO L(\ 
/ T 
A 	Asp187 	 -HN., 
3rO 
' 	 hr4O 
: 224 	
/ - 0 
0 NH 
HN - Ser105 
O\ OH 
B 	Asp18(( 	-I-IN.. 
Thr4OVal 




Ser105 HN - 
(S)-8 
OH 0 
8 	 9 
Figure 4: A: wild type enzyme, B: Thr4OVal mutant displaying substrate assisted 
catalysis. 
Recent reviews of lipase protein engineering have been published containing 
details of some of the variations which have been addressed 57  and the production of 
commercially important microbial lipases 58 
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1.2.3 Combinatorial design of enzymes 
One distinct advantage of combinatorial (or directed) evolution of biocatalysts 
over rational design, is that the former requires no prior knowledge of the three 
dimensional structure of the catalyst. The former can be achieved either in an iterative 
fashion by the accumulation of point mutations (e.g. by low-rate error prone PCR) over 
a series of generations or by recombination of related genes (DNA shuffling 12, 1)• The 
key steps in a directed evolution process are shown - Figure 5. This technique has been 
applied to manipulate the properties of several different enzymes including the 
enantioselectivity and activity of lipases and esterases. 
1. Select gene 
Figure 5: Key steps in a typical directed enzyme evolution experiment 
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Research in the Arnold'° laboratories has successfully directed the evolution of 
Subtilisin E to enhance its activity in dimethylformamide. In 1996, Arnold and Moore9 
directed the evolution of a para-nitrobenzyl esterase (pNB) from Bacillus subtilis to 
enhance the enzymes activity towards the deprotection of the antibiotic Lorcabef nucleus 
p-nitrobenzyl ester 10 - Scheme 11. 10 is very insoluble in aqueous media, so the mutant 
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Scheme 11: Deprotection of Lorcabefnucleus-p-nitrobenzyl ester 
The p-NB esterase mutants were screened, in 96 well plates, against a p-
nitrophenyl ester of Lorcabef. The p-nitrophenyl ester is more conveniently screened (at 
405nm) than the target p-nitrobenzyl ester, although the former is chemically more 
active. This procedure does violate the first law of directed evolution, coined by Arnold 
herself, namely - 'You get what you screen for'; although the compromised accuracy is 
more than compensated for by the increased throughput of the screen. 
The overall result of four rounds of sequential mutagenesis and one 
recombination step was a 50-60 fold increase in activity - this increase also accounts for 
the increased expression level, which was also achieved. The best mutant esterase 
performed as well in 30% DMF/H20 as the wild type enzyme in H20. In addition, the 
effective amino acid substitutions do not directly interact with the substrate, further 
emphasising the difficulty in mimicking this success by 'rational design'. 
Further developments on p-NB esterase from B. subtilis were made by Giver et 
59 al. 	In this study a 14°C increase in the melting temperature (]Fm) was achieved after 
IN 
four cycles of random mutagenesis and one of DNA shuffling. Screening was carried out 
for thermostabiity and activity at 30°C. This screening technique allowed a variant 
which was both thermostable and, retained its catalytic activity at low temperatures to be 
identified. 
In the area of enantioselectivity, several excellent examples of evolved lipases 
have been, published. Reetz and co workers have published several reports 60-65 on the 
evolution of a lipase from Pseudomonas aerginosa (PAL). The wild type form of PAL 
displays poor enantioselectivity (E =1, (S)-12 with 2% e.e.) for the resolution of 2-
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Scheme 12: Resolution of 2-methyldecanoic acid p-nitrophenyl ester 
A simplified version of the overall directed evolutionary process60 is shown in 
Figure 6 and some of the improvements are discussed. Initially, four successive rounds 
of random mutagenesis by error-prone PCR gave a mutant lipase with an increased 
selectivity factor, E=1 1.3 (mutant A). 65 Further, more comprehensive directed evolution 
studies using site-specific saturation mutagenesis (applied at 'hot-spots') increased the E 
value to 20 (mutant B). A further round of error prone PCR gave a final mutant with an 
F value of 25 (mutant C).61 Mutant C had five mutations S149G, S 15SF, V46G, V55G 
and S146G compared to the wild type. In addition, elucidation of the 3D structure of 
wild type PAL indicated that mutant C had much increased flexibility, in distinct loops 
I VA 
of the enzyme, due to the introduction of four glycine residues .6' Subsequent rounds of 
error-prone PCR did not give any significant improvements. 
In further studies, the application of the recombinant methods, DNA shuffling 
and combinatorial multiple-cassette mutagenesis (CMCM),60 gave a fmal mutant 
enzyme with an F value >51 (mutant J). This mutant consisted of six amino acid 
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Figure 6: Summary of directed evolution of PAL by Reetz and co-workers 
In an extension of their work on PAL, Reetz et al.,M  inverted the direction of 
enantioselectivity from (5)-11 towards (R)-11 - Scheme 12. Using error prone PCR, at a 
high mutation rate, and DNA shuffling a mutant PAL with an enantioselectivity factor 
E=30 towards (R)-11 was created. The new mutant had 11 amino acid substitutions 
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suggesting that R-selectivity required greater structural change than S-selectivity. These 
mutations were also at different 'hot-spots' than had been identified for the S-selective 
variants. This extensive level of mutation would be difficult to predict by molecular 
modelling. 
Continuing on the same theme, Bornscheuer et al. 66 foccussed on improving the 
enantioselectivity of an esterase from Pseudomonas fluorescens (PFE) towards the 
resolution of the 3-hydmxy esters 13 and 14 - Scheme 13. 
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Scheme 13: Resolution of sterically hindered 3-hydroxy esters 13 and 14. 
Mutations of PEE were acheived using the mutator strain E. coli XL1 epicurian 
red and the enzyme libraries created were screened using pH indicators on minimal 
media agar plates. Hydrolysis of 13 releases the acid 15, which lowers the pH of the 
surrounding media, thus producing a red colour with the pH indicator. A second 
selection criterion was introduced using ester 14, which is hydrolysed to release glycerol 
16. The released glycerol facilitates growth on the minimal media. By combining both 
selection criteria, only larger colonies surrounded by red halos, were picked for further 
examination. Overall, one double mutant was identified which gave a 25% e.e. for the 
remaining ester 13 (E-5). 
In a second study, Henke and Bornscheuer67 mutated PEE, this time by error 
prone PCR or mutator E. coli., to increase the enantioselectivity from E =3.5 to 6.6. 
Again the useful mutations were found to be located on the surface of the enzyme, far 
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away from the active site. On this occasion, screening was performed using resomfrn 
esters of (R) and (S)-3-phenylbutyric acid 17 with detection by fluorescence - Scheme 
14. Tn common with reports by Reetz,6065 the (R) and (S) esters must be screened 
pairwise in separate wells because it was impossible to determine which enantiomer 
liberated the resonifin 18. The Eapp values were compared with the Etrtie value 
determined for the hydrolysis of (RIS)-3 -phenylbutyric acid methyl ester and found to 
differ only slighty (E +/-0.3). 
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Scheme 14: Screening of P. fluorescens esterase mutants using resorufin esters 
Other recent publications documenting the evolution of an enantioselective 
aldolase68, hydantoinase69 and a lipase 70 (with increased phospholipase activity) have 
been made. In addition, several informative reviews, which cover other properties of 
enzymes which can be manipulated, have also been published. 15' 39' 49' 57' 71' 72 
1.3 	Screening novel enzymes 
Screening novel enzymes can have two different meanings: 
1. Searching for new enzymes in commercially available enzyme libraries, collections of 
micro-organisms/culture sources or from clone banks.3 
20 
2. Testing a library of mutant enzyme variants generated from directed evolution/site-
directed mutagenesis. 
In both cases, the target is the same, namely to quickly and accurately discover a more 
suitable enzyme for the synthetic challenge. In addition, another decision must be made, 
to screen by detection or to select for the desired properties. Genetic selection is a 
powerful technique for isolating new mutants as only those that pass a specific test are 
considered. This approach includes the use of the substrate of interest as the sole carbon 
source, phage display and suicide inhibitors. These selection techniques have been 
recently reviewed 20, 73 and phage libraries using a mechanism-based inhibitor have been 
used for the in vitro selection of Lip olase®  variants .74 
When enantioselectivity is the property being measured, selection is not 
generally possible and individual bacteria or microorganisms must be separated and 
assayed. Usually a hierarchical (multi-tiered) screening approach  is applied but newer 
automated high-throughput and ultra-high throughput screens21 allow quantitative 
screening of every enzyme. Some of the techniques commonly applied are discussed in 
Section 1.3.1. 
1.3.1 Agar plate based screening 
This qualitative technique requires a good system for visualising positives. 
Several methods have been employed including: the use of substrates which upon 
hydrolysis release precipitable coloured product75, detection of the released acid by pH 
indicator colour changes66 and the use of tributyrin emulsions .75, 76 Some examples of 
useful substrates are given - Scheme 15. It must be noted that the p-nitro phenolate 
anion 20 is water soluble and less sensitive for on-plate assays than the fluorescent 








X,Y = H or Halogen 
0 0 	Hydrolase 	 0 	Methyl umbelliferone 0 	
HO\ 	








-o 	 absorb at 405nm 
20 
Scheme 15: Useful compounds for on-plate detection 
Other methods of on-plate assays involve detection of the hydrolysis products by 
the use of simple staining systems. Ninhydrin77 and 4-p-nitro beuzyl pyridine 78 have 
both been successfully used to detect the products generated by lactamases and epoxide 
hydrolases, respectively. 
Perhaps the most elegant examples of on-plate assay systems have been 
developed by Arnold and co-workers, .79, 80 By combining the oxygenase-catalysed 
hydroxylation of aromatic substrates, with the ability of horseradish peroxidase (HRP) to 
oxidatively couple phenols and catechols, an efficient in vivo or in vitro screen for 
P450cam and toluene-dioxygenase variants was developed. For rapid screening in vitro, 
the HRP may be added to the medium containing the dioxygenase-catalysed reaction 
and assayed using a 96-well plate reader. Alternatively, the HRP can be co-expressed 
with the oxygeuase to create an in vivo pathway for the formation of the 
coloured/fluorescent compounds. The libraries can then be screened on the agar plate 
using digital imaging or sorted using a microfabricated fluorescence activated cell sorter 
(FACS).81 Overviews of the in vitro and in vivo processes are shown in Scheme 16 and 
Scheme 17, respectively. 
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Scheme 17: In vivo P450cam screen suitable for on-plate assays 
In addition, the screen is sensitive to the regiospecificity of hydroxylation with 
different hydroxylated products generating different colours. This can be especially 
useful to quickly identify cells displaying altered product profiles e.g. wild type P450cam 
generates only blue fluorescence (naphthalene converted to 1- or 2-naphthol) but one 
mutant P450cam clone exhibited pink fluorescence (naphthalene converted to 1,3-
dihydroxynapthalene). 
1.3.2 	pH indicator methods 
The use of pH indicators or pH changes (pH-stat method) to monitor the progress 
of enzyme reactions is not new; researchers have been using this technique since the 
1940's. However, by careful choice of the reaction buffer, the colour change of the 
indicator can be directly proportional to the number of protons released. This technique 
was first employed by Kazlauskas et al. 82 for the quantitative measurement of the 
hydrolysis of solketal butyrate 21 - Scheme 18. 72 commercially available hydrolases 
23 
were screened using p-nitrophenol indicator, in conjunction with a UV spectrometer, and 
estimated enantioselectivity ratios calculated. Using this pH indicator technique horse 




buffer, pH 7.2 
+ iT 	+ H 
0 
21 	





Scheme 18: Hydrolysis of solketal butyrate and detection using p-nitrophenol indicator 
This pH-indicator method was improved by Kazlauskas et al. 5' by the 
introduction of a reference. Resorufin ester 22 was included as a competitive substrate. 
The improved version was implemented in the substrate mapping of 4 new hydmlases.83 
0 ~CCN' :]Cro 
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A similar, although non-quantitative approach was applied by Demiijian.84 This 
screen required careful matching of the indicator and the pH of the buffer. This method 
would be useful as the first level in a hierarchical screening process. Bomscheuer et 
24 
al. 85  employed bromothymol blue as the first level of a hydrolase screen, with any 
positive 'hits' later confirmed by quantitative GC analyses. 
1.3.3 	Chromogenic substrates 
The most convenient reactions to test by high-throughput methodologies are 
those involving chromogenic or fluorogenic (discussed in Section 1.3.4) substrates. 
There are countless reports on the application of chromogenic substrates to screening 
enzymatic reactions, in which the released alcohol or carboxylic acid is UV active. 
Many of these have been covered in an excellent review 75  by Beisson et. al.. 
One of the most widely used chromogenic substrates are esters of p-nitrophenol 
and 2,4-dinitrophenol. The former was used as the substrate in the directed evolution of 
a lipase (Section 1.2.3) and forms the basis of the Quick E method reported by 
Kazlauskas et. al.86 Quick E measures the rate of hydrolysis of an enantiomerically pure 
p-uitrophenol ester (S)-23, against the reference compound, resomfm tetradecanoate 24 - 
Scheme 19. The ratio of these rates gives the selectivity of the hydrolase towards (S)-23 
over 24. In tandem with this, the selectivity of the hydrolase for (R)-23 is also measured 
against 24. The ratio of the selectivities gives the enantiomeric ratio, E. 
Detect at 405nm 
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	:II + 2H 14 
24 
Detect at 572nm 
Scheme 19: Quick  method 
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Jnspite of these succesful reports, several arguments against the use of p-mtrophenol 
esters have been presented 75: 
They are not specific lipase substrates and can be hydrolysed by non-specific 
esterases, proteases and moreover, the non-catalytic C-terminal domain (336-
449) of porcine pancreatic lipase (PPL) can hydrolyse para-nitrophenol acetate 
at the same rate as purified PPL.87 
p-nitrophenol acyl esters are tertiary esters whereas most lipases act on primary 
ester bonds. 
The carbonyl function of these compounds is activated and therefore likely to 
undergo non-enzymatic hydrolysis in alkaline or acidic media. 
1.3.4 Fluorogenic substrates 
An attractive property of fluorogenic substrates is the high sensitivity with which the 
hydrolysis products can be detected. This makes them particularly attractive when 
either: substrate concentration is very dilute, a small amount of biocatalyst is available 
or low substrate turnover is to be measured. The majority of assays have employed 
simple esters of either umbelliferone88 25 or resomfin67 26 as the substrate. However, 
much like simple p-nitrophenol esters these esters are highly chemically activated and as 
such may lead to erroneous results. 
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Klein and Reymond have developed 89  fluorescent lipase/esterase substrates 27/28 
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Considering the example of ester (R)-27, the alcohol 29 (released by enzymatic 
hydrolysis of this acetate) is oxidized by horse —liver alcohol dehydrogenase (HLDH) to 
an unstable ketone 30. This ketone then undergoes 13-elimination, catalysed by bovine 
serum albumin (BSA), to release umbelliferone 25. The overall process (for (R)-27 only) 
is shown - Scheme 22. A similar mechanism occurs for 28. 
CH3 
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Scheme 22: Release of umbelliferone 25 from (R)-27 
By measuring the release of 25, from (S)-27 and (R)-27 separately, an estimated 
enantiomeric ratio E can be predicted. The authors predicted E values for 30 enzymes 
and found them to lie within +1- 20% of the true value. By modification of the 
fluomgenic substrates and the assay conditions, Reymond et. al. have developed similar 
substrates 31 and 32 for stereoselective aldolases 90 and other hydrolytic enzymes 









Continuing with fluorescent assays, Reymond and co-workers developed 92 an anti-
body sensor assay for monitoring catalysis in real time. This system is based on the cat-
ELISA technique developed by Green 93 and Hilvert,94 although these systems only 
furnished a single-point measurement of product formation. The principle of 
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Antibodies that can bind hapten 33 with high selectivity over the derivative 35 
(which is a substrate for the enzyme to be measured) were developed. A selective 
fluorescent sensor for hapten 33 was prepared by combining anti-33 antibodies with 34, 
an analogue of 33 containing the fluorescent tag acridone. The fluorescence of 34 is 
quenched while bound to the antibody, although fluorescence returns when 34 is 
released. Hog liver esterase hydrolysis of 35 released 33 (step i, Figure 7) which 
subsequently displaced 34 (step ii, Figure 7), and the fluorescence generated was 
measured (step ffl, Figure 7). The rates of product release were calculated and the 
apparent reaction rates were proportional to enzyme concentration at low catalyst 
concentrations. The system was also applied to the measurement of f3—galactosidase 
activity using modified substrates. 
Reymond and Klein 95  have developed another fluorescent sensor system, this 
time based on measuring the change in concentration of free metal ions using the orange 
fluorescent metal sensor 36. 36 responds to the prescence of Cu2 ions, forming the 
macrocyclic chelate 37 - Scheme 23. This is accompanied by an almost quantatative 
quenching of fluorescence. Any enzymatic reaction, which produces products that can 
act as a metal chelator, such as simple bi-dentate ligands e.g. amino acids, can compete 
with 36 for the free metal ions. This system has been used to monitor the release of free 
amino acids using acylases and aminopeptidases. 
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Scheme 23: Enzymatic assay using pM 
The use of fluorescence resonance energy transfer (FRET) substrates have been 
used to study a range of catalysts including ribozymes96, proteases using a combinatorial 
library97 and phospholipases98. FRET substrates have also been used in conjunction with 
fluorescence activated cell sorting to screen a library of mutant proteases.20 
1.3.5 Instrumental methods 
The demand for screening large compound collections against an ever-expanding 
number of therapeutic targets has stimulated technological development in the area of 
assay automation, miniaturization and detection methodologies. 21 Assay throughput was 
initially addressed by the use of 96-well plates and the development of automated 
sample preparation including robotic colony pickers and liquid-dispensing technologies. 
Throughput was further increased with the introduction of 384-well plates and the trend 
is continuing towards higher density, smaller volume plate formats. In addition, the 
development of microfabricated devices designed to perform continuous flow assays, 
offer the potential to achieve the following advances; order-of —magnitude reductions in 
reagent consumption, parallel sample processing for higher throughput, implementation 
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of unique assay read-outs and improved data quality.2' These techniques have allowed 
ultra-high throughput rates in excess of 100,000 samples per day and will soon become 
more widespread in the screening of mutant enzyme libraries. At present however, the 
screening of enzyme libraries, for more enantioselective mutants, generally relies on the 
modification of more-traditional techniques (ITIPLC, GC and MS) into higher throughput 
formats. 
1.3.5.1 	Chromatographic techniques 
Reetz et a199 have described a GC system capable of high-throughput screening 
of mutant lipases for improved enantioselectivity. This system uses two gas 
chromatographs (both fitted with chiral columns) controlled by one sample manager and 
PC - Figure 8. The GC system was capable of approximately 700 exact E and e.e. 
determinations per day and the analytical data can be manipulated using commercially 
available software. Manipulation of the injection timing can further increase throughput 
by interlocking the chromatograms and utilising all available instrument time but this 
technique requires a degree of trial and error. 
[ Sample manager capable of injecting onto both chromatogram 
PC 
Figure 8: Optimized twin GC unit for high throughput GC analyses. 
31 
Using this system (Figure 8), Reetz et a199 studied the lipase-catalysed 
stereoselective esterification of (+/) 2-phenyl-1-propanol 38 by a library of mutant 
Pseudomonas aeriginosa lipases (see Section 1.2.3) to give the corresponding esters 39 
- Scheme 24. 







Scheme 24: Acylation of2-phenyl-1-propanol catalysed by mutant P. aeriginosa lipases. 
Reetz 19  also suggested the use of chiral thin layer chromatography to measure 
enantioselectivity. Rapid screening using TLC, would require computer image 
processing of the chiral TLC plates to determine the relative sizes of the separated 
enantiomers of product and starting material. As yet, no reports of enzyme screening 
using TLC have been published. 
1.3.5.2 	Electrophoretic techniques 
The introduction of commercially available capillary array electrophoresis 
(CAB) instruments and capillary electrophoresis (CE) on microchips has allowed CE to 
be applied to high throughput screening. The introduction of chiral modifiers to the 
running buffer allows the determination of enantiomeric purity and makes either 
technique suitable for screening mutant enzymes. 
Reetz et. al.'°° utilized an automated 96 array CAB system, with laser-induced 
fluorescence (LIF) detection, to measure the enantiomeric ratio of known mixtures of 
chiral amines. A range of chiral amines (R)-40a-f and (5)-40a-f were investigated. In 
principle, these amines could be generated by enzymatic hydrolysis of the appropriate 
acetamide 41 - step i, Scheme 25. To facilitate fluorescent detection, the free amines 
were dervatised using fluorescene isothiocyanate 42 to give the fluorescence active 
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derivatives (R) and (S)- 43 (step ii, Scheme 25). The overall procedure is shown in 
Scheme 25, with only (R)- 43 shown for clarity. By careful optimisation of the running 
buffer, (R) and (S)-43 can be easily separated. A typical run-time of 19 mins (for 
(R)+(S)-43c) was achieved allowing more than 7000 e.e. determinations per day. In a 
similar area, recent reports101' 102  on the separation of enantiomers of amino acids by 
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Scheme 25: i Enzymatic resolution of 41; ii. pre-capillary derivatisation of (R)-40 
1.3.5.3 	Mass-Spectrometric assays. 
Reetz and co-workers, 103  have developed a high-throughput mass-spectrometric 
screening technique for enantioselective catalysis. The underlying principle is based on 
the use of isotopically labeled substrates in the form of pseudo-enatiomers or pseudo-
prochiral compounds. The relative amounts of reactants and/or products were detected 
by electrospray mass spectrometry (ESi-MS). This technique is applicable to several 
different asymmetric transformations - Figure 9. 
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Figure 9: Application of mass-spectrometry to measurement of enantioselective 
catalysis 
Figure 9 (i) represents a typical enzymatic kinetic resolution: compounds 44 and 
45, which differ in absolute configuration and in isotopic labelling of the functional 
group (FG*), are synthesized independently and mixed to give a racemic mixture. After 
resolution, true enantiomers 46 and 47 are formed as well as the nonlabeled and labelled 
achiral products 48 and 49. The ratio of the total intensities 44/45 and 48/49 allows 
determination of the enantio selectivity. 
Figure 9 (II) represents a typical kinetic resolution similar to (i) except in this case 
labelling occurs at residue R2. In this case, using the mlz intensities of the pseudo- 
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enantiomers 44/50 and 46/51 allows the conversion, enantioselectivity and the 
selectivity factor to be determined. 
Figure 9 (iii) and (iv) represent the resolution of pseudo -meso and pseudo-prochiral 
substrates, respectively. In both cases only a single labelled compound is required (e.g. 
52) since the stereodifferentiating reaction delivers a detectable mixture of two pseudo-
enatiomers 53 and 54. 
Reetz and co-workers 103  applied this system to study three different lipase-
catalysed reactions; hydrolytic kinetic resolution, stereoselective esterification and the 
enantioselective hydrolysis of a meso compounds. In all cases, the results achieved by 
ESi-MS were comparable with those determined by GC and throughput was 
approximately 1000 samples per day. 
Finn and co-workers 104  applied a different approach to the determination of e.e. 
values of alcohols. It is based on dervatization of the alcohol using chiral mass-tagged 
acylating reagents, and requires a measurable degree of kinetic resolution during the 
derivatization step. This idea was first proposed by Horeau and co-workers in several 
reports. 105-108  In general, the reactions of enantiomers with any pair of chiral reagents 
will proceed with non-equal rates (kf >k; f=fast and s=slow) - Scheme 26. Scheme 26 
displays the reaction of different enantiomers of an alcohol with two chiral mass tagged 
acids, A-CO2H and B-0O2H. In this report, Finn et al. 104  used the two mass-tagged 
proline derivatives 58 and 59. The relative amounts of the product esters, measured by 
mass spectrometry, can be used to determine the enantiomeric composition of the 
starting substrate according to Equation 1 and two separate calibration measurements. 
Calibrations measurements must be performed on a racemic sample and a sample of 
known enantiomeric excess. Calibration measurements allow q, a correction factor for 
differences in ionization efficiencies between compounds differing by a methyl group, 
and s, the ratio of the rate constants, to be calculated. The enantiomeric excess can then 
be calculated using Equations 1 and 2 
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Scheme 26: Mass spectrometric measurement of e.e. using kinetic resolution 
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Finn et. al. 104  applied this technique to measure the e.e. values of nine secondary 
alcohols and five primary and secondary amines. All the measured e.e. values fell within 
+1- 10% of the true value and this method should be amenable to automation and high 
throughput analysis. 
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A recent informative review109 of the applications of mass spectrometry for the 
screening of new biocatalysts, highlighted advances in instrumentation, analysis 
strategies and high throughput detection. Three 'real-life' examples were also given. 
1.3.5.4 Thermographic assays. 
Time-resolved JR thermography was applied by Reetz et al."° to measure the 
progress of the Candida antarctica lipase (NOVO SP 435) catalysed acylation of 1-









60 	 (R)-61 	(S)-61 
Scheme 27: Enantioselective acylation of] -phenylethanol 
Separate reactions of (R)-60, (S)-60 and (R/S)-60 with vinyl acetate and enzyme 
were measured in individual wells of a 96-well plate. The results clearly indicated that 
(R)-60 reacted preferentially with respect to (S)-60, with those wells containing (R)-60 
showing a significantly larger rise in temperature compared with those containing only 
(S)-60 or (R/S)-60. This method has yet to be applied in a quantitative fashion, or to 
reactions in which the enantioselectivity is so marked. 
In a similar area, Connolly and Sutherland"' demonstrated the use of an 
automated multiplex array of thermistors to measure the temperature change associated 
with biochemical reactions. In general, thermistors are more sensitive than IR-
thermography and can measure reactions in which only a small amount of substrate has 
been converted to product. This technique was applied to the exothermic 13-lactamase 
catalysed hydrolysis of penicillin G 62 to penidillinoate 63 - Scheme 28. 
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Scheme 28: /3-lactamase hydrolysis ofpenicillin G 62. 
1.3.5.5 	Other instrumental techniques 
High throughput HPLC with circular dichroism (CD) detection has been 
applied' 2 to determine the enantiomeric purity of 1 -phenylethanol 64 formed in the 
reductase catalyzed reduction of acetophenone 65 - Scheme 29. (Note 64 could also be 
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Scheme 29: Enantioselective reduction of acetophenone. 
Studies using enantiomerically pure 64 determined a linear relationship between 
g and the e.e. value. The rate of sample throughput is dependent on the speed of the 
separation of the starting material from the product. In the example given - Scheme 29, 
baseline separation was achieved, of 65 from (R)I(5)-64, in less than 1.5 mins allowing 
700-900 e.e. determinations per day. CD based assays can also be performed' 12 using no 
chromatographic step, although this relies on the transformation of a prochiral substrate 
into a UV-active product. 
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Radioactivity assays"3 and '9F NMR"3 have also been indicated as potential 
instruments for the rapid determination of enantioselectivity although no high-
throughput techniques have yet been developed. 
Shair and 	 have utilised DNA microarray technology to develop a 
high-throughput fluorescence assay for the determination of the enantiopurity of amino 
acids - Figure 10. This technique consists of five synthetic steps beginning with the 
formation of N-Boc derivatives of the amino acid 67 to be measured. These are then 
coupled to amino-functionalised glass slides, followed by capping any unreacted amino 
groups with acetic anhydride. Complete acidic de-protection reveals the free amino 
group of the amino acid which are then reacted with two pseudo-.enantiomeric 
fluorescent probes, 68 and 69. The fluorescence spectra of the surface bound 
fluorophores provide the ratio of 68 to 69 and the original optical purity of the amino 
acid. Using this technique, mixtures of 5 chiral amino acids were measured in steps of 
10% e.e. and the values measured were within (+1-) 10% of the actual value. In a high-
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Figure 10: Microarray determination of enantiomeric purity. 
1.3.6 Biological techniques 
As mentioned previously (Section 1.3.4), antibodies can be used to monitor 
enzyme reactions. The development of the competitive cat-ELISA assay by Mioskowki 
and co-workers115'116 allowed the testing of the activity and selectivity of a biocatalyst 
towards substrate. In a similar development by the same group,117 enzyme 
immunoassays were applied to measure the e.e. of the product of an enantioselective 
reaction. The enantioselective Ru-catalysed hydrogenation of benzyl formic acid 70 
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gives a mixture of R and S mandelic acid 71 - Scheme 30. By generating two 
antibodies, one which binds the racemate, and the other, which binds only one 
enantiomer of 71, the yield and e.e. value can be determined. This technique can be 
automated to facilitate 1000 e.e. determinations a day and easily applied to enzymatic 
reactions. 
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Scheme 30: Enzyme immnoassay screening of enantioselective reactions 
The QUEST118 system (Querying for EnzymeS using the Three-hybrid system) 
detects catalysis by coupling substrate turnover to a transcriptional event. This method 
involves the use of bacterial cells capable of expressing a synthetic transcriptional 
activator, which can bind the substrate of an enzymatic reaction and a chemical inducer 
of dimenzation (CID) 72. Dimerization by the CD allows the cells to metabolize 
arabinose and subsequently acidify the growth media. A pH indicator detects this drop in 
pH. The addition of substrate competes with the CD for binding to the activator and 
prevents metabolism of the arabinose. However, if an enzyme, capable of converting the 
substrate to product, is present then the in vivo equilibrium favours CD re-binding of 
the activator and resumption of arabinose metabolism. The process and structure of the 
CD used are displayed - Figure 11. This technique was used to detect the fungal 
enzyme scytalone dehydratase in bacteria and was applied to a library of 192 mutant 
colonies. 
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Figure 11: Schematic of QUEST system and CID-72. 
Bornscheuer and co-workers"9 have used a cascade of enzymatic reactions to 
monitor the release of acetic acid, formed in the lipase/esterase catalysed hydrolysis of a 
methyl ester 73 - Scheme 31. Initial rates of acetic acid formation can be measured by 
initial rate of formation of NADH (at 340nm). By measuring the initial rate of NADH 
formation from (R)-73 and (S)-73 separately, Eapp can be calculated. The enzyme 
cascade is supplied from a test kit and about 13 000 mutants can be screened per day. 
This system was used to screen a variety of lipases/esterases but it use is applicable in 
any enzymatic reaction which liberates acetic acid. Several other biologically based 
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Scheme 31: Enzyme-cascade detection of hydrolytic enzymes 
1.3.7 Summary 
As can be seen from the previous examples a myriad of solutions can be applied 
to the screening of biocatalyst libraries. However, the development of further techniques 
and instrumentation is required because no one technique is likely to be truly universal. 
One technique which we propose to employ for biocatalyst library screening is Surface 
Enhanced Resonance Raman Scattering (SERRS). 
1.4 	Surface Enhanced Resonance Raman Scattering 
It is well established 120, 121 that surface enhanced resonance rainan scattering 
(SERRS) is one of the most sensitive and selective techniques for the detection of a wide 
range of chromophoric analytes. SERRS can provide 120-122  molecularly distinct spectra 
of each analyte with minimal to no separation. As the name suggests SERRS is a 
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combination of two spectroscopic techniques; namely surface enhanced Raman and 
resonance Raman scattering. In the broadest sense it involves excitation of a surface 
adsorbed analyte, using a laser excitation frequency tuned to the absorption maximum of 
the analyte, and detection of the resultant Raman scattering. 
1.4.1 Raman Scattering 
When a photon of light interacts with a molecule it can undergo one of 3 
processes almost simultaneously: absorption, absorption followed by emission or 
scattering. An interaction between the photon and the molecule that results in scattering 
of the light can occur in two ways: elastic or inelastic. The majority of the photons are 
scattered elastically and thus emerge at the same frequency as the excitation radiation in 
a process termed Rayleigh scattering. A small number of photons, about 1 in every 
million, are inelastically scattered and emerge with a different frequency to the incident 
photon. This process is known as Raman scattering and it is this radiation which is 
measured in Raman spectroscopy. 
Raman scattering can be described as the re-radiation of scattered light, by 
dipoles induced in the molecule by the excitation light, which is modulated by the 
vibrations in the molecule. Therefore, a major advantage of Raman spectroscopy is its 
ability to provide structural information on a molecule because the frequency of the 
Raman scattered photons is dictated by transitions between the rotational and/or 
vibrational energy levels within the molecule. However, the small proportion of photons 
emitted as Raman scattering means that a large number of analyte molecules are 
required rendering the technique unsuitable for trace analysis. This inherent lack of 
sensitivity has been improved significantly in recent years by the introduction of high 
intensity monochromatic laser sources capable of producing stronger scattering signals. 
Raman scattering can be split into Stokes and anti-Stokes scattering. In Stokes 
scattering, the molecule in the lowest vibrational energy state of the ground electronic 
state is excited into a short lived virtual state whose energy is equal to the energy of the 
incident photons (huo). Relaxation occurs to an excited vibrational energy level in the 
ground electronic state and this is accompanied by an emission of light with decreased 
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frequency (UOUm). With anti-Stokes scattering, excitation occurs from a molecule that is 
in an excited vibrational level of the ground state to a virtual state. This is followed by 
relaxation to a low level, resulting in an emission of light with the increased frequency 
(Uü+Um). Both of these processes are displayed - Figure 12. The majority of Raman 
scattering is Stokes rather than anti-Stokes, resulting in the former producing more 
intense lines, which are more suitable for analytical purposes. 
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Figure 12: Transitions involved in Rayleigh and Raman scattering. 
1.4.2 Resonance Raman Scattering 
As previously mentioned, Raman spectroscopy can suffer from a lack of 
sensitivity. The inherent poor sensitivity can be addressed by using a laser excitation line 
which lies close to the absorption maximum of the analyte molecule. 120-122  The 
interaction of the incident photon with the analyte molecule promotes the molecule into 
an excited electronic state rather than a 'virtual state', as occurs in Raman scattering, 
before it returns to the ground state with the emission of the scattered photons. This 
results in an enhancement of approximately 103  to  104  over Raman scattering. 
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1.4.4 Surface Enhanced Raman Scattering 
Surface enhanced Raman scattering (SERS) requires that the analyte is in close 
proximity to the suitably roughened surface of certain metals,of which gold and silver 
are the most widely used. In general, these roughened surfaces are generated on an 
electrode or by aggregating a colloidal suspension. 120  SERS is thought to be due to either 
or both of two general mechanisms: electromagnetic and/or charge-transfer (sometimes 
termed chemical) enhancement. Electromagnetic enhancement occurs when a surface 
plasmon is excited by the incident light, this in turn enhances the electromagnetic field 
of the incident light at the surface and any analyte adsorbed onto the surface experiences 
an enhancement of the its Raman scattering. Chemical enhancement has its basis in the 
generation of new electronic transitions from the metal surface to the adsorbate and vice 
versa, which allows charge —transfer excitations to and from the absofoate. The main 
analytical consequence of these processes is an enhancement of scattering of up to 106  in 
comparison to conventional Raman scattering. However, the magnitude of enhancement 
is dependent on the physical nature of the enhancing surface and on the orientation of 
the analyte at the surface. 
1.4.5 Surface Enhanced Resonance Raman Scattering 
SERRS combines molecular resonance with surface enhancement and the result 
is a technique which can provide sensitivity at the femto or even attomolar level.120122 
This increase in sensitivity is due to enhancement factors of up to 1010  over conventional 
Raman scattering. When the frequency of the excitation laser is tuned to the molecular 
resonance of the analyte, the spectrum obtained is related to that of molecular resonance. 
This gives a molecularly specific signal from the analyte on the metal surface and allows 
positive identification and selective detection of analytes in the presence of nonresonant 
interferences. In addition, it should be possible to quantify the amount of one resonant 
analyte in the presence of another resonant species by deconvolution of the SERRS 
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spectra. In many cases, the interaction of the incident light with the chromophore 
reduces the dependence of the scattering on the orientation of the molecule to the 
surface123. In addition, energy transfer can occur from excited states of the molecule to 
the surface causing fluorescence quenching and enabling the use of a wide range of 
chromophores.'24 A graphical representation of SERRS is displayed - Figure 13. 
hu±v 
Citrate Surface Layer 
F luoreseen 
Silver Colloid 
Figure 13: Schematic of SERRS 
1.4.6 Quantitative analysis using SERRS 
Quantitative analysis by SERRS has been reported 120  recently. However, it 
suffers from a lack of reliability and reproducibility due to the non-reproducible binding 
of the analyte to the colloidal surface. The non —uniform binding produces changes in 
the analytes spectrum. These changes are mainly caused by orientational changes and 
desorption of the analyte from the colloidal surface125. The use of monoazo-
benzotriazole dyes have been shown'20 '21 to circumvent these problems, due to the 
ability of benzotriazole to covalently attach to a metal surface. Benzotriazole compounds 
have been employed in a myriad of processes including corrosion inhibitors '26; image 
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intensifies in photography, dyestuffs127, chiral derivatisation agents128 and as a 
synthetically useful moiety in organic chemistry129. 
Graham et al. reported 121  the synthesis of 4 monoazo-beuzotriazole dyes 74-77 
and the measurement of their SERRS spectra at concentrations ranging from 5x10M to 
1 x 10 5M. 76 was studied in more detail at concentrations between 5 x 10 9M and 1 x 
10 6M and the signal was found to be proportional to concentration allowing quantitative 
analysis by SERRS. 
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More extensive studies in the same laboratories 120, 125 reported the importance of 
colloid preparation, aggregation processes, linearity of response and the chemistry at the 
silver surface. Pre-aggregation of the colloid with poly (L-lysine) or spermine was found 
to give less SERRS enhancement than nitric acid or sodium chloride but the former 
aggregating agents were found to provide greater signal stability and therefore improve 
precision. At concentrations between 10 8M and 1042M a proportional increase in 
intensity occurs with an increase in monoazo-benzotriazole dye concentration. At 
concentrations above 10 8M no further increase in intensity was observed and this was 
attributed to complete monolayer coverage of the surface. Once monolayer coverage is 
achieved, further dye molecules do not contribute significantly to the SERRS signal 
obtained. The SERRS signals of monoazo-beuzotriazole dyes 74-77 were compared 120  to 














In contrast, to the monazo-benzotriazole dyes, the reactive dyes did not display 
linearity of response over any concentration range and the spectrum obtained was 
different above and below 10 8M. This indicated that the interactions of the two families 
of dyes with the silver surface were different. The mono azo-benzotriazole dyes are 
thought to displace the citrate layer, around the colloidal silver particles and bind 
strongly to the silver surface through the triazole ring - Figure 13. In contrast, the 
reactive dyes are expected to form polar interactions with the citrate layer. These polar 
interactions are thought to be much more susceptible to small changes in the chemical 
environment and thus give non-reproducible analyses. 
Figure 14: Displacement of citrate layer and interaction of benzotriazole with silver 
surface 
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1.4.7 Applications of SERRS 
SERRS has been applied to a wide range of processes including the detection of 
labeled DNA (at 8 x 103M),130' 131  studies on mutant flavocytochrome b2 (L-
lactate:cytochrome c oxidoreductase from Sacchromyces cerevisiae)132 and as an 
identification tool in column liquid chromatography133. In 2001, the first practical use of 
monoazo-benzotriazole as SERRS analytes was reported. Graham et. al. 130  applied a 
specifically designed benzotriazole dye 79 to the detection of poly-nucelic acid (PNA) 
and DNA. A 26-mer DNA oligomer and 8-mer PNA oligomer were labeled with 79 and 
the SERRS spectra obtained for both. 
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1.5 	Aims of Project 
With recent developments allowing a greater understanding of the experimental 
conditions that facilitate accurate and reproducible SERRS analysis it was envisaged that 
SERRS could be applied to the study of enzymatic reactions. 
The SERRS activity of the benzotriazole dyes is dependant on interaction of the 
triazole ring with the silver surface 121 - Figure 14. In contrast, 1-substituted 
benzotriazole derivatives are postulated to be virtually SERRS inactive. Therefore by 
'blocking' the triazole nitrogen of the monoazo-benzotriazole dye with an enzyme 
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cleavable moiety we can temporarily 'deactivate' the dye. Subsequent treatment of the 
'blocked' dye with an enzyme would re-activate the dye and allow it to be detected by 
SERRS. This is represented in Figure 15. 
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Figure 15: Enzymatic conversion of 'blocked' SERRS dye to active SERRS dye 
It is envisaged that this can be extended to screening enzymatic resolutions by 
generating pseudo-enantiomers of the general form shown - Figure 16 and treatment of 
these with enzymes. The initial rate of hydrolysis of the 2 pseudo-enantiomers can then 
be used to determine the enantioselectivity of the enzymatic reaction. Separation of the 
derivatised dyes is not required because SERRS can provide molecularly distinct 
spectra, theiby allowing the quantification of dye 1 in the presence of dye 2. 
Mixture of both compounds in one-pot' 
Detect 
Hydrolytic enzyme 
SERRS dye 1 
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S enantiomer 	FSERRdye 2 S) 
NO SERRS ACTIVITY 
Hydrolytic enzyme 	
s enantioliserf<SERRS dye ) 
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Further to this, is the application of SERRS to the screening of vast libraries of 
mutant enzymes generated by directed evolution. SERRS has already demonstrated its 
potential as an ultra-sensitive technique and developments are continuing in the design 
of high throughput measurements in 96-well plate format. 
Therefore, the initial aims of this project are to synthesize compounds containing 
benzotriazole which are substrates for hydrolytic enzymes (i.e lipases/esterases but the 
system should also be applicable to proteases) e.g. 80. Following enzymatic hydrolysis 
in aqueous media, the reaction product fragments to release benzotriazole 81 which can 
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Where X= N or 0 
Scheme 32: Fragmentation of enzymatic reaction products to release benzotriazole 
The chemistry developed for benzotriazole will then be applied to generate the pseudo-
enantiomeric 'blocked' SERRS dyes. These 'blocked' SERRS dyes will then be 
analysed using SERRS, by our collaborators at the University of Strathclyde to 
determine if they are suitable substrates for enzymes and can be applied to determine the 
enantioselectivity of enzyme-catalysed reactions. 
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Chapter 2 - Results and Discussion I 
2.1 	Preliminary studies on benzotriazole 
2.1.1 Reported syntheses of 1-(benzotriazol-1-yl)alkyl esters 
In 	1957, Gaylord and Naughton 134  reported the synthesis of 1- 
benzoyloxymethyl-1H-benzotriazole 82 by direct treatment of 1-hydroxymethyl-1H-
benzotriazole 83 with beiizoyl chloride or benzoic anhydride in yields of only 27% and 








Scheme 33: Reagents and conditions i. PhCOC1 or (PhCO)20, base 
A similar approach was taken by Ono and Itoh135 who prepared the levulinate 
and acetate esters 84 and 85 respectively, by the reaction of the appropriate anhydride 
















Scheme 34 Reaction conditions i. Pyridine (4 equivs.), DMAP (cat.), THF (aim.) 
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Further investigations into the preparation of 1-(benzotriazol-lyl)alkyl esters 87 
led to the publication of two reports 136,137  by Katritzky et al.. The first, in 1991,136 
reported the synthesis of 1-(benzotriazol-lyl)alkyl esters, in yields of 71-90%, by the 
displacement of chlorine from 1-(1-chlomalkyl) benzotriazoles 88 with sodium 
carboxylates as shown - Scheme 35. 
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Scheme 35: Reagents and conditions: i. SOC12, CHC13, reflux, ii. DMSO, 50°C 
In 	the later report, published in 1999, Katritzky et al. 137 synthesized 
benzotriazole esters by the reaction of N-acyl benzotriazoles 89 with either aliphatic or 
aromatic aldehydes in acetonitrile - Scheme 36. The reaction proceeded smoothly at 
room temperature with aliphatic aldehydes and electron deficient aromatic aldehydes but 
electron rich aromatic aldehydes required elevated temperatures. In general, the yields 
approached quantitative over two steps for the best case e.g. R' = C6H5 and R" = C2H5. 
Most esters were obtained as the 1' isomer 90 however, some products contained small 
quantities (8-18%) of the 2'isomer 91. The 2' isomer 91 seemed to be more readily 
formed when aliphatic aldehydes were employed, although this was greatly dependent 
on the reaction conditions used. The ratio of 90:91 ranged from 4:1 with acetonitrile to 
10:1 with hexane. The implications of this will be discussed in more detail in Section 
3.3. 
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Scheme 36 Reagents and conditions i. Et3N, DCM, ii. CH3CN, base 
2.1.2 Synthesis of 1-(benzotriazol-1-yl)alkyl esters from achiral N acyl 
benzotriazoles. 
The synthetic route outlined - Scheme 36 allows the generation of a range of 1-
(benzotriazol-1-yl) alkyl esters 90 from readily synthesized N-acyl benzotriazole 89 
simply by manipulating the aldehyde used. This synthetic route will form the basis of 
our initial investigations into these compounds. A range of these esters will be prepared 
and subjected to enzymatic hydrolysis to investigate if they are substrates for 
lipases/esterases and that they fragment, according to Scheme 32, to release 
benzotriazole into solution. 
N-acyl benzotriazoles 92 and 93 were generated from the reaction of 
benzotriazole with the commercially available acid chlorides in anhydrous DCM with 
triethylamine - Scheme 37. The N-acyl benzotriazoles were obtained exclusively as the 
1' isomer 137  in good to excellent yield. Butryl chloride was chosen because this will 
generate butyryl esters of benzotriazole and in general, butyrate esters are known 
substrates of lipases/esterases.23 The N-acyl benzotriazoles were found to be relatively 
unstable at room temperature decomposing over a few weeks but could be stored for 
several months below 0°C. 
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Scheme 37: Reagents and conditions i. butryl chloride, DCM, Et3N ii. phenylacetyl 
chloride, DCM, Et3N. 
N-acyl benzotriazole 92 was readily converted to the 1' esters 94a-e and 2' esters 
95a-e by reacting with the appropriate aldehyde in CH3CN with a catalytic amount of 
K2CO3 (15mol%) - Scheme 38. 93 was converted to the 1' ester 96 by reaction with 
propionaldehyde - the 2' ester was not isolated from the reaction mixture. The yields 
obtained are displayed - Table 2. 
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93 	 96 
Scheme 38: Reagents and conditions i. RCHO, K2CO3, CH3CN, RT, ii.CH3CHO, 
K2CO3, CH3CN 
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Compound R' Yield Compound Yield Ratio 94:95 
94a H 68% 95a 3% 20.6:1 
94b CH3  75% 95b 16% 4.7:1 
94c CH2CH3  68% 95c 15% 4.6:1 
94d CH(CH3)2 72% 95d 16% 4.7:1 
94e p-NO2C6H4 62% 95e * - 
96 CH3  75% 
Table 2 Yields and ratios of 94.95 * denotes: not isolated in pure form due to 
contamination with p-mtro benzaldehyde 
The combined yields (94+95) obtained were slightly lower than those 
reported, 137  ranging from 82 to 88% compared to the quantitative conversions obtained 
by Katritzky and co-workers. The yield was lower despite the use of a much longer 
reaction time of 16 hours (the reactions were not complete in the 1-4 hours suggested by 
Katritzky). The slightly lower yield for 94a may be due to the presence of H20 and 
methanol, in the formaldehyde solution, which could breakdown the N-acyl 
benzotriazole. In addition, the ratio of 94a/95a was markedly in favour of the 1' ester 
(-20:1) however, this was not as pronounced for 94b-d/95b-d. The ratio of 1' (94b-d) to 
2' (95b-d) were similar for these three esters and similar to that observed by Katritzky '37 
(-4:1) under the same conditions. 
Katritzky et. al. 138  investigated, by NMR, the effect increasing the steric bulk of 
the aldehyde had on the solution equilibrium of the beuzotriazole adducts 97 and 98 - 
Scheme 39. It was reported that the ratio of 97 to 98 was approximately 40:1 where R = 
H but remained constant, at - 10 to 13:1, across the series R = CH3 I (CH3)2CH / 
(CH)3C. However, the proportion of adduct formed decreases in the order: CH3CHO> 
(CH3)2CHCHO> (CH3)3CCHO. These equilibrium studies support our observations for 
the ratio of 94a/95a compared to 94b-d,15b-d. 
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Scheme 39: Conditions i. deuterated solvent 
2.1.3 Enzymatic hydrolysis of 1-(benzotriazol-1-yl)aikyl esters 
With the benzotriazole esters in hand, their suitability as substrates for lipases 
and esterases had to be established. Small scale hydrolysis reactions (0.003mmol of each 
substrate) were performed using 9 lipases from Fluka Lipase Basic Kit and 10 esterases 
from Fluka Esterase Basic Kit - Table 3 and Table 4. The substrates were incubated 
with the enzyme at room temperature in pH7 buffer for three hours and the amount of 
benzotriazole released determined by HPLC. All experimental details are given in 
Chapter 5. 
Lipase Conversion 
94a 94b 94c 94d 95d 94e 96 
Pseudomonas cepacia (PCL) ++ ++ ++ + ++ - - 
Porcine Pancreatic (PPL) +++ +++ +++ +++ ++++ + ++ 
Aspergillius niger ++ ++ ++ + ++ - - 
Mucor miehei ++ ++ + + ++ - - 
Pseudomonasfluorescens (PFL) ++ ++ ++ + ++ - - 
Rhizopus niveus + + + + + - - 
Rhizopus arrhizus + + + + ++ - - 
Candida antarctica (CAL) 100 100 100 100 100 ++ +++ 
Candida cylindracea (CCL) ++++ ++++ 100 ++++ 100 ++ ++ 
Control - - - - - - - 
Table 3: + (0-25%), ++ (26-50%), +++ (51-75%), ++++ (76-99%). 
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Esterase Conversion 
94a 94b 94c 94d 95d 94e 
Candida lipolytica ++ ++ + + + + 
Horse Liver ++ ++ + ++ ++ + 
Hog Liver 100 100 100 ++++ ++++ ++++ 
Control - - - - - 
Table 4: + (0-25%), ++ (26-50%), +++ (51-75%), ++++ (76-99%). 
The qualitative results displayed in Table 3 indicate that all of the benzotriazole 
esters were hydrolysed, at least to some extent, by at least one lipase from the kit. 
Encouragingly, both the 1' isomer 94d and 2'isomer 95d were hydrolysed by all nine 
lip ases. 
With 94e, where R = p-NO2C6H4 only CAL, CCL and PPL display activity and 
much less hydrolysis was detected compared to the esters generated from aliphatic 
aldehydes. In addition, to benzotriazole, p-nitrobenzaldehyde was detected by HPLC for 
these substrates indicating that the hemiaminal product 99 fragmented further - Scheme 
40. With ester 96 only CAL, CCL and PPL displayed activity towards this ester 
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Scheme 40: Fragmentation of 99 to p-nitrobenzaldehyde and benzotrizole 
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The results displayed in Table 4 indicate that of the 10 esterases tested only 
Candida lipolytica, horse liver and hog liver esterase exhibit activity towards the 
benzotriazole esters. Again, both the 1' isomer 94d and the 2' isomer 95d were 
hydrolysed to the same degree. Ester 96 was not subjected to hydrolysis by the esterases. 
Overall, the benzotriazole esters (94a-e, 95d and 96) seem to be substrates for lipases 
and esterases. At this point, it was decided to concentrate on esters generated from 
formaldehyde i.e. 94a since these esters are generated from primary alcohols and as such 
are achiral. Esters of this type allow introduction of a chiral centre in the acyl portion 
(either (x, 13  or more remote from the carbonyl) by simply starting from chiral N-acyl 
benzotriazoles - Scheme 41. 
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Scheme 41: Reagents and conditions: i. CH20, base 
This would be crucial when we attempt to synthesize the blocked SERRS dyes 
since we require substrates with only one chiral centre. Esters 94b-e and 96 contain a 
racemic secondary alcohol that cannot be synthesized in enantiomeric ally pure form 
using this reaction. However, these esters are good model compounds to study the action 
of lipases on substrates bound to combinatorial chemistry resins - this is discussed in 
Section 2.1.11. 
At this point it was still unclear, whether the 1-hydroxymethylbeuzotriazole 100 
generated from the hydrolysis of the ester 94a fragmented further to release 
benzotriazole - Scheme 42. Previously, Ono and Itoh135 had utilised the aqueous 
instability of 1-hydroxymethylbenzotriazoles to generate the free benzotriazole and 
Katritzky et al. 13' had reported the solution instability of other hemiaminals generated 
from aliphatic aldehydes. In order to investigate this, 1-hydmxymethylbenzotriazole 
100, was synthesized from formaldehyde and benzotriazole according to the method 
reported by Hall et. al. '39 - Scheme 43. 
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Scheme 42: Aqueous fragmentation of] -hydroxymethylbenzotriazole. 






Scheme 43: Reaction conditions: i. acetic acidI1120. 
1-Hydroxymethylbenzotriazole 100 was obtained as a white precipitate in 
excellent yield (93%). 'H NMR and '3C NMR indicated that the 1-
hydroxymethylbenzotriazole was formed exclusively as the 1' isomer. Using the reverse 
phase HPLC method used to study the enzymatic cleavage reactions, 100 was found to 
co-elute with benzotriazole. Further method development generated an isocratic method 
that resolved benzotriazole from 100. HPLC analysis of an acetonitrile solution of 100 
gave two peaks - one at the retention time of benzotriazole (<5 area%, 3.3 mins) and the 
other at 3.1 mins which was assigned as the 1 -hydroxymethylbenzotriazole 100 - Figure 
17. Spiking of this solution with benzotriazole increased the size of the peak at 3. 3mins. 
Analysis of an aqueous buffered solution (pH7) of 100 gave essentially one peak at the 
retention time of benzotriazole (-l% of 100 was detected) - Figure 18. This confirmed 
that 100 was unstable in buffer solution although a small amount of on-column 








Figure 18: HPLC analysis of 100 in aqueous buffer 
2.1.4 Preparation of 1-(benzotriazol-1-yl)alkyl esters from chiral acyl-
benzotriazoles 
For SERRS analysis to be successful, it was necessary to generate 
enantiomerically pure pseudo-enantiomers of the blocked SERRS dyes. Following the 
successful synthesis of ester 94a, it was decided to investigate benzotriazole esters 
containing chiral acyl moieties. Three different acids were chosen: 3-phenylbutyric acid 
101, 2-methylbutyric acid 102 and Z-protected phenylalauine 103. These acids would 
62 
allow investigation of the ease with which benzotriazole esters with both cx and P chiral 
centres could be prepared. Esters generated from 103 should be substrates for 
a—chymotrypsin, a serine protease, known 2, 144 to hydrolyse protected aromatic amino 
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2.1.5 Synthesis of 3-phenylbutyric acid benzotriazol-lyl-methyl ester 
Investigations began with (S)-3-Phenylbutyric acid 101 because it was thought to 
be the least likely to undergo racemisation of the chiral centre and both isomers were 
commercially available. In addition, Reeve et a1138 reported the preparative scale 
enzymatic hydrolysis of 3-phenylbutyric acid methyl ester 104 with E values ranging 
from 2 to >153 using porcine liver esterase (Chirazyme El and E2) and 
Chromobacterium viscosum lipase, respectively - Scheme 44. This should allow us to 
compare the E values reported for the methyl ester 104 with those determined for the 
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Scheme 44: Conditions i. pH 7.8 phosphate buffer 
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Starting from commercially available (S)-101, the acid chloride (S)-106 was 
synthesized in 88% yield by treatment with thionyl chloride - Scheme 45. Subsequent 
formation of the N-acyl benzotriazole derivative (S)-107, exclusively as the 1' isomer, 
was also achieved in excellent yield. The esters (S)-105 and (S)-108 were isolated in 
70% and 1.6% yield respectively by treatment of (S)-107 with formaldehyde and 
25mo1% K2CO3. This ratio of (S)-105 to (S)-108 ester was similar to that which had 
been observed for 94a to 95a. The 'H NMR of 105 and 108 gave the CthO as AB 
doublets with J values of 11.2 and 9.9Hz respectively. The 13C NIVIR signal for the 
CHO was shifted from 67.3 p.p.m. in 105 to 74.9 p.p.m. in 108. 
The enantiomeric purity of 105 was determined by HPLC to be >99% e.e. which 
is in excellent agreement with the starting acid (99% e.e. determined by HPLC) 
indicating that no racemisation of the chiral centre had occurred during the synthesis - 
Figure 19. The above reactions were repeated with (+/-)-101 to give (+f-)-106, 107, 105 
and 108. (+/-)-105 was used as an HPLC standard to measure the enantiomeric purity of 
(S)-105 and will be used for the enzymatic resolution studies - Section 2.2. 
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Scheme 45: Reactions and conditions i. SOC12, ii. beuzotriazole, DCM, Et3N, 0°C, iii. 
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Figure 19: Enantiomeric purity of (S)-105 
rR 
2.1.6 Preparation of benzotriazole esters from acids with an a-chiral centre 
Following the successful synthesis of (S)-105 attention was turned to the 
synthesis of (S)-111. 
Acids with an cx—chiral centre will be more prone to racemization due to the 
increased acidity of the proton at the chiral centre and as a result the synthetic mute used 
should minimise the use of base. However, from preliminary investigations into the 
synthesis of the blocked SERRS dyes, which were carried out in tandem, it appeared that 
routes to these via the N-acyl derivative would be most successful - discussed in more 
detail in Chapter 3. With this in mind initial investigations focused on a route similar to 
that used for (S)-3 -phenylbutyric acid (i.e. Scheme 45). 
2.1.7 Synthesis of 2-methyl butyric acid benzotriazole-1-yl methyl ester 
Starting from commercially available (S)-2-methylbutan-1-ol (>98% e.e.) - 
Scheme 46, (S)-102 was synthesized in 57% yield by permanganate oxidation according 
to the procedure detailed by Begley et. al. 	The literature yield was moderate (55%) 
and attempts to improve the yield of (S)-102 using Jones oxidation were unsuccessful, 
with only a 38% yield obtained. Conversion to the acid chloride (S)-109 using thionyl 
chloride proceeded in good yield again as described by Begley et. al.. 141  Formation of 
the N-acyl benzotriazole (5)-10, as the 1' isomer, by reaction of (S)-109 with 
benzotriazole proceeded in good yield. Conversion to the ester (5)-111A was achieved 
by treatment of (5)-11 with formaldehyde in CH3CN with 15mol% potassium 
carbonate. The ester (5)-111A was isolated as a thick clear oil which solidified on 
freezing in 47% yield. Due to the small scale of the reaction a sample of the 2' isomer 
(S)-111B was not isolated. 
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Steps ii-iv in Scheme 46 were repeated with commercially available (R/S)-2-
methylbutyric acid to give (R/S)-109, 110, lilA in comparable yields to the optically 
pure compound. (R/S)-111B was also isolated in 3% yield. 
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(5)-111A47% yield 
(RIS) - 111B - 3% 
	
(R/5) - lilA 67% yield 
Scheme 46: Reagents and conditions: i. KMnO, Na2CO3, 0°c, ii. SOC12, iii. 
beuzotriazole, DCM, Et3N, 0°c, iv. formaldehyde, CH3CN, K2CO3. 
The enantiomeric purity of ester (S)-111A was determined by normal phase 
HPLC and found to be 75% e.e. This indicated that a substantial amount of racemisation 
had occurred during preparation. Treatment of (S)-111A with Et3N or K2CO3 in CH3CN 
did not alter the enantiomeric purity proving that the ester was not sensitive to base. 
Attempts to determine the enantiomeric purity of (S)-110 by chiral HIPLC, which was 
the only intermediate in the synthetic route with a chromophore, were unsuccessful. The 
other intermediates in the synthetic route all gave comparable optical rotation values to 
those previously reported. Other routes to (S)-1 hA were investigated to determine if the 
racemization could be minimized and reduce the number of synthetic steps - Scheme 47. 
A variety of coupling reagents and conditions were investigated. 
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Scheme 47: Reagents and conditions: i. See Table 5 
The coupling reactions were carried out on a small scale and then analysed by 
HPLC to determine the yield of (S)-111A. Any reactions that appeared promising, were 
scaled up and (S)-111A isolated. The results are displayed - Table 5. 






1 EEDQ, DCM 6.5% - - 
2 DCC, DIPEA, DCM 36.6% - - 
3 DCC,DMAP,DCM 37.0% - - 
4 PP113, DEAD, THF 72.5% 78% >98% 
5 PPh3, DEAD, DMF - 43% >98% 
6 PPh3 (resin bound), DEAD, DMF N/D N/D N/D 
Table 5: Coupling of 100 with (S)-102 
Note: Entry 5 from Table 5 was performed because it was known that the 
monoazo- benzotriazole dyes are sparingly soluble in most organic solvents but readily 
soluble in DMF and the use of this solvent maybe necessary in the synthesis of the 
'blocked' SERRS dyes. The synthesis of the blocked SERRS dyes is discussed in more 
detail in Chapter 3. As can be seen from Table 5, Mitsunobu conditions in THF gave a 
good yield of (S)-111A with an excellent e.e. This allows the preparation of the 
benzotriazole esters in one step from the parent acid. 
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2.1.8 Synthesis of benzotriazole esters from protected amino acids 
For the synthesis of (S)-112 the acid fluoride of Z-phenyalanine 113 was used in 
preference to the acid chloride because it is known142 that in general the former are more 
stable to hydrolysis and Z-amino acid chlorides are unstable upon treatment with base. 
Z-L-phenylalanine 103 was converted to the acid fluoride (S)-113 by treatment with 
cyanunc fluoride using the method described by Bertho et al 143 in good yield and with 
excellent enantiomeric purity - Scheme 48. (S)-113 was converted to the N-
acylbenzotriazole (S)-114 by reaction with benzotriazole in the presence of base and 
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Scheme 48: Reagents and conditions i.) cyanuric fluoride, pyridine, DCM, ii.) 
benzotriazole, Et3N, DCM, iii.) formaldehyde, CH3CN, K2CO3- 
The enantiomeric purity of (S)-112 was determined, by normal phase Chiral 
HPLC, as 90% e.e. after comparison with a standard of (R/S)-112. (RIS)-112 had been 
generated in 24% yield from the coupling of 1-hydroxymethylbenzotriazole with (RIS)-
103 using EDCI. In light of the racemization detected in (S)-112 synthesized via the acid 
fluoride, the optically pure form of (S)-112 was synthesized with >99% e.e. using EDCI 
rM 
and HOBt - Scheme 49. Although the yield of this single step was relatively modest the 
yield is greater than the overall yield achieved for synthesis of (S)-112 from the acid 
fluoride. No optimisation of this reaction was performed. 
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PhO,N,(,(OH + N']J 1. 
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(S) - 103 	 100 	 (S)-112 
Scheme 49: Reaction conditions i. EDCI, HOBt, DIPEA, DCM 
2.1.9 Preparation of N-El  -(benzotriazol-1 -yl)alkyl] amides 
Following the successful synthesis of (S)-112 it was decided to extend our 
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Compounds of type 115 should be substrates for a—chymotrypsin, a serine 
protease, which in nature2' 144  acts as a protein endopeptidase and catalyses the 
hydrolysis of non terminal peptide bonds that are adjacent to a phenylalanine, tyrosine or 
tryptophan residue. It also accepts a broad range of aromatic amino acid amides, esters 
and other carboxylic acid derivatives. 
Katritzky and co-workers published several reports '29' 145-148  on the synthesis of 
compounds similar to 115. The reaction occurs in moderate to good yields from the 
condensation of an amide, aldehyde and benzotriazole in refluxing toluene under Dean 
Stark conditions - Scheme 50. The reaction is fairly general for most primary (including 
protected amino acid amides, as in our case) and secondary amides (i.e. R#H).  The yield 
Li] 
of adduct is generally improved by the addition of a catalytic amount of p-
toluenesuiphonic acid to the reaction mixture. 







Scheme 50: Reagents and conditions i. toluene (cat. TsOH) or acetic acid, reflux, Dean 
Stark apparatus 
This reaction was explored with commercially available Z-L-phenylalanine 
amide 116, benzotriazole and a variety of aldehydes to generate two benzotriazole 
adducts 117 and 118 - Scheme 51. 
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Scheme 51: Reagents and conditions i. toluene, cat. TsOH, reflux, Dean Stark 
Initial results from this reaction were disappointing. The use of aromatic 
aldehydes resulted in complex mixtures of products and starting materials, making 
isolation of the desired adduct very difficult. In contrast, the use of isobutyraldehyde or 
formaldehyde resulted in the isolation of the desired product, albeit in low yields - Table 
6. 
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Adduct R Yield Ratio of Diastereomers 
HPLC 	NMR 
117 CH(CH3)2 44% 1:1 1:1 
118 H 24% (33%)* * * 
Table 6: Preparation of adducts 117 and 11. denotes see text. 
The benzotriazole adducts 117 and 118 were obtained as the 1' isomers, 
confirmed by comparison with the 'H NMR of other 1-substituted benzotriazole 
compounds. 1  H NMR and reverse phase HPLC analysis indicated that 117 was formed 
as a 1:1 mixture of diastereomers. At this point, it was unclear whether the diastereomers 
of 117 would be hydrolysed with equal rates by a—chymotrypsin - this will be discussed 
in Section 2.2.4. 
The maximum yield (44%) of 117 was achieved after careful distillation of the 
iso-butyraldehyde under nitrogen and the introduction of a stirring step prior to 
refluxing. The yield of adduct 118 was increased slightly from 24% to 33% by refluxing 
1-hydmxymethylbenzotriazole 100 with 116 in glacial acetic acid - Scheme 52. The 
enantiomeric purity of 118 was determined as >99% e.e. using normal phase chiral 
HPLC. 
Ph 	 (OH 





116 	 100 	 118 
Scheme 51: Reagents and conditions i. acetic acid, reflux. 
2.1.10 	Summary 
We have designed synthetic routes to N-substituted benzotriazole esters and 
amides that contain optically active acids. Esters generated from acids with a 13—chiral 
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centre could be synthesised in excellent enantiomeric purity from the N-acyl 
benzotriazole. With protected amino acids and a chiral acids, the chiral centre was 
found to be more prone to racemisation. In these cases, the esters were synthesized in 
optically pure form using either EDCI and/or Mitsunobu conditions. Access to the 
amides was achieved in a one-pot reaction in moderate yield. 
2.1.11 	Future Work 
In light of the racemisation observed in the synthesis of (S)-111 (A+B) and (S)-
112 from N-acyl beuzotriazoles, a variety of bases could be used to determine if this 
could be reduced. In hindsight the use of pyridine instead of triethylainine, in the 
acylation step, may have avoided this racemisation. Further optimization studies on the 
synthesis of 1-(benzotriazole-1-yl) alkyl esters have been performed and will be 
discussed in Chapter 3, Section 3.3. 
Further optimization studies on the synthesis of 1-(benzotriazol-1-yl) alkyl 
amides may result in improved yields. However, significant development work has 
already been performed 149  in our laboratory, on a similar reaction, and yields remained 
inconsistent. 
As mentioned previously, esters 94b-e, 95b-d, 96 and amide 117 may be useful 
model compounds to investigate the design of enzyme cleavable linkers'50 - Figure 20. 
Potentially these could be synthesized in three different ways, either linking to the resin 
through benzotriazole, or via an aldehyde or amide. The synthesis of resin bound 
benzotriazole'51 '53 has been reported in the literature and compounds similar to linker 
type 1 are currently being investigated,154 in our laboratory, for the attachment of peptide 
aldehydes to solid supports. In addition, linker type 1 could be used in enzymatic 
resolutions of resin bound esters. The un-hydrolysed ester would remain bound to the 
solid support allowing simple separation. A similar structure to linker type 3 has been 
developed as a penicillin amidase cleavable linker for alcohols'55  
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Figure 20: Proposed synthesis of benzotriazole based enzyme cleavable linkers. 
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2.2 	Enzymatic studies on 1-(benzotriazol-1-yl) alkyl esters of chiral acids 
(R/S)-3 -phenylbutyric acid benzotriazol- 1 yl-methyl ester 105 was chosen as a 
substrate for more detailed lipase/esterase hydrolysis studies - Scheme 53. 
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Scheme 53: Reagents and conditions i. lipase/esterase, pH7 buffer, RT. 
2.2.1 Screening of lipases/esterases. 
As a starting point, enzymes from the Fluka Lipase Basic Kit and Fluka Esterase 
Basic kit were tested, to establish which enzymes exhibited activity towards (R/S)-105 - 
Scheme 53. Small scale screening reactions (0.009mmol 105) were performed with 
enzyme at room temperature in pH 7 buffer. The enzymatic reactions were carried out 
for 24 hours, quenched by addition of acetone, and analysed by reverse phase IHPLC. 
The amount of benzotriazole released (area%) was calculated and displayed -Table 7. 
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Lipase Conversion Esterase Conversion 
P. cepacia 100 T brockii ++ 
Porcine Pancreatic 100 S. cerevisiae + 
A. niger 100 C. lipolytica 100 
M miehei 100 M. miehei 100 
P. fluorescens 100 Hog Liver 100 
R. niveus ++ Horse Liver 100 
R. arrhizus + B. the rmoglucosidasius 100 
C. antarctica B. steartherinophillus 
C. cylindracea + Bacillus sp. 100 
Control - Acetylcholine ++ 
Table 7: Hydrolysis of (R/S)-105 + (0-25%),++ (26-50%), +++ (51-75%),++++ (76-
99%). 
No hydrolysis was detected in the control indicating that the ester was stable in 
pH 7 buffer. In addition, (R/S)-105 was suspended in pH 7 buffer and analysed by HPLC 
every day for four days - no hydrolysis was detected after 4 days. Encouragingly, all 19 
enzymes displayed activity towards (RIS)-105 indicating that it was readily hydrolysed 
by both lipases and esterases. 
2.2.2 Comparison of (RIS)-105 with (RIS) 3-phenylbutyric acid methyl ester 
Attention was then turned to measuring the enantioselectivity of a selection of 
lipases and esterases towards (RIS)-105 and comparison of the E values determined with 
those reported for the resolution of (R/S)-104. The methyl ester 104 was easily prepared 
by refluxing (R/S)-101 in acidified methanol - Scheme 54. 
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Scheme 54: Reagents and conditions i. methanol, cat. H2SO4, reflux 
Using identical conditions (concentration of substrate, enzyme and pH of buffer) 
resolutions of (R/S)-104 and (R/S)-105 were tim in tandem. The conversion, C (using 
previously determined relative response factors for both substrates) and the enantiomeric 
excess of the non-hydrolysed substrate were determined using reverse phase HPLC and 
chiral HPLC, respectively. Mean E values (from four separate determinations) were 
calculated using the method reported by Sih'56 and compared to those reported by 
Reeve 140  for the resolution of (R/S)-104 - Table 8. 
Enzyme E-(105) E-(104) Reported '4° E for 
104 
P. cepacia lipase 11.7 12.6 - 
C. viscosum lipase >133 136 >153 
P. fluorescens lipase 29 - >34 
Hog liver esterase 1.1 1.1 2 
Horse liver esterase 2.7 1.3 - 
C. lipolytica esterase 2.3 2.2 - 
Table 8: Enantioselectivity of lipase and esterase catalysed hydrolysis of (RIS) - 105 
and (RIS)-104 
The results obtained with these six enzymes are very encouraging indicating that the 
enantioselectivity displayed towards the benzotriazole ester 105 was similar to that 
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observed for the methyl ester 104. For 104 and 105 the same enantiopreference was 
observed, with all enzymes hydrolyzing the (S)-ester more rapidly than the (R)-ester. 
These results are encouraging and indicate that these benzotriazole esters have potential 
as chromophoric substrates for screening enzymatic reactions. They could potentially be 
used in preference to the more regularly employed p-nitrophenyl esters which are known 
to undergo non-specific hydrolysis .75  We then turned our attention to determining the 
initial rate of hydrolysis for (RIS)-105 compared to (R/S)-104. 
2.2.3 Comparison of initial rates of hydrolysis of 104 and 105 
The initial rate of enzymatic hydrolysis of (RIS)-104 and (RIS)-105 was 
determined for the six enzymes used in the previous experiment - Table 9. The initial 
rate was measured for both esters, under identical conditions, using concentrations 
where both esters remained fully soluble - full experimental details are documented in 
Chapter 5. 
Enzyme Initial rate for 104 
(pmoles min-') 
Initial rate for 105 
(pmoles min-') 
P. cepacia lipase 1.6 62 
C. viscosum lipase 0.5 150 
P.fluorescens lipase 2.3 43 
Hog liver esterase 6.0 214 
Horse liver esterase 3.0 2 
C. lipolytica esterase 1.6 0.5 
Table 9: Initial rates measured for the enzymatic hydrolysis of (R/S)-104 and (R/S)-105 
The initial rates measured do not seem to follow any general trend. Four of the 
enzymes tested hydrolyse the benzotriazole ester 105 considerably faster than the methyl 
ester (Entries 1-4, Table 9). Horse liver esterase hydrolyses the esters at approximately 
equal rates and the esterase from Candida lypolytica hydrolyses the methyl ester more 
rapidly (Entries 5 and 6, respectively). Interestingly, despite this much higher hydrolysis 
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rate the lipase from Chromobacterium viscosum still exhibits a high enantioselectivity 
towards the (S)-isomer of the beuzotriazole ester. A graph comparing the rate of 
hydrolysis of (R/S)-104 with that of (RIS)-105 using Pseudomonasfluorescens lipase is 
displayed - Graph 1. Due to a shortage of time no further investigations could be 
performed with the benzotriazole ester 105. 
Graph 1: Hydrolysis of 104 and 105 using Pseudomonasfluorescens lipase 
2.2.4 c—ChymoIrypsin hydrolysis of ester 112 and amides 117 - 118 
The benzotriazole containing compounds 112, 117 and 118 were proposed as 
substrates suitable for cleavage by the serine protease, a-chymotrypsin. 112, 117 and 
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Scheme 55: Reagents and conditions i. a-chymotrypsin, pH 7.8 buffer, RT, 10%MeOH 
The amount of hydrolysis of 112, 117 and 118 was determined by quantification 
of the amount of Z-phenylalanine 103 released —Table 10. For all the amides a control 
was performed in tandem and in all controls no hydrolysis was detected indicating that 
the compounds were stable in the reaction buffer. As expected, ester 112 was hydrolysed 
much more readily than the equivalent amide 118 to release the acid and benzotriazole. 





Table 10: Hydrolysis by a-chymotrypsin* denotes area% result. 
An interesting phenomenon, concerning the two diastereomers of 117, was 
observed, notably one diastereomer was hydrolysed almost exclusively over the other 
diasteiomer. This was examined further using reverse phase HPLC and relative rates of 
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Graph 2: ct-c hymotrypsin hydrolysis of the individual diastereomers of 117 
The configuration of the faster reacting diastereomer of 117 was not identified. 
These results indicated that stmctures of this type, generated from an amide and an 
aliphatic aldehyde (other than formaldehyde) would be unsuitable as enzyme labile 
'blocking' groups for SERRS dyes due to unequal reactivity of the diastereomers. 
2.2.5 Summary 
Enzymatic resolutions have been performed on (R/S)-105 and (R/S)-104. E 
values determined for 105 were comparable with those determined for the methyl ester 
and with those previously reported by Reeve and co-workers.'40Amides 112, 117 and 
118 were substrates for a-chymotrypsin although the individual diastereomers of 117 
were hydrolysed at significantly different rates. 
2.2.6 Future Work 
One area of research which has attracted attention recently is the application of 
colour tests suitable for the detection of enzyme activity e.g. the use of 4-(p-nitro 
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benzyl) pyridine 78  to detect the products of epoxide hydrolases. The use of benzotriazole 
ester substrates e.g. 105 could offer similar opportunities. Konopski and Kielczewska 
reported 164  the use of 2-trichloromethylbenzimidazole as a sensitive dyeing reagent 
suitable for the detection of five-membered heteroaromatic compounds in TLC. 2-
trichloromethylbenzimdazole was used to detect benzotriazole, through the generation of 
a yellow coloured compound, with detection limits of 0.3tg. Interestingly, this stain did 
not show any colour change with 1 or 2-methylbenzotriazole suggesting that the 
coloured compound generated occured via reaction at one of the triazole nitrogens. 2-
Trichlorobenzimidazole could potentially be used to detect the benzotriazole released 
during the enzymatic hydrolysis of 105. Chemical modification of 2-
trichloromethylbenzimidazole may produce a stain that generates a more distinctive 











Chapter 3— Results and Discussion II 
3.1 	Application of developed synthetic methodology 
3.1.1 	The synthesis of SERRS blocked dyes 
The success of measuring enzymatic reactions using SERRS is dependant on the 
ability to quantify the concentration of one SERRS dye in the presence of another 
SERRS dye, without the need for a separation step. This requires that the dyes used have 
suitably distinct spectra, so that a unique peak from each spectrum can be used for 
quantification purposes. At the time of initiating this study very little data was available 
on the quantification of SERRS dyes in mixtures, and therefore several different dyes 
had to be synthesized. In light of this, a range of SERRS dyes will be generated in order 
to investigate their properties and the ease with which they could be converted into the 
'blocked' dye - Scheme 56. 
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Scheme 56: Conversion of SERRS active dye to SERRS inactive dye 
The exact position of the azo linkage to the benzotriazole ring has not been 
defined because desymmetrisation of the benzotriazole rings leads to regioisomerism 
around the triazole ring. Several reports129' 157, 158 have described the tautomerism of the 
hydrogen attached to the nitrogen in ring substituted benzotriazoles, two examples of 
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Scheme 57: Regioisomerism in ring-substituted benzotriazo les 
At this point, it is important to note that it was decided to derivatise the 
benzotriazole ring after dye formation in order to introduce the 'valuable' chiral acid as 
close to the end of the synthetic pathway as possible. It was felt that if SERRS analysis 
of enzymatic reactions was to become a viable technique then the amount of 
enantiomerically pure acids required and the number of synthetic manipulations needed 
to obtain the ester derivatives should be minimised. 
The dyes synthesised during this investigation can be divided easily into two 
distinct families; phenolic and N'N' diinethyl aromatic dyes. The syntheses of both are 
very similar but they will be discussed independently for clarity. 
3.1.2 Synthesis of phenolic monoazo-beuzotriazole dyes 
Starting from commercially available 5-aminobenzotriazole, dyes 119 and 120 
where synthesized by diazotisation with NaNO2 in conc. HC1 followed by coupling with 
the appropriate activated aromatic phenol in sodium hydroxide solution (1M) containing 



















Scheme 58: Reagents and conditions 1. NaNO, HC1 (36%), ii. 2,4-dimethoxyphenol, 
NaOH (1M), sodium acetate, iii. a—naphthol, NaOH (1M), sodium acetate. 
The yields of 119 and 120 were moderate, at 54 and 65%, respectively. The low 
yields were attributed primarily due to problems experienced during purification. 
Column chromatography on silica gel was problematic due to the very limited solubility 
of the dyes in most suitable organic solvents and the poor elution characteristics of the 
dyes when pre-adsorbed on to silica. The dyes were obtained as highly coloured 
amorphous powders after extensive trituration in methanol, DCM and diethyl ether in 
accordance with methods reported by Graham et al. 121  The dyes have been designated as 
the 6'-isomer although no crystal structure could be determined due to poor crystal 
formation. This will be discussed in more detail in Section 3.1.3. 
3.1.3 Syntheses of N'N-diinethyl aromatic monoazo-benzotriazole dyes 
Following the successful synthesis of dyes 119 and 120, the aromatic compound 
coupled to 5-aminobenzotriazole was modified; replacing the phenol with an N'N'-
dimethyl moiety 121-123 or pyrollidine ring 124. Three different NN'-dimethyl 
aromatic compounds were chosen, N'N'-dimethylaniline, 3-dimethylaminoanisole and 
N'N' dimethylnapthylamine to generate dyes 121, 122 and 123 respectively. The 
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aromatic compounds were chosen specifically to produce dyes that would give very 
different SERRS spectra from each other and therefore allow discrimination between 
them. The introduction of the methoxy group or incorporation of a fused aromatic ring 
should shift the absorbance maximum of dyes 122 and 123 to a longer wavelength with 
respect to dye 121. This shift was reported 121 for dyes generated from phenylaniine 
analogues. The longer absorbance maxima dyes generally display enhanced sensitivity 
due to an increase in resonance generated by the excitation laser (5 l4nm). Dye 124 was 
synthesised to investigate if any non-specific interactions occur between the N 'N '-
dimethyl moiety and the negatively charged surface of the colloid - See Chapter 4 for 
further discussion in this area. The dye synthesis is displayed - Scheme 59. 
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Scheme 59. Reagents and conditions i. NaNO2, conc. HC1 (36%), ii, iii, iv,v appropriate 
aromatic compound, NaOAc(1M). 
Dyes 121-124 were synthesized in a similar manner to 119 and 120, except the 
coupling reaction is carried out below pH 7. In general, yields were higher than the 
phenol dyes, ranging from 61% for 124 to 86% for 121. 121-124 were all isolated as 
highly coloured amorphous powders. Purification was achieved by trituration in DCM, 
methanol and diethyl ether but column chromatography on silica was possible because 
the dyes displayed much better elution properties than the phenolic dyes. 
Recrystallisation of the dyes was attempted but only 122 gave crystals, from an 
acetone/hexane mixture, which could be used for x-ray crystal diffraction studies. 
Recrystallisation was attempted from a variety of other solvents but the dyes displayed 
very poor crystal formation, a phenomenon which was reported by Graham et al.. 121 
The crystal structure of dye 122 was obtained (see Appendix 7.1 for full details) and is 
represented in Figure 21. The structure clearly indicates that this dye exists as the 6-
isomer. This suggests that the 6-isomer is lower in energy than the 5-isomer once 
functionalised. This structure is consistent with those obtained for similar monazo-
benzotriazole dyes and with that reported 160  for 6-(6 ' -azobenzotriazolyl)-7-methoxy-
2,2,4-trimethyl-1,2-dihydroquinoline 125 which is currently the only published 
structure. The azo bond was defined as existing with trans geometry. 





4.3 	Proposed routes to 'blocked' monoazo-benzotriazole dyes 
With six different dyes in hand 119-124 investigations began into their 
conversion into the 'blocked' derivatives. From preliminary studies on benzotriazole 
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Scheme 60: Proposed routes to blocked dyes A 1. R'COCl, Et3N ii. HCHO, CH3CN, 
K2CO3. B iii. H, HCHO, solvent, iv. coupling reagent, R' 'COOH 
Both routes A and B consisted of two synthetic steps and would allow 
incorporation of a range of chiral acids either as acid chlorides or as the parent acid. It 
was decided to investigate mute A with the both the phenolic dye 120 and the N'N'-
dimethyl aniline dye 121. Consideration had been made of the nucleophilicity of the 
phenolic OH but Graham et. al. 121, 130 had reported that the nucleophiicity of the amine 
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moiety of a similar dye, generated from aniline, was dramatically reduced due to 
electron donation into the ring system. 
3.1.4 	Acylation of monoazo-benzotriazole dyes 
Acylation of dye 120 was attempted with (RIS) 2-methylbutryl chloride 109 in an 
attempt to form the N-acyl derivatives 126 and 127 - Scheme 61. 
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Scheme 61 Reagents and conditions i. (RIS) 2-methylbutyryl chloride, Et3N, anhydrous 
DCM, 0°C 
The above reaction generated a very complex mixture of compounds, which 
were inseparable by column chromatography (due to the poor miming properties of the 
dye). Preparative HPLC allowed the isolation of 4 main peaks from the reaction mixture, 
2 of which gave interpretable NN'IR data and were identified as 128a+128b and 129 - 
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Figure 22: Compounds isolated from acylation of dye 120. 
The 1H NMR's of the other two compounds did not indicate that they contained 
acylated benzotriazole rings, i.e. neither contained a signal at approximately 4 p.p.m 
which was present in the corresponding benzotriazole compound, (R/S)-110. The 
acylation reaction was repeated and the crude mixture treated with formaldehyde in 
CH3CN (step ii. in Route A, Scheme 60) but no 'ester' compound was detected by mass 
spectroscopy. In a similar manner, 119 was acylated with acid chloride 109 and again 
very complex mixtures were generated. 
In sharp contrast to this, acylation of dye 121 with butyryl chloride generated a 
mixture of the N-acyl derivatives 130 and 131 - Scheme 62. The yield of 130 and 131 
combined was 75% and the ratio of regioisomers was approximately 1:1, as calculated 
from comparison of the 'H NMIR signals from the isolated benzotriazole ring proton. 
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Scheme 62: Reagents and conditions; i. butyryl chloride, DCM, Et3N, 0°C 
The crude reaction mixture was relatively clean, compared with the complex 
mixture generated for the acylation of dye 120, consisting of only 130 and 131 and 
unreacted 121. Separation of the unreacted dye was easily accomplished by column 
chromatography but isolation of each regioisomer could not be achieved using this 
technique. However isolation of the regioisomers was possible by reverse phase 
preparative HPLC on a Biotage FLEX system. Separation was achieved on a small scale 
using injections of a mixture of 130 and 131 at a maximum concentration of Smg/ml. 
The separation was however, very time consuming due to gradual loss of baseline 
resolution during the purification process and slight on-column degradation. The acyl 
derivatives 130 and 131 were shown to be water sensitive, although any degradation 
products could be removed easily by further silica gel chromatography. Following the 
success of this reaction 121 was acylated with (R) and (S)-3-phenylbutyryl chloride - 
this is discussed in Section 3.2.1. 
3.1.5 Preparation of 1-hydroxymethyl derivatives of phenolic SERRS dyes. 
Despite the synthetic problems encountered using the phenolic dyes it was 
decided to continue with their use and attempt to synthesize the ester derivatives via the 
hydroxymethyl derivative - i.e Route B - Scheme 59. The analogous reaction with 
beuzotriazole is well documented 139  and proceeded easily with precipitation of 1- 
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hydroxymethylbenzotriazole 100 in almost quantitative yield. It was envisaged that this 
could easily be applied to the mono azo-benzotriazole dyes therefore dye 121 was 
reacted with formaldehyde in an attempt to form the hydroxymethyl derivatives 132 and 
133 - Scheme 63. 
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Scheme 63: Reagents and conditions i. acetone, acetic acid, H20, formaldehyde 
121 was found to be insoluble in aqueous acetic acid, so acetone was added to 
aid solubility and the reactions were heated. A highly coloured precipitate was recovered 
on removal of the acetone, isolated and analysed by NMR. The 'H NMR of 132/133 
gave a doublet at 6.20 p.p.m (J= 11.2Hz) which was assigned to the CH20H doublet 
signal although the integral corresponded to only 1.4Hz. This compared favourably with 
the COH signal previously seen in 100 which resonated at 6.0 p.p.m (J= 7.3Hz). 
Further evidence was noted in the 13C NMR with 132/133 displaying two CH20H 
signals at 70.5 and 70.6 p.p.m, which is practically identical to that obtained for 100 
(H20H at 70.4 p.p.m). Unfortunately, the other regions of the 'H NMR spectra were 
broad and complicated. This was attributed to the precipitate containing both 132/133 
and the unreacted dye 121. Column chromatography on silica was problematic because 
132/133 eluted at the same time as the unreacted dye and did not chromatograph well. 
Column chromatography was attempted, by Kirk Malone as part of an Honours project, 
and resulted in the isolation of the parent dye only. HPLC analysis of 132/133 gave two 
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peaks, one of which had a similar retention time to the azo dye. The other peak 
disappeared after two hours on standing in CH3CN suggesting that the other product was 
unstable in solution. In an attempt to obtain pure 132/133 the reaction conditions were 
varied including changing the acetic acid to trifluoroacetic acid, acetone to other organic 
solvents and performing the reaction at room temperature. In all cases no pure products 
could be isolated. 
A similar situation was observed for the synthesis of hydroxymethyl derivative 
145/146 from dye 119 - Scheme 64. Again pure product could not be isolated but NMR 
analysis of the crude products displayed similar resonances to those which had been 
observed for 132/133 i.e. the CH20H group resonated at 70.4 + 70.5 p.p.m in 13C NMR 
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Scheme 64: Reagents and conditions i. acetone, acetic acid, H20, formaldehyde. 
Despite the failure to isolate a pure sample of 132/133 a number of attempts were 
made to convert the suspected 1-hydroxymethyl derivatives into the esters 134/135 
according to Scheme 65. 
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Scheme 65: Regents and conditions - i. See Table 11. 
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Katritzky et al. 161  reported successfully acylating 1 -hydroxymethylbenzotriazole using 
beuzoyl chloride in pyridine with lOmol% DMAP to give the ester 136 - Scheme 66. 
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Scheme 66: Reagents and conditions i. PhCOC1, DMAP, pyridine. 
Using the above conditions, and a range of other conditions, which had 
previously been shown to be successful with 1-hydroxymethylbenzotriazole (Section 
2.1.7) the conversion of the impure mixture of 132/133 to esters 134/135 was attempted 
—Table 11. HPLC and mass spectrometry was used to follow the progress of each 
reaction. It was hypothesized that the esters 134/135 would be less polar than 132/133 
and as such would elute later using reverse phase HPLC. In all reactions where later 
eluting products were observed, attempts were made to isolate and identify these 
products. 
Entry R Conditions Comments 
1 CH3CH2CH2COC1 (cat.)DMAP, DMF 2 products by HPLC 
2 CH3CH2CH2COC1 (cat.) DMAP, py, DMF 2 products by HPLC 
3 CH3CH2CH2COC1 Et3N, DCM 2 products by HPLC 
4 CH3CH2CH2COC1 DIPEA, DMF 2 products by HPLC 
5 (CH3CH2CH2CO)2 (cat.)DMAP, py, THF 2 products by HPLC 
6 (+/-) CH3PhCHCH2COOH PPh3, DEAD, DMF No reaction by HPLC/MS 
7 (+/-) CH3PhCHCH2COOH EDCI, DMAP, DMF No reaction by HPLC/MS 
8 (+/-) CH3PhCHCH2COOH DCC, DMAP, DMF No reaction by HPLC/MS 
Table 11: All reactions carried under anhydrous conditions ('py' denotes pyridine) 
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Using the conditions in entry 1 and 2 (fable 11) two less polar products were 
detected but mass spectroscopy did not indicate the formation of the ester. The amount 
of products formed was greater for entry 1 than 2 (55% compared to 15.5%). The 
products formed were found to be very unstable in the reaction mixture and degraded 
over time. Reaction 1 was repeated, quenched after 1 hour and the 2 less polar products 
isolated by preparative scale HPLC- full experimental details are given in Chapter 5. 
Following isolation, the 2 products were found to be contaminated with the parent dye 
120 indicating that that they were degrading. 1H NMR of the isolated compounds were 
very poor and neither displayed the CthOC=O signal expected (between 6.4 and 6.6 
p.p.m). This process was repeated with the removal of TFA from the mobile phase but 
the isolated products were still unstable during isolation. 
For reactions 3-5 a similar process was performed with the components again 
breaking down on isolation. It was postulated that at least one of the isolated products 
was probably the N-acyl derivative. To test this hypothesis, the isolated products from 
reaction 4 were treated with formaldehyde and K2CO3 in CH3CN in an attempt to form 
the desired ester - unfortunately this led to breakdown of the product to the parent dye. 
In a second experiment, the isolated products were treated with Candida antarctica 
lipase in pH7 buffer to determine if either was the ester. Again this resulted in the 
breakdown of the products to the parent dye, however this was mirrored in the control 
indicating it was the action of the medium and not the enzyme. Due to a shortage of 
time, and failure of reactions with 132/133 the conversion of 145/146 to the ester was 
not attempted. 
At this point, it was decided to abandon the use of the phenol dyes 119-120, and 
concentrate on dyes 121-124. In light of the success achieved in acylating 121 with 
butyiyl chloride - Scheme 62 it was decided that investigations would continue on the 
acylation of these dyes with (S) and (R)- 3-phenylbutyryl chloride 106. 
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3.2 	Generation of pseudo -enanliomeric blocked SERRS dyes 
3.2.1 Acylation of dyes 121-124 with (S) and (R)-3-Phenylbutyryl chloride. 
Commercially available (S)-and (R)-3-phenylbutyric acid 101 were converted to 
the corresponding acid chlorides (S) and (R) 106 in excellent yield using thionyl chloride 
or oxalyl chloride - Scheme 67. 
- 0 	 i. 	 Ph 0 
OH >80% 	 CI 
(S) or (R) -101 	 (S) or (R) -106 
Scheme 67: Reagents and conditions i. SOd 2! COd 2, reflux, cat. DMF. 
The enantiopure acid chlorides 106 were then used to acylate dyes 121-124 in 
good to excellent yield to give the N-acyl dervatives (S) and (R)— 137 to 140 (A and B) - 
Scheme 68. (Note - Dye 124 was reacted with (S)-106 only.) The yields and ratios of 
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Scheme 68: Reagents and conditions i. (R) or (S) 106, Et3N, DCM, 0°C, 1 hour. 
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Ratio of regioisomers 
A 	 B 
Separation 
of A+ B 
(S)-137 121 (S)-106 54% 48 52 
(R)-137 121 (R)-106 68% 48 52 - 
(S)-138 122 (S)-106 84% 44 56 - 
(R)-138 122 (R)-106 83% 45 55 - 
(S)-139 123 (S)-106 57% 50 50 - 
(R)-139 123 (R)-106 85% 50 50 - 
(S)-140 124 (S)-106 49% 50 50 - 
Table 12— Yields of N-acyl derivatives of dyes 121-124 
All the N-acyl derivatives were formed as approximately equimolar mixtures of 
the 5' (A) and 6' (B) regisomers which were inseparable by silica gel chromatography. 
Preparative HPLC separation of (S)-137A + (S)-137B using a Biotage Flex system was 
successful - Figure 23 although this process was time-consuming due to poor resolution 
of the regioisomers. The shaded area shows the fractions collected from the analyses - 
any fractions containing both peaks were pooled and re-separated. 
Figure 23: Preparative HPLC separation of (S)-137A and (S)-137B 
NIVIR data from isolated samples of (S)-137A and (S)-137B was used to confirm 
that the other N-acyl derivatives were mixtures of the 5' and 6' isomer. Separation of 
(S)-138A + (S)-138B could not be achieved despite extensive method development. 
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Separation of the other acyl derivatives (139A+B and 140A+B) was not attempted due 
to 'scrambling' of the regioisomerism during the next step as discussed in Section 3.2.2. 
(S)-137B was confirmed as the 6' isomer by crystallisation of the isolated sample 
from CH3CN and x-ray crystal structure determination - Figure 24 and full details in 
Appendix 7.2. The crystals of (S)-137B were of insufficient size to provide an accurate 
hand determination. As can be seen from Figure 24. the azo bond adopts trans geometry. 
(S)-137A produced crystals, which were very small and did not diffract sufficiently to 
provide a crystal structure. (S)-137A was assigned as the 5' isomer because acylation of 
the middle nitrogen of beuzotriazole has not been reported in the literature. 
(46 
Figure 24: X-ray crystal structure of (S)-137B 
3.2.2 Conversion of N-acyl SERRS dyes into esters 
The mechanism, by which an N-acyl benzotriazole (e.g. (S)-137B) is converted 
to the ester, by reaction with formaldehyde, is unknown. It is known 162  however, that N-
acylated benzotriazoles undergo intermolecular thermal isomerisation and can act as 
weak acylating agents - Scheme 69. 
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Scheme 69: Reaction conditions i. O-xylene under N2 
With this in mind, the single iegioisomer (S)-137B was suspended overnight in 
CH3CN with 15 mol% K2CO3 in either the presence or absence of formaldehyde. The 
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Scheme 70: Reagents and conditions, i. K2CO3, CH3CN, RT 
The results shown in Scheme 70 indicated that the N-acyl beuzotriazole (S)-
137B undergoes an acyl transfer rearrangement under the reaction conditions used in the 
formation of the ester. After 16 hours suspension in CH3CN with K2CO3 the ratio of (S)-
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Scheme 71: Reagents and conditions i. KCO3, CH3CN, formaldehyde 
The results displayed in Scheme 71 show that all 3 possible regioisomers of the 
ester are formed - (S)-141A, 141B and 141C. Esters (S)-141A and (S)-141B were 
isolated by preparative HPLC and the ratio was determined as 39:61, respectively. (S)-
141C was not isolated due to the small scale of the reaction (0.03mmols) although TLC 
of the crude reaction mixture confirmed its presence. These results do not provide a 
definitive indication of the mechanism of the reaction (the intermolecular acyl transfer, 
Step i, makes definitive mechanism determination very difficult) but the following 
mechanism is proposed - Scheme 72. Step W. could be either intra-molecular or inter-
molecular making determination of the mechanism more difficult. Step W. would most 
likely occur intermolecularly due to the planer nature of the benzotriazole ring. 
Measurement of the kinetics of the reaction may shed more light on the mechanism but 
this was outwith the scope of this work. Note: JR analysis of the N-acyl benzotriazole 
100 
(S)-137B shows that the carbonyl stretch is at 1740cm' indicating that it is more ketone-


















Scheme 72: Proposed esterfo rmation mechanism 
Due to the observed 'scrambling' of regioisomerism, a mixture of both N-acyl 
benzotriazoles was converted to the esters - Scheme 73. Only the reaction of (S)-137 
(A+B) is shown but all acylated dyes (S) and (R) 137-140 (A+B) were reacted. For 
clarity the approriate ester generated from each N-acyl dye is shown in Table 13. The 
yields obtained and the ratios of each ester obtained are documented in Table 14. 
N-Acyl dye(A+B) Ester 
(S)-137 (S)-141 A, B and C 
(R)-137 (R)-141 A, B and C 
(S)-138 (S)-142 A, B and C 
(R)-138 (R)-142 A, B and C 
(S)-139 (S)-143 A, B and C 
(R)-139 (R)-143 A, B and C 
(S)-140 (S)-144 A, B and C 
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A from B 
(S)-141 33% 3.2% 36.2% -10:1 
(R)-141 31% 2.9% 33.9% -11:1 
(S)-142 51% 7.5% 58.3% -7:1 X 
(R)-142 48% 4.2% 52.2% -11:1 X 
(S)-143 82% 7.6% 88.6% --11:1 
(R)-143 67% 6.7% 73.7% -10:1 
(S)-144 65% 10% 75% -7:1 X 
Table 14: Yields and ratios of esters A,B and  
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For all dyes, isolation of regioisomer C was easily achieved by column 
chromatography on silica gel, however isolation of A from B could only be achieved by 
preparative scale HPLC. Full experimental details are documented in Chapter 5. The 
regioisomers (S)-142A+B, (R)-142A+B and (S)-144A+B were inseparable by 
preparative HPLC despite extensive method development. The yield of esters (A+B), C 
and a combined yield (A+B+C) are documented in Table 14. The ratio of (A+B): C is 
also documented. Due to the small scale of these reactions and the problematic 
separation of A from B, the overall ratio A: B: C was not calculated. Full experimental 
yields and ratios of A: B are given in Chapter 5. 
3.2.3 Structural determination of ester regioisomers A, B and C 
The structure of the regioisomers A, B and C were confirmed by NMR and 
nuclear Overhauser enhancement (nOe) experiments. (S) and (R)-141C to 144C were 
easily identified by comparison of the resonance obtained for the H2O peak in 13C 
NMR with that obtained for 108 i.e. 144C gave a signal at 75.4 compared to 74.9 for 
108 while 141A + 141B gave 67.6 p.p.m and 67.4 p.p.m respectively. nOe spectroscopy 
confirmed the identity of (S)-141A, (S)-141B and (S)-141C and the results are displayed 
in Figure 25. This data was used to confirm the identity of the (R)- enantiomers. 
The identity of (S)-143A was confirmed by COSY and nOe spectroscopy with 
irradiation at the frequency of the CH20 giving an enhancement of 3.5% at the 7 
position of the benzotriazole ring. In addition, irradiation of the CH20 group gave no 
enhancement at the isolated benzotriazole proton - Figure 26. (Note (S)-143B did not 
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Figure 26: nOe results for (S)-143A 
Measurement of the aD values for these compounds was hampered by their 
strong absorbance at 589nm. The chiral integrity of the esters was established by 
cleavage using 1M NaOH and analysis by Chiral HPLC. The chromatograms obtained 




A wide range of phenolic, NW dimethylaniline and pyrollidine monoazo-
beuzotriazole dyes 119-120 and 121-124 were produced. The crystal structure of 122 
was obtained. The dyes (121-124) were successfully acylated with both (R) and (S) 
enantiomers of 3-phenylbutyryl chloride to generate both regioisomers of the N-acylated 
dye. In the case of (S)-137A and (S)-137B the regioisomers were separated by 
preparative scale HPLC and the crystal structure obtained for (S)-137A. These acyl 
derivatives were transformed into esters by the action of formaldehyde to generate three 
regioisomers and these were fully characterized by spectral analysis. Preparative scale 
HPLC and column chromatography were used to separate all three regioisomers of (S) 
and (R) -141 (A-C) and (S) and (R)-143 (A-C). Chiral HPLC indicated that chiral 
integrity had been maintained throughout the synthesis. 
3.2.4 Future Work 
The generation and characterization of the 'ester' dyes was successful although 
separation of the regioisomers was protracted and final yields were low. There are 
several avenues that could be explored. 
The 1-hydroxymethyl derivative e.g. 147 (shown for 121 only) of the nitrogen 
dyes 121-124 could be investigated and this may prove more fruitful than the 
corresponding compounds made from the phenolic dyes. If these can be successfully 
prepared then it should be possible to extend the chemistry to the preparation of esters of 
acids with a—chiral centres or of amino acids. This would allow much easier synthesis 







3.3 	Further studies on the synthesis of 2' benzotriazole esters. 
During investigations into the formation of the SERRS blocked dyes 141-144 it 
became evident that the separation of regioisomer C from the other regioisomers was 
much more straightforward i.e. it could be easily achieved by column chromatography 
without the need for prep-scale HPLC. It was felt that it might be possible to optimise 
the formation of this regioisomer, over the other two regioisomers, by careful control of 
the reaction conditions. Previously Katritzky et al. 137 had reported that the ratio of 1-
(benzotriazol-1-yl)alkyl esters to 1-(benzotriazol-2-yl)alkyl esters could be influenced 
by the base and reaction solvent used. The ratio of 148:149 varied from 2.6:1 (K tBuO 
in CH3CN, 47% yield) to 13:1 (K2CO3 in hexane, 98% yield) for the reaction of 1-
benztriazol-1-yl (phenyl) methanone 150 with propionaldehyde - Scheme 74. 
-p 	
i. 
 ()A ( r) 	. N 0 r )__i + 	 0 N 
N 	
N:N 
150 	 148 	 149 
Scheme 74: Reagents and conditions: i. various bases, solvents, CH3CH2CH=O 
With this in mind it was decided to investigate the reaction more fully and 
attempt to optimise the formation of the 2' isomer, in preference to the other 
regioisomer. In order to do this, the model reaction between (RL)-107 with 
formaldehyde to produce (R/S)-105 and (RIS)-108 was performed using a range of 
different reaction solvents and bases - Scheme75. 
106 
(R/S)-107 
UJ 	 - 




N - N 
"'ZD 
(R/S)-108 
Scheme 75: Reagents and conditions: i. base, solvent, formaldehyde, RT 
3.3.1 Studies on the influence of base concentration 
Potassium carbonate and triethylamine have been shown 137 to give excellent 
yields, 100% and 86% respectively, of 1-(1H-benzotriazol)pmpyl benzoate 148+149 
however the ratio of 148:149 varied from 4:1 to 10:1, respectively - Scheme 74. These 
two bases were the starting point for our study. Each base was used at a concentration of 
5, 15 or 25 mol%, with respect to the N-acylbeuzotriazole 107, to investigate its effect 
on the ratio 105:108. Small scale (0.4mmol) reactions were performed using a Gilson 
SK233 system and the reactions monitored by HPLC every hour for 5hours and then 
again after 24 hours - Table 15. The 24hour time point allowed us to monitor slower 











5% KCO3 1.2% N/D 44.7% 0.7% 64:1 
15% K2CO3 66.7% 1.6% 70.3%* 1.7% 41:1 
25% K2CO3 68.7% 1.5% 71.1%* 1.5% 47:1 
5% Et3N 0.5% - 8.5% - - 
15%Et3N 36.8% 0.4% 46.2% 0.6% 77:1 
25%Et3N 43.7% 0.5% 54.5% 0.8% 68:1 
Table 15— Effect of varying concentration of K2CO3 and Et3N (5 and 24 hour results) 
107 
The results are similar to those obtained by Katritzky'37 with triethylaniine 
giving markedly lower combined yields of the esters and a higher ratio of 105:108 ester 
than K2CO3. Under all reaction conditions with K2CO3, the ratio of 105:108 esters was 
significantly in favour of 105, much more so than that which had been reported for the 
propionaldehyde esters. This phenomenon had been observed previously during the 
preparative scale reactions and discussed in Section 2.1.2. The ratio observed by IIPLC 
was much higher than that observed from the prep-scale reactions but only small 
amounts of 108 were ever isolated and the HPLC results are area% only. 
This series of experiments did identify that 15 mol% was the optimum 
concentration of base required to maximise both the combined yield and the yield of the 
2' ester. This concentration of base was used to study the effect other bases, both organic 
and inorganic, had on the formation of ester 108. 
3.3.2 Studies on the influence of different bases 
A range of different organic and inorganic bases were used in the reaction 
displayed - Scheme 75. All were used at the optimal concentration of 15 mol % in 
CH3CN. Again the reactions were analysed by HPLC every hour for five hours and then 
again at 24hours. The results are displayed - Table 16. 
Kt-BuO, DMAP and DBU all give comparable yields to K2CO3 with Kt-BuO, 
giving an increased yield of ester 108. This is in agreement with the results of Katritzky 
et a1137 who reported a ratio of 2.6:1 (148:149, 47% yield) for Kt-BuO and a reaction 
time of 0.25hrs. In addition, Chiral HPLC analyses of the reaction mixture indicated no 
racemisation of 105 using Kt-BuO. 
In these small-scale experiments the reactions were complete (within 
experimental error) in under 5 hours for the aforementioned three bases. Na2CO3 gave 
the highest yield of product and a slightly increased yield of the 108 but the reaction was 
slower and remained incomplete after 48 hours. 
108 
Base 











Na2CO3  16.8 0.6 76.9* 3.1* 25:1 
Li2CO3  0.7 N/D 4.4 N/D - 
CaCO3  0.5 N/D 0.7 N/D - 
KH2PO4 No Reaction 
Kt-BuO 68.7 2.7 68.9 2.9 24:1 
Pyridine 0.8 N/D 1.0 N/D - 
N-Ethyl Morpholine 0.6 N/D 10.0* N/D - 
Cyclohexylamine 3.0 N/D 34•9* 0.5% 69:1 
Morpholine 5.7 N/D 
DMAP 66.9 1.2 70.2 1.3 54:1 
DBU 76.0 1.2 76.0 1.3 59:1 
DIPEA No Reaction 
Guanidine No Reaction 
Imidazole 0.6 N/D 0.3 N/D - 
Table 16- Effect of base on the ratio of 105:108 (*denotes 48 hour time point) 
3.3.3 Studies on the influence of different solvents 
The reaction in Scheme 75 was further studied using 15mol% K2CO3 in a range 
of polar and non-polar solvents and the results displayed - Table 17. All the solvents 
studied gave much lower yields of 105 and 108 compared to acetonitrile and the ratios 
105:108 are skewed because the reaction has not gone to completion. The breakdown of 
the starting material in MeOH, formaldehyde and DIVIF is probably due to the presence 












DCM 1.1 N 21.3 0.9 24:1 
EtOAc 2.2 N/D 20.3 0.8 25:1 
THF 7.8 0.5 7.1 0.5 14:1 
Formaldehyde breakdown to beuzotriazole 
WA 4.3 N/D 27.6 1 	0.6 1 	46:1 
MeOH breakdown to benzotriazole 
DMF breakdown to benzotriazole 
DMSO 41.4 1.0 44.3 1.2 39:1 
t-Butyl methyl ether 3.2 N/D 4.5 N/D - 
1,4 Dioxane No Reaction 
2,2 19.2 
Dimethoxypmpane  
0.5 38.7 0.7 55:1 
Table 17- Effect of solvent on ratio of 105:108 
3.3.4 	Application to SERRS dyes 
To complete this study (S)-139 (A+B) was reacted with formaldehyde in the 
presence of Kt-BuO to determine if the yield of (S)-143C was increased - Scheme 76. 
Using these conditions, the yield of (S)-143(A+B) was 79% and the yield of (S)-143C 
was 8%, giving a ratio of -10:1. This was identical to that obtained using K2CO3 
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Scheme 76: Reagents and conditions i. formaldehyde, CH3CN, Kt-BuO, RT 
3.3.5 	Summary 
In conclusion, limited success was achieved with the reaction optimization 
studies. Four bases (Na2CO3, Kt-BuO, DBU and DMAP) were identified which could 
potentially increase the yield of ester 108, although only small changes were observed. 
The use of Kt-BuO, did not result in the increase of regioisomer C when applied to N-
acyl SERRS dye (S)-139(A+B). Changing the solvent from CH3CN had a severely 
detrimental effect on the yield of the reaction. 
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Chapter 4— Results and Discussion III 
4.1 	Preliminary SERRS results 
Following the successful synthesis and isolation of the blocked SERRS dyes (S) 
and (R) 141-144 (A, B and C), these and the parent dyes 121-124 were supplied to the 
laboratories of Dr Duncan Graham and Dr Bathe Moore, at the University of 
Strathclyde, for analysis by Loma Stevenson using SERRS. Unfortunately, at the time of 
writing only limited data is available. 
4.1.1 SERRS analysis of dyes 121-124. 
As mentioned previously, for SERRS determination of enantioselectivity to be 
successful the dyes must be able to be distinguished from each other and the amount of 
each dye quantified without a separation step. In addition, the 'blocked' SERRS dyes 
141-144 (A, B and C) must remain SERRS inactive until the parent dye is released by 
enzymatic hydrolysis. 
Firstly, the dyes were analysed individually to determine if they were SERRS 
active and provided a measurable SERRS spectra at the chosen excitation wavelength 
(5 l4nm) and concentration (10 7M). A typical procedure for measuring SERRS spectra 
is documented in Chapter 5. The spectra obtained for dye 121 is shown - Figure 27. 
The most intense peak at - 1400cm 1 is attributed to stretching of the azo bond. The 
spectra obtained for dyes 121, 122 and 123 are contained within Appendix 7.3. At 
present, no SERRS spectrum is available for dye 124 and the limit of quantification of 
dyes 121-123 has not been established. 
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Figure 27: SERRS spectra of Dye 121 
4.1.2 SERRS quantification of mixtures of dyes 121 and 122. 
A regression model was built by analysing known mixtures of dyes 121 and 122 
(i.e. using solutions ranging from 100% 121 / 0% 122 to 0% 121 / 100% 122). This 
model was then used to predict, using a variety of processing methods, a known 
concentration of dye 121 in the presence of dye 122 - Table 18. 
Data processing method Known vs. Predicted composition 
12.5% - 121 33% - 121 67% - 121 87.5% -121 
Raw spectra - full range 38.2 48.4 46.6 47.6 
Raw spectra - (1000-1800 cm') 37.1 48.3 45.7 47.0 
1derivative - full range 36.4 26.3 43.9 46.3 
1 	derivative —(1000-1800cm') 28.9 45.2 41.9 54.6 
1 	derivative —(1300-1450cm') 35.5 41.8 48.7 56.1 
1 derivative —(1450-1700cm') 34.0 19.9 47.1 55.7 
Table 18: Known vs Predicted compositon of 121 (results in bold are actual 
composition) 
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The results displayed - Table 18 indicate that quantification of dye 121 in the 
presence of 122 was not possible using SERRS analysis. The reason for this remains 
unknown although several possible explainations have been suggested - e.g. variability 
of spectra with time due to changes in level of aggregation or the spectrum from each 
dye is not significantly distinct from each other (a comparison of the spectrum from 121 
with that from 122 is contained within Appendix 7.3). At the time of writing, 
investigations into the variability of SERRS spectra with time and degree of aggregation 
are continuing. It is hoped that continuous flow analysis may reduce the inherent 
variability of each spectrum. Further investigations are also underway into the 
quantification of dye 121 in the presence of dye 123. 
4.1.3 SERRS analysis of ester 141 (A). 
A 10 6M solution of (S)-ester 141(A) was analysed by SERRS using an 
excitation wavelength of 514 urn - Figure 28. 
Figure 28: SERRS spectra of ester 141A 
It is clear from Figure 28 that ester 141A does not display a SERRS spectra 
similar to the parent dye 121. It must be noted however, that the order of addition of 
reagents altered the SERRS spectra observed. A simple buffered solution of ester 141A 
and colloid gave a SERRS spectra but the addition of a protein, prior to addition of the 
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ester gave the spectra displayed in Figure 28. This observation suggested that a non-
specific interaction, i.e. not through the nitrogens of the benzotriazole ring, between 
141A and the silver colloid was occurring. It was suggested that this might be due to the 
N'N' -dimethylaniline moeity of the compound, a feature common to esters 141-143 (A-
C). Following this observation dye 124, replacing the NN'-dimethyl moiety with a 
pyrollidine ring, was synthesized and converted to the esters 144(A-C). Unfortunately at 
present no data is available to determine if this has solved the problem. Further studies 
are also continuing into the use of other additives to reduce the SERRS activity of the 
'blocked' dyes. 
4.1.4 Treatment of ester 141 (A) with lipase. 
Into a buffered solution of colloid and Pseudomonas cepacia lipase (with the 
lipase acting as the protein additive) was added a solution of ester (S)- 141A. The 
SERRS spectrum of the solution was measured at time zero and after 895 seconds - 
Figure 29. 
Figure 29: SERRS spectra of ester 141A at zero (bottom) and 895 seconds (top) with 
PCL 
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Figure 29 clearly shows that ester (S)-141A has been hydrolysed to release the parent 
dye 121. This was confirmed by monitoring the reaction by HPLC. The intensity of the 
SERRS signal increased with time indicating that the concentration of dye 121 present 
was also increasing with time. A control reaction, with no lipase present, did not show 
the appearance of the dye SERRS spectra. 
Following the successful monitoring of an enzyme reaction using SERRS we 
compared the rate of enzymatic hydrolysis of (R)-141A with that of (S)-141A using 
Pseudomonas cepacia lipase (PCL) and Candida antarctica lipase (CAL). PCL is 
known to hydrolyse (S)-105 more rapidly than the (R) enantiomer (E = 11.7, Section 
2.2.2). The results obtained are displayed in Figure 30 and Figure 31. Each figure 
shows the increase in intensity of the stretch at 1407cm 1 with time. 
Figure 30: Comparison of hydrolysis rates of (S) and (R)-141A using PCL 
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Figure 31: Comparsion of hydrolysis rates of (S) and (R) -141A using CAL 
Comparison of the absolute intensity of the signal generated during PCL and 
CAL hydrolysis clearly indicates that PCL hydrolyses the ester more rapidly. 
Unfortunately, this series of experiments was carried out using unknown concentrations 
of (S) and (R)-141A, making determination of the E value impossible. However, the 
concentration of the esters was constant between each different enzyme indicating that 
PCL is qualitatively more enantioselective than CAL, prefering to hydrolyse the (S) 
enantiomer of 141A more rapidly. 
4.1.5 Future Work 
At the time of writing investigations are continuing into several areas concerning 
the analysis of enzymatic reactions using SERRS. These include the use of various 
additives to reduce the SERRS signal for the blocked esters, investigations into the 
quantification of mixtures of dyes and studies on controlling the reproducibility of 
SERRS spectra using different colloids and continuous flow cell measurements. 
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Chapter 5 - Experimental 
5.1. General Experimental 
5.1.1. Instrumentation 
1H-NMR and 13C-NMR spectra were recorded on Bruker AC200, Bruker AC250 Varian 
Gemini 200 and Varian Inova 600 instruments. Chemical shifts (811, ) are reported in 
p.p.m. and coupling constants (J) are in Hertz (Hz). 
Electrospray (ES) mass spectrometry was performed using a Micromass platform II 
instrument with Mass Lynx software. Fast Atom Bombardment (FAB) mass 
spectrometry was performed using a Kratos MS50TC instrument. 
Infrared spectroscopy was performed using a Perkin Elmer Paragon 1000 FT-JR 
spectrometer with the frequencies (v) measured in wavenumbers (cm'). Samples were 
measured on disposable JR cards (Type 61 3M, polythene, 19mm aperture), in DCM as 
thin films, neat or as nujol mulls. 
Experimental design experiments were carried out on an Machem SK233 system and 
analysed by reverse phase HPLC. 
Optical rotations were measured on an Optical Activity AA-1000 polarimeter (sodium 
589nm detection). Sample concentration was measured in g/lOOml and [a]20D values are 
quoted in 10' deg cm-1. 
Melting points were recorded on a Gallenkamp melting point apparatus and were 
uncorrected. 
Elemental analysis (CHN) was performed on a Perkin Elmer 2400 CHN Elemental 
Analyser. 
A 360° Stuart scientific SB1 blood rotator was used for enzymatic hydrolysis 
experiments. 
5.1.2. Chromatography 
Analytical thin layer chromatography (TLC) was performed using aluminium-
backed plates coated with silica gel 60F 4 (Merck: layer thickness of 0.2 mm). 
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Identification was carried out using U.V. fluorescence (254nm), p-anisaldehyde, 
ammonium molybdate, potassium permanganate and niithydrin dips. Flash column 
chromatography was carried out with a variety of columns using BDH silica gel (40-
63tm) or a Biotage pre-packed cartridge system. 
5.1.3. High Pressure Liquid Chromatography 
Analytical high-pressure liquid chromatography (HPLC) was performed using a 
Waters tuneable 486 Absorbance Detector, Waters autosampler and a Waters 600E 
pump and controller. These were managed by the Waters Millennium Chromatography 
software package. A Phenomenex Sphereclone 25cm x 0.46 cm 5j.im ODS 2 column 
was used for all reverse phase HPLC and either a Diacel Industries Chiracel OD 25cm x 
0.46cm, OD-H 25cm x 0.46cm or Chiralpak AD 25cm x 0.46cm column was used for all 
normal phase chiral HPLC. In all cases, a flow rate of imi/min was used and detection 
was at 210nm for reverse phase and 254nm for normal phase chromatography. Due to 
the number of methods developed the exact mobile phase composition and column 
temperature is documented within the analytical data for the specific compound of 
interest. Retention times (Ri) are quoted in minutes. 
For quantitative analyses, two concordant standards bracketed the samples or the 
relative response factor of each analyte with respect to the main peak was calculated. For 
qualitative analyses results are quoted on an Area% basis. 
5.1.4. Preparative High Pressure Liquid Chromatography 
Preparative scale HPLC was performed on a Biotage FLEX system using FLEX 
control software. 2 columns were used depending on the amount of sample to be 
purified; less than 40mg a Supelcosil ABZ+ Scm x 21.2mm W. with 0.5m1 injection 
volume was used and greater than 40mg a Supelcosil ABZ+ 25cm x 21.2mm W. with 
imi injection volume. A flow rate of 20mlJmin at ambient temperature was used for both 
columns and detection was by UV absorbance at 254 and 220nm. Due to the number of 
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methods developed the exact mobile phase composition is documented within the 
analytical data for the specific compound of interest. Fractions were collected into 
plastic 48 or 96 well plates, carefully pooled and subjected to further purification if 
required. 
5.1.5. Solvents and Reagents 
All reagents were standard laboratory grade and used as supplied unless 
otherwise stated. For HPLC methods: UV grade acetonitrile, distilled water, HPLC 
grade iso-propanol, hexane and trifluoroacetic acid were used. Dichloromethane was 
distilled from calcium hydride, while tetrahydrofuran was pre-dried over sodium wire 
and distilled from sodium benzophenone ketal. All other 'dry' solvents were purchased 
as anhydrous grade. 
5.1.6. Enzymes 
All enzymes were purchased from Sigma, Fluka (from a Basic Lipase or Esterase 
kit) or Biocatalysts and the specific activities are documented below. cx-Chymotrypsin 
was purchased from Sigma as a three times recrystallised lyophilised powder with an 
activity of 40U/mg of solid. 
Lipase Activity Esterase Activity 
Pseudornonas cepacia 40U/mg Bacillus sp. 0.15U/mg 
Porcine pancreatic 16.8U/mg Bacillus stearthermophillus 0.4 lU/mg 
Aspergillus niger 1.4U/mg Bacillus the rmoglucosidasius 0.082U/mg 
Mucor miehei 1.3U/mg Candida lipolytica O.1U/mg 
Pseudomonas. fluorescens 42.5U/mg Mucor miehei 1 .2U/mg 
Rhizopus. niveus 2.6U/g Horse Liver 0.96U/mg 
Rhizopus. arrihzus 2U/g Saccharomyces cerevisiae 2 .55U/g 
Candida. antarctica 2.9U/mg Hog Liver 251.OU/mg 
Candida cylindrecea 2.4U/mg Therinoanaerobium brockii 4.9U/g 
Mucor. javanicus 5.2U/mg 
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5.1.7 SERRS instrumentation 
All SERRS measurements were performed by Lorna Stevenson at the University 
of Strathclyde using a Reinshaw Mark III probe system (Reinshaw Ltd, UK) with a 
Spectra Physics 362C 15mW-argon ion laser. All spectra were collected using a 
excitaition wavelength of 514.5nm. Silver coffid solutions were prepared using a 
modified Lee and Meisel procedure. 124 
5.2.0 Preparation of benzotriazole containing substrates 
5.2.1 (S)-2-methyl butyric acid (102) 
OH 
CH3 
(S)-2-Methyl butan-1-ol (5g, 57mmols) and sodium carbonate (1.22g, 15mmols) 
were dissolved in 6m1 of H20 and cooled to 0°C in an ice bath. The resulting solution 
was stirred vigorously and potassium permanganate (11.5g, 73mmols) dissolved in H20 
(220m1) was added dropwise over a period of 4 hours. The reaction mixture was allowed 
to stir overnight at mom temperature. The black precipitate was filtered off and the 
solution concentrated to small volume under reduced pressure. The remaining aqueous 
solution was acidified with H2504 (1M) and the aqueous layer extracted with ether 
(250m1). The organic layer was separated, dried over MgSO4, filtered and the solvent 
removed under reduced pressure to give a clear liquid (3.7g, 64%). The liquid was 
further purified by distillation to give the desired product as a clear liquid (3.3g, 57%). 
Bp 54°C at imbar, Lit 141  Bp 50-52°C at 0.7torr; u max(nujol)/ciii' 3091 broad to 2565 
(OH) , 2969, 2936, 2878 (CH), 1706 (C=O) ; S, (CDC13; 250MHz) 0.93 (3H, t, J 7.4Hz, 
Cth), 1.16 (3H, d, J 6.9Hz, Cth),  1.43-1.57 (1H, in, CjHbCH3), 1.61-1.79 (1H, in, 
CHbCH3) and 2.41 (1H, tq, 7.0 and 7.0Hz, CH2CHC=O); 6c (CDC13; 63MHz) 11.0 
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(CHH3), 14.6 (CHCH3),  24.8 (CH2), 43.3 (CH) and 179.6 (C=O); [a]D20+19.3  (1.44, 
CHC13), Lit 141 [aID20  +19.6 (1.15, CH03). 
5.2.2 General Procedure for preparation of acid chlorides 
Two methods were employed for the conversion of the carboxylic acid to acid 
chloride. For small amounts of acid, oxalyl chloride was used and for large scale (>5g) 
conversion thionyl chloride was employed. 
Thionyl Chloride method: 
The appropriate acid (1 equiv.) was refluxed neat with an excess of thionyl 
chloride and a catalytic amount of DMF for 2 hours (or until conversion to the acid 
chloride was complete as determined by JR spectroscopy). The unreacted thionyl 
chloride was removed by distillation and the acid chloride purified by bulb to bulb 
kegelrohr distillation under reduced pressure (if required). 
Oxalyl Chloride method: 
The acid (1 equiv.) was stirred at room temperature with oxalyl chloride (1.5 
equiv.) and a catalytic amount of DMF (typically 2-3 drops) for 2 hours (or until 
conversion to the acid chloride was complete as determined by JR spectroscopy). The 
acid chloride was purified by bulb-to-bulb kegebohr distillation under reduced pressure 
(if required.) 
5.2.3 (R/S)-3-Phenyl-butyryl chloride (107) 
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The general procedure (5.2.2) was followed with (R/S)-3-phenylbutyric acid 
(6.56g, 4mmols), thionyl chloride (1.5 equivs, 4.32m1, and 6mmols) and catalytic 
amount of DMF to provide the desired product as a moisture sensitive clear liquid 
(5.99g, 82%). 
Bp 100°C at 0.5mbar, Lit165 Bp 104 at 0.4mbar; u (neat)/cm' 3029 (CH), 2968, 
2936, 2878 (CH), 1801 (C=O), 1604 (C=C), 1495, 1453 (C=C); 3H (CDC13; 250MiHz) 
1.36 (3H, d, J 6.911z, Cjj3), 3.13 (11-1, dd, J 16.5 and 811z, CHaHbCH3), 3.19 (1H, dd, J 
16.5 and 6.511z CH 1,CH3), 3.37 (1H, m, CHCH3) and 7.19-7.37 (514, m, Ph); Sc 
(CDC13; 63MHz) 21.8 (CH3), 37.1 (CH), 55.5 (CH2), 127.1 &Ha, x 2), 127.4 (CH), 
129.2 (H x 2),144.4 () and 172.8 (C=O). 
5.2.4 (S)-3-Phenyl-butyryl chloride (107) 
00 
The general procedure 5.2.2 was followed with (S)-3-phenylbutyric acid (2.5g, 
15mmols), oxalyl chloride (1.5 equivs, 2.9g, 23mmols) and a catalytic amount of DMF 
to provide the desired product as a moisture sensitive clear liquid (2.47g, 88%). 
Analysis comparable to 5.2.3 except; Bp 105°C at 0.4mbar, Lit... Bp 104°C at 0.4mbar; 
[cx]D20 +21.9 (1.2, CHC13), Lit [c]D2° +21.5 (1.1, CHCT3). 
5.2.5 (R)-3-Phenyl butyryl chloride (107) 
,-,~Ci 
The general procedure 5.2.2 was followed with (R)-3-phenylbutyric acid (2.5g, 
0.015mols), oxalyl chloride (1.5 equivs, 2.9g, 0.023mols) and a catalytic amount of 
DMF to provide the desired product as a moisture sensitive clear liquid (2.29g, 83%). 
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Analysis comparable to 5.2.3 except Bp 110°C at 0.6mbar, Lit 16' Bp 104°C at 0.4mbar; 
[(YID 20 —22.1 (1.2, CHC13), Lit [a]D20-22.0 (1.0, CHC13) 
5.2.6 (R/S) 2-methyl-butyryl chloride (109) 
The general procedure 5.2.2 was followed with commercially available (R/S)-2-
methylbutync acid (5g, 0.05mols), thionyl chloride (2 equivs, 7.7m1, and 0.065mols) 
and catalytic amount of DMF to provide the desired product as a moisture sensitive clear 
liquid (4g, 67%). 
Bp 112-116°C, Lit'65 Bp 114-120°C; u m (neat)/cm 1 2971, 2936, 2878 (CH), 1794 
(C=O); SH (CDC13; 250MHz) 0.93 (3H, t, J 7.4Hz, CH2CH), 1.16 (311, d, J 6.9Hz, 
CHCth), 1.43-1.57 (1H, m, CfjHbCH3), 1.61-1.79 (111, m, CHCH3) and 2.39 (11-1, 
tq, J 6.9 and 7.0Hz, CHCH3); 6c  (CDC13; 63MHz) 11.4 (CH2CH3), 16.2 (CHCR), 26.4 
(GH2), 40.9 (CH), and 183.5 (C=O). 
5.2.7 (S)-2-methyl-butyryl chloride (109) 
The general procedure 5.2.2 was followed with (S)-2-methylbutyric acid (S)-102 
(2.2g, 0.021mols), thionyl chloride (1.5 equivs, 3.78g, 0.032mols) and a catalytic 
amount of DMF to provide the desired product as a moisture sensitive clear liquid 
(1.96g, 76%). 
Analysis comparable to (R/S)-109 except Bp 114-116°C, Lit Bp"' 110-116°C; [aID2°  
+10.5 (1.13, CHC13), Lit [cx]D26 +12.1 (neat). 
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5.2.8 General procedure for preparation of N-acyl benzotriazoles 
Benzotnazole (1 equiv.) was dissolved in an appropriate volume of 'anhydrous' 
DCM under an inert atmosphere of nitrogen. The solution was cooled to 0°C in an ice 
bath and a solution of triethylamine (1.2 equiv.) in 'anhydrous' DCM was added 
dropwise followed by dropwise addition of a solution of the appropriate acid chloride 
(1.1 equiv.) in 'anhydrous' DCM. The solution was stirred at 0°C for 30mins then 
allowed to warm to mom temperature and stirring continued for a further 1 hour. After 
this time the reaction was quenched by addition of HO (2M) and the organic layer 
separated. The organic layer was washed with further volumes of HC1 (2M), H20, brine, 
then dried over MgSO4, filtered and the organic solvent removed under reduced pressure 
to provide the desired acylated benzotriazole as the 1' isomer. Purification (if necessary) 
by column chromatography on silica gel or recrystallization was then performed. 
5.2.9 1-Benzotriazol-1-yl-butan-1-one (92) 
CN N 
The general protocol 5.2.8 was followed with benzotriazole (lOg, 0.084moles) 
dissolved in 'anhydrous' DCM (170m1) with the addition of triethylamine (1.2equivs., 
14.3m1, 0.101mols) and butyryl chloride (1.1 equivs., 9.85g, 0.092mols). The desired 
product was isolated as an off white solid and recrystallised (from pentane) to give clear 
crystals. Note: The solid is unstable at room temperature releasing the very characteristic 
smelling butyric acid. 
Rf (Hexane: EtOAc, 5:1) 0.52; Mp 58-60°C, Lit 166  60-62; u max  (nujol)/cm' 2968, 2914, 
2881, 2852 (CH), 1738 (C=O), 1594 (C=C), 1482; 3H  (CDC13; 250MHz) 1.08 (3H, t, J 
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7.5Hz, CthCH2), 1.92 (2H, tq, J 7.5 and 7.5Hz, CH3C), 3.38 (211, t, J 7.5Hz, 
CjC=O), 7.47 (1H, ddd, J 8.2, 7.1 and 1.1Hz, CHbt), 7.62 (1H, ddd, J 8.2, 7.1 and 
1.1Hz, 	8.09 (1H, ddd, J 8.2, 1.1 and 1.0Hz, CHbt) and 8.26 (1H, ddd, J 8.2, 1.1 
and 1.0Hz, CHbt); 811  (CDC13; 63MHz) 13.5 (CH3CH2), 17.8 (CH3CH2), 37.2 (CH2C=O), 
114.3 (CHbt),  119.9 (CHbt), 125.9 (CHbt), 130.2 (CHbt), 130.9 (cbt),  146.0 (cbt)  and 
172.4 (C=O); mlz (ESi +ve, 45kV) 190 (100%, [MH]'); mlz (FAB, 3-NOBA) 190 (90%, 
[MHf'), 162 (65%, [MiH-CH2CH3]), 146 (60%, [MH-CH2CH2CH3]), 120 (100%, 
[BtH]) and 77 (45%, [Ph]); mlz (FAB, 3-NOBA) Found 190.098037 C10H12N30 
requires 190.09775. 
5.2.10 1 -Benzotriazol-1-yl-2-phenyl-ethanone (93) 
The general protocol 5.2.8 was followed with benzotnazole (2.98g, 25mmols, 1 
equiv.) dissolved in 'anhydrous' DCM (50nil) with the dropwise addition of 
triethylamine (4.25m1, 30mmols, 1.2 equiv.) and phenacetyl chloride (4.25g, 27.5mniols, 
1.1 equiv.) Purification by column chromatography on silica gel eluting with DCM 
provided the desired product as a pale yellow oil (4.37g, 78%). 
Rf (DCM) 0.80; 1.) max  (nujol)/cm' 2968, 2914, 2881, 2852 (CH), 1740 (CO), 1594 
(C=C), 1482; S (CDC13; 250MHz) 4.72 (2H, s, CjC=O), 7.24-7.45 (511, m, CH x 5), 
7.49 (1H, ddd, J 8.3, 7.2 and 1.1Hz, CHbt), 7.62 (111, ddd, J 8.3, 7.2 and 1.1Hz, CHbt), 
8.11 (111, ddd, J 8.2, 1.0 and 1.0Hz, CHbt) and 8.25 (111, ddd, J 8.2, 1.1 and 1.0Hz, 
CHbt); 611  (CDC13; 63MIHz) 41.2 (CH2C=O), 114.3 (CHbt), 120.0 (CHbt), 126.1 (CHbt), 
127.5 (CH), 128.7 (CH x 2), 129.7 (CH x 2), 130.3 (CHbt), 131.1 (), 132.2 (cbt), 
146.1 () and 170.1 (C=0); mlz (BSi +ve, 45kV) 238 (100%, [MHj); mlz (FAB, 3- 
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NOBA) 238 (90%, [M"'), 120 (100%, [BtHfl and 77 (45%, [Ph]); m/z (FAB, 3-
NOBA) Found 238.93897 C14H12N30 requires 238.93951. 
5.2.11 (S)-2-Methyl-butyryl benzotriazole (110) 
The general protocol 5.2.8 was followed with benzotriazole (0.606g, 5.1mmols, 
1 equiv.) dissolved in 'anhydrous' DCM (15rnl). To this was added dropwise a solution 
of triethylamine (0.618g, 6.1mmols, 1.2 equiv.) and (S)-2-methyl-butyryl chloride 109 
(0.675g, 5.6mmols, 1.1 equiv.) Column chromatography on silica gel eluting with DCM 
yielded the desired product as a clear oil (0.820g, 79%). 
Rf (DCM) 0.48; 	(thin film)/cm' 2968, 2942, 2880 (CH), 1738 (C=O), 1606, 1595 
(C=C), 1483, 1450 and 1387; SH (CDC13; 250Mhz) 0.99 (3H, t, J 7.4Hz, CH2CH3), 1.39 
(311, d, J 6.9Hz, CHCH3),  1.62-1.79 (1H, m, CHaHb), 1.89-2.07 (111, ifi, CHaHb), 4.02 
(111, tq, J 6.9 and 6.911z, CHCH3), 7.48 (111, ddd, J 8.2, 7.1 and 1.1Hz, CHbt), 7.63 (1H, 
ddd, J 8.2, 7.1 and 1.1Hz, CHbt), 8.10 (1H, ddd, J 8.2, 1.0 and 1.0Hz, 	and 8.29 
(1H, ddd, J 8.2, 1.1 and 1.0Hz, CHbt); SH  (CDC13; 63MHz), 11.4 (CH3), 16.6 (CH113), 
26.2 (CH2), 40.3 (CH), 114.4 (CHbt), 119.9 (CH), 125.9 (CHbt), 130.2 (CHbt), 131.1 
(bt), 146.1 (Cbt)  and 176.2 (C=O); mlz (ESi +ve, 45kV) 204.4 (50%, [MH]+); mlz 
(FAB, TI-HOG) 204 (70%, [MH]), 120 (100%, [BtH]); mlz (FAB, THIOG) Found 
204.11373 C11H14N30 requires 204.11366; [c]D2°  -28.9 (0.994, CHC13). 
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5.2.12 (R/S)-1 -Benzotriazol-1 -yl-3-phenyl-butan-1 -one (107) 
The general protocol 5.2.8 was followed with benzotriazole (3.0g, 25.2mmols, 1 
equiv.) dissolved in 'anhydro'us' DCM (75m1). To this was added dropwise a solution of 
triethylamine (3.541n1, 30.2mmols, 1.2 equiv.) and (R/S)-3-phenyl-butyryl chloride 106 
(5.05g, 27.7mmols, 1.1 equiv.) In addition to the normal work-up procedure the organic 
layer was washed with NaHCO3 (1M, 20m1), separated, dried over MgSO4, filtered and 
the solvent removed under reduced pressure to give a white solid (6.05g, 9 1%). 
Note: (R/S)-107 was analysed by normal phase chiral chromatography eluting on a 
gradient from Hexane:IPA: TFA (98:2:0.01) to Hexane: WA: TFA (90:10:0.01) over 20 
minutes with a column temperature of 2°C. 
Rf (DCM) 0.74; R (S) 13.4mins, (R) 14.2; U 	(thin film)/cm 1 3024 (CH), 2968, 
2942, 2880 (CH), 1738 (C=O), 1606, 1595 (C=C), 1483, 1450 and 1387; 6H  (CDC13; 
250MHz) 1.44 (3H, d, J 6.6Hz, Cth),  3.59-3.70 (2H, m, Cth),  3.76-3.86 (1H, m, C, 
7.15-7.36 (5H, m, Ph), 7.46 (1H, ddd, J 8.2, 7.1 and 1.1Hz, 	7.60 (1H, ddd, J 8.2, 
7.1 and 1.1Hz, 	8.08 (1H, ddd, J 8.3, 1.0 and 1.0Hz, CH,) and 8.23 (111, ddd, J 
8.3, 1.1 and 1.0Hz, CHbt); 811 (CDC13; 63MHz), 21.9 (CH3), 35.9 (CH), 43.4 (H2), 
114.2 (.Hbt), 119.9 (Hbt), 125.9 (CHbt),  126.6 (H), 126.7 (CH  x 2), 128.4 (CH x 
2), 130.1 (Hbt), 130.8 (C), 145.9 (cj3t),  146.6 () and 170.9 (C=O); mlz (ESi +ve, 
45kV) 266.1 (100%, [MH]4), 120 (50, [BtH]; mlz (FAB, 3-NOBA) 266 (80%, [MH]4), 
120 (90%, [BtH]+) and 77 (35%, [Ph]4); mlz (FAB, 3-NOBA) Found 265.12159 
C1QH12N30 requires 265.12151. 
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5.2.13 (S)-1-Benzotriazol-1-yl-3-phenyl-butan-1 -one (107) 
The general protocol (5.2.8) was followed with benzotriazole (0.30g, 2.52mmols, 
1 equiv.) dissolved in 'anhydrous' DCM (lOml). To this was added dropwise a solution 
of triethylarnine (0.360g, 3.Ommols, 1.2 equiv.) and (S)-3-phenylbutyryl chloride 106 
(5.06g, 2.8mmols, 1.1 equiv.) Purification by column chromatography eluting with 
DCM provided the desired product as a colourless glass/oil (0.517g, 77%). 
Note: The enantiomeric purity of (S)-107 was confirmed by normal phase chiral 
chromatography eluting on a gradient from Hexane:IPA:TFA (98:2:0.01) to 
Hexane:IPA:TFA (90:10:0.01) over 20 minutes with a column temperature of 2°C. 
Analysis comparable to 5.2.13 (R/S)-107 except; R (S) 13.4mins, (R) 14.2mins; mlz 
(FAB, 3-NOBA) Found 265.12139 C16H16N30 requires 265.12151; [cx]n2° - 10.6(l.27, 
CHC13). 
5.2.14 General procedure for preparation of benzotriazole esters 
The N-acyl benzotriazole (1.0equiv.) was dissolved in the specified volume of 
acetonitrile. To this solution was added crushed potassium carbonate (10-25 mol %) and 
the appropriate aldehyde (1.05-1.1equiv.). The reaction mixture was allowed to stir at 
room temperature until TLC analysis indicated complete consumption of the N-acyl 
benzotriazole. The potassium carbonate was removed by filtration and the solvent 
removed under reduced pressure to provide a crude mixture containing the 1' and 2' 
esters. Column chromatography on silica gel eluting with the specified solvent system 
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provided the desired 'ester' product. Chiral integrity (where applicable) of the 'ester' 
products was determined by normal phase chromatography and the HPLC conditions are 
detailed along with the experimental details for each compound. 
5.2.15 Butyric acid benzotriazol-1-yhnethyl ester (94a) and butyric acid 
benzotriazol-2-ylmethyl ester (95a) 
+ LXN 
N- N 
The general protocol 5.2.14 was followed with 92 (ig, 5.29mmols) dissolved in 
acetonitrile (18m1). To this was added formaldehyde (37%, 0.415m1, 5.6mmols) and 
potassium carbonate (0.100g, 15mol%) and the resulting mixture stirred at room 
temperature for 16hours after which time the reaction mixture had turned cloudy. The 
reaction was worked up as normal. Column chromatography on silica gel eluting with 
DCM provided the ester products 94a and 95a as thick colourless oils (0.79g, 68%) and 
(0.04g, 3%). 
94a 
Rf (DCM) 0.01; u 	(thin film)/cm' 3054 (CH), 2986, 2936, 2876 (CH), 1751-(C=O), 
1616, 1591 (C=C), 1455, 1422; SH  (CDC13; 250MIHz) 0.86 (3H, t, J 7.4Hz, Cth),  1.61 
(2H, tq, J 7.4 and 7.4Hz, CH3CjjCH2), 2.31 (1H, t, J 7.4Hz, CC=O), 6.58 (2H, s, 
CiO), 7.40 (1H, ddd, J 8.3, 7.1 and 1.0Hz, 	7.54 (1H, ddd, J 8.3, 7.1 and 1.0Hz, 
CHbt), 7.76 (1H, ddd, J 8.3, 1.0 and 1.0Hz, CHbt) and 8.06 (1H, ddd, J 8.3, 1.0 and 
1.0Hz, CHbt); S (CDC13; 63MHz) 13.8 (Cl3), 17.9 (CH3cH2),  35.4 (H2C=O), 67.5 
(CH20), 109.9 (CHbt), 119.9 (CHbt), 124.4 (CHbt), 128.2 (CHbt), 132.6 (cbt),  145.9 (cbt) 
and 172.6 (C=O); mlz (ESi +ve, 45kV) 220.2 (100%, [MIfl); mlz (FAB, THIOG) 220 
(95%, [MH]) and 120 (100%, [BtH]); mlz (FAB, THIOG) Found 220.10872 
C11H11N302 requires 220.10858. 
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95a 
Rf (DCM) 0.21; u 	(thin film)/cm' 3061 (CH), 2967, 2936, 2876 (CH'), 1761 (C=O), 
1563 (C=C), 1455; SH (CDC13; 250MIHz) 0.91(3H, t, J 7.4Hz, CH-j), 1.65 (2H, tq, J 7.4 
and 7.4Hz, CH3CjjCH2), 2.37 (1H, t, J 7.4Hz, CthC=O), 6.57 (2H, s, CO), 7.36-7.44 
(2H, m, Cllbt x 2) and 7.84-7.91 (2H, m, CHbt x 2); & (CDC13; 63MHz) 13.4 (H3), 17.9 
(CH3CH2), 35.5 (CH2C=O), 75.0 (CH20), 118.5 (Hbt x2), 127.3 (CHbt x2), 144.8 
x 2) and 171.7 (C=O); m/z (ESi +ve, 45kV) 220.2 (55%, [MH]4); m/z (FAB, THIOG) 
220 (100%, [MEIf') and 120 (75%, [BtH]'); m/z (FAB, THIOG) Found 220.10864 
C11H11N302 requires 220.10858. 
5.2.16 Butyric acid- 1-benzotriazol-1-ylethyl ester (94b) and butyric acid 1-
benzotriazol-2-ylethyl ester (95b) 
o 
Q19 + 	 0 N 
N I~D 
The general protocol 5.2.14 was followed with 92 (ig, 5.3mmols) dissolved in 
acetonitrile (15m1). To this was added acetaldehyde (0.277g, 5.6mmols) and potassium 
carbonate (0.182g, 25mo1%) and the resulting mixture stirred at room temperature for 16 
hours after which time the reaction mixture had turned cloudy. The reaction was worked 
up as normal and the crude product pre-absorbed on silica gel. Column chromatography 
on silica gel eluting with EtOAc:Hexane (4:1) provided the ester products 94b and 95b 
as thick colourless oils (0.92g, 75%) and (0.20g, 16%), respectively. 
94b 
Rf (EtOAc:Hexane, 4:1) 0.3; u (thin film)/cm' 3025 (CH), 2965, 2937, 2875 (CH), 
1746 (C=0), 1612, 1591, 1490 (C=C), 1453, 1413; 6H (CDC13; 250MHz) 0.83 (3H, t, J 
7.4Hz, C), 1.57 (2H, tq, J 7.4 and 7.4 Hz, CH3CfCH2), 2.08 (3H, d, J 6.4Hz, CH3), 
2.25 (1H, dt, J 16.0 and 7.4Hz, CH2CHaHbCO), 2.31 (1H, dt, J 16.0 and 7.7Hz, 
CH2CHaHbC=O), 7.37 (1H, ddd, J 8.3, 7.2 and 1.011z, C) partially overlapping 7.40 
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(1H, q, J 6.4Hz, CHCH3), 7.50 (1H, ddd, J 8.3, 7.2 and 1.0Hz, 	7.73 (1H, ddd, J 
8.3, 1.0 and 1.0Hz, C) and 8.04 (1H, ddd, J 8.3, 1.0 and 1.0Hz, Cj±,t); S (CDC13; 
63IV1Hz) 13.3 (CHH3), 17.9 (cH2), 19.3 (CHCH3), 35.6 (CH2C=O), 76.0 (CH), 110.1 
( .Hbt), 119.9 (Hbt), 124.2 (Hbt), 127.8 (CHbt), 132.1 (ca), 145.8 () and 172.1 
(C=O); mlz (ESi +ve, 45kV) 273.2 (30%, [MK]4), 255.7 (70%, [MNa]') 234.1 (15%, 
[MH]); mlz (FAB, NOBA) 234 (100%, [MH]), 190 (70%, [MH-CH3CH2CH2COI 
120 (90%, [BtH]); mlz (FAB, 3-NOBA) Found 233.11657 C12H16N302 requires 
233.11643 
95b 
Rf (EtOAc:Hexane, 4:1) 0.49; u .(thin filrn)/cm 1 3 024  (CH), 2967, 2942, 2877 (CH), 
1754 (C=O), 1612, 1591, 1490 (C=C), 1453, 1413; SH (CDC13; 250MHz) 0.83(3H, t, J 
7.4Hz, CHI), 1.57 (2H, tq, J 7.4 and 7.4 Hz, CH3CCH2), 2.08 (311, d, J 6.4Hz, Cth), 
2.25 (1H, dt, J 16.0 and 7.4Hz, CH2CHaHbC=O), 2.31 (111, dt, J 16.0 and 7.7Hz, 
CH2CHdJbC=O), 7.34-7.44 (3H, m, CH bt x 2 overlapping with CHCH3) and 7.83-7.93 
(2H, m, CHbt x 2); S (CDC13; 63MHz) 13.6 (CHH3), 17.9 (CH2), 20.3 (CHCH3), 34.9 
(CH2C=O), 84.1 (CH), 117.6 (Hbt x 2), 126.0 (CHbt x 2), 143.3 (C3t x 2) and 171.9 
(C=O); m/z (ESi +ve, 45kV) 255.8 (25%, [MNa]) 233.7 (45%, [MIH]); mlz (FAB, 
NOBA) 234 (30%, [MH]), 190 (50%, [MH-CH3CH2CH2C=O]+), 120 (100%, [BtH]); 
mlz (FAB, THIOG) Found 233.11650 C13H18N302 requires 233.1 1643. 
5.2.17 Butyric acid-1-benzotriazol-1-ylpropyl ester (94c) and butyric acid 1-





The general protocol 5.2.14 was followed with 92 (ig, 0.00529) dissolved in 
acetonitrile (15m1). To this was added propionaldehyde (0.322g, 0.0056mols) and 
potassium carbonate (0.182g, 25mo1%) and the resulting mixture stirred at room 
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temperature for 16hours after which time the reaction mixture had turned cloudy. The 
reaction was worked up as normal and the crude product pre-absorbed on silica gel. 
Column chromatography on silica gel eluting with EtOAc:Hexane (4:1) provided the 
ester products 94c and 95c as thick colourless oils (0.89g, 68%) and (0.20g, 15%), 
respectively. 
94c 
Rf (EtOAc: Hexane, 4:1) 0.29; U ,,,(thin fihn)1cm 1 3024 (CH), 2967, 2942, 2877 
(CH), 1746 (C=O), 1612, 1591, 1490 (C=C), 1453, 1413; Sj-j (CDC13; 250MIHz) 
0.89(311, t, J 7.4Hz, C), 0.99 (3H, t, J 7.4Hz, Crn), 1.63 (2H, tq, J 7.4 and 7.3Hz, 
CH3CthCH2), 2.32 (1H, ddq, J 15.9, 7.4 and 7.3Hz, CHCHaHbCH3), 2.37 (1H, ddq, J 
15.9, 7.4 and 7.3Hz, CHCH,IJbCH3), 2.52 (1H, dt, J 14.4 and 7.3Hz, CH2CjHbC=O) 
2.58 (1H, dt, J 14.4 and 7.5Hz, CH2CHaffbC=O), 7.21 (1H, t, J 7.2Hz, CHCH2CH3), 7.42 
(1H, ddd, J 8.3, 7.2 and 1.0Hz, CHbt), 7.55 (1H, ddd, J 8.3, 7.2 and 1.0Hz, CHbt), 7.78 
(1H, ddd, J 8.4, 1.0 and 1.0Hz, CHJ)t)  and 8.10 (1H, ddd, J 8.4, 1.0 and 1.0Hz, C1113t); 
& (CDC13; 63MHz) 9.6 (QH3), 13.8 (CH3), 18.5 (CH2), 26.9 (çH2),  36.2 (CH2C=O), 
81.0 (CH), 110.7 (Hbt), 120.5 (Hbt), 124.8 (CHbt), 128.4 (Hbt), 133.0 (cbt),  146.3 
(Qt) and 172.8 (C=O); nilz (ESi +ve, 45kV) 285.8 (10%, [MK]), 269.9 (50%, [MNa]') 
247.9 (5%, [MH]'); rnlz (FAB, NOBA) 248 (100%, [MH]), 190 (70%, [MH-
CH3CH2CH2C=0] 120 (100%, [BtH]); mlz (FAB, 3-NOBA) Found 248.13967 
C13H18N302 requires 248.13990. 
95c 
Rf (EtOAc:Hexane, 4:1) 0.46; 1) max(thll film)1cm 1 3 024  (CH), 2967, 2942, 2877 (CH), 
1752 (CO), 1612, 1591, 1490 (C=C), 1453, 1413; Sj (CDC13; 250MHz) 0.89 (311, t, J 
7.4Hz, Cj), 0.99 (311, t, J 7.4Hz, Cth),  1.63 (211, tq, J 7.4 and 7.3Hz, CH3CthCH2), 
2.32 (1H, ddq, J 15.9, 7.4 and 7.311z, CHCHaHbCH3), 2.37 (111, ddq, J 15.9, 7.4 and 
7.311z, CHCHCH3), 2.52 (1H, dt, J 14.4 and 7.311z, CH2CjHbC=O) 2.58 (111, dt, J 
14.4 and 7.5Hz, CH2CHbC=O), 7.18 (1H, t, J 7.211z, CHCH2CH3), 7.34-7.44 (211, m, 
CHbt x 2) and 7.83-7.93 (2H, m, CHbt x 2); Sc (CDC13; 63M}Iz) 7.8 (CH3), 12.6 (H3), 
133 
17.3 (CH2), 26.5 (CH2), 34.9 (CH2C=O), 85.9 (H), 117.8 (Hbt x 2), 126.2 (Hbt x 2), 
143.4 (bt  x 2) and 170.9 (C=O); m/z (ESi +ve, 45kV) 285.8 (10%, [MK]), 269.9 (50%, 
[MNa]) 247.9 (5%, [MH]); m/z (FAB, NOBA) 248 (30%, [MH]+), 190 (50%, [MH-
CH3CH2CH2C=01+), 120 (100%, [BtH]+); m/z (FAB, THIOG) Found 248.13951 
C13H18N302 requires 248.13990. 
5.2.18 Butyric acid-i -benzotriazol-1 -yl-2-methyl-propyl ester (94d) and butyric 
acid-i -benzotriazol-2-yl-2-methyl-propyl ester (95d) 
+ 
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The general protocol 5.2.14 was followed with 92 (ig, 5.3nimols) dissolved in 
acetonitrile (12m]). To this was added iso-butyraldehyde (0.485ni1, 5.6mmols) and 
potassium carbonate (0.16g, 25mo1%) and the resulting mixture stirred at room 
temperature for 16 hours. Column chromatography on silica gel eluting with DCM 
provided the title compounds 94d and 95d as thick colourless oils (ig, 72%) and 
(0.215g, 16%), respectively. 
94d 
Rf (DCM) 0.1; Rt 9.8 and 10.6 mins; u max  (thin film)1cm 1 3063 (CH), 2967, 2935, 
2876 (CH), 1750 (C=O), 1612, 1490 (C=C), 1452; 5H (CDC13; 250MHz) 0.79 (3H, d, J 
6.8Hz, CHCH3), 0.88 (311, t, J 7.4Hz, CthCH2), 1.22 (3H, d, J 6.7Hz, CHCH3), 1.55-1.7 
(2H, m CH3C), 2.25-2.45 (211, m, CJj2C=O), 2.95-3.10 (1H, dqq, J 9.7, 6.7 and 
6.7Hz, CH(CH3)2), 6.91 (1H, d, J 9.7Hz,CHCH(CH3)2), 7.41 (1H, ddd, J 8.4, 7.0 and 
1.0Hz, CHbt), 7.54 (1H, ddd, J 8.4, 7.0 and 1.0Hz, CHbt), 7.78 (1H, ddd, J 8.4, 1.0 and 
0.911z, CHbt) and 8.09 (1H, ddd, J 8.4, 1.0 and 0.9Hz, C); 8H (CDC13; 63MHz) 13.9 
(CH3), 18.2 (CHCH3), 18.5 (CH3(:H2), 18.9 (CHCH3) 33.3 (CH(CH3)2), 36.2 
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(CH2C=O), 84.4 (CHCH(CH3)2), 110.7 (CHbt), 120.4 (CHbt), 124.7 (CHbt), 128.4 (CHbt), 
133.2 (bt),  146.2 (Cbt) and 172.8 (C=O); mlz (ESi +ve, 45kV) 262.3 (70%, FrviBfl; mlz 
(FAB, NOBA) 262 (35%, [MH]),120 (100%, [BtH); m/z (FAB, THIOG) Found 
262.15521 C14H20N302 requires 262.15553. 
95d 
Rf (DCM) 0.3; Rt 6.5 and 10.1 mins; u ,(thin film)/cm-1 3063 (CH), 2967, 2935, 2876 
(CH), 1755 (C=O), 1612, 1562 (C=C), 1466 (C=C), 1451; 611  (CDC13; 250MHz) 0.80 
(311, d, J 6.8Hz, CHCth),  0.93 (3H, t, J 7.4Hz, CH3CH2), 1.16 (3H, d, J 6.8Hz, CHCH3), 
1.55-1.7 (2H, m, CH3C), 2.25-2.45 (214, m, CH2C=O), 2.95-3.10 (1H, dqq, J 9.7, 6.7 
and 6.7Hz, CH(CH3)2), 6.96 (1H, d, J 9.OHz,CHCH(CH3)2),  7.39-7.44 (2H, m, CHbt x 2) 
and 7.89-7.94 (2H, m, CHbt); 6 (CDC13; 63MHz) 13.9 (CH3), 17.8 (CHH3),18.3 
(CHCH3) 18.5 (CH3CH2), 32.2 (CH(CH3)2), 36.1 (CH2C=O), 90.1 (CHCH(CH3)2), 
119.1 (CHbt x 2), 127.4 (CHbt x 2), 144.5 (cbt  x 2) and 172.8 (C=O) 84.4 
(HCH(CH3)2), 110.7 (CHbt), 120.4 (CHbt), 124.7 (CHbt), 128.4 (CHbt), 133.2 
146.2 () and 172.8 (=O); mlz (ESi +ve, 45kV) 284.5 (70%, [MNa]4 ), 262.6 (25%, 
{MITJ1); mlz (FAB, NOBA) 262 (55%, [MIH] 4), 120 (100%, [BtH]'); mlz (FAB, 3-
NOBA) Found 262.15579 C14H20N302 requires 262.15553. 
5.2.19 Butyric acid benzotriazol-1-yl-(4-nitro-phenyl)-methyl ester - (94e) 
The general protocol (5.2.14) was followed with 92 (2g, 10.6mmols) dissolved in 
acetonitrile (24m1). To this was added p-nitrobenzaldehyde (1.38g, 11. immols) and 
potassium carbonate (0.3g, 25mo1%) and the resulting mixture stirred at room 
temperature for 16 hours. The reaction went purple during stirring and was worked up as 
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normal. Column chromatography on silica gel eluting with EtOAc:Hexane (4:1) 
provided the l-yl ester product as a thick colourless oil (2.15g, 62%). The 2' (95e) 
isomer could not be isolated in pure form due to contamination with p-
nitrobenzaldehyde. 
Rf (DCM) 0.21; Rt 10.8 and 14.7 mins; u (thin film)/cm' 3063 (CH), 2964, 2937, 
2875 (CH), 1756 (C=O), 1608, 1526 (C-NO2), 1492 (C=C), 1451 and 1348 (C-NO2); 
SH (CDC13; 250MHz) 0.89 (3H, t, J 7.4Hz, C), 1.67 (2H, tq, J 7.4 and 7.4Hz, 
CH3CkJ2), 2.44 (1H, dt, J 16.2 and 7.2Hz, CjHbC=O), 2.50 (111, dt, 16.2 and 7.6Hz, 
CHJJbC=O), 7.35-7.50 (3H, m, CH,,, x 3), 7.62 (1H, ddd, J 8.2, 7.0 and 1.0Hz, 
7.65 (1H, ddd, J 8.2, 7.0 and 1.0Hz, CHbt), 8.05 (1H, ddd, J 8.2, 1.0 and 1.0Hz, CHbt), 
8.22-8.28 (211, m, CH+ CHbt overlapping) and 8.50 (in, s, CHOC=O); SH (CDC13; 
63MHz) 13.3 (CH3), 17.9 (CH3CH2), 35.5 (CH2C=O), 78.5 (HO), 109.9 (CHbt), 120.3 
(CHbt), 123.9 (CH. x 2), 124.6 (CHbt), 124.6 (CHbt), 127.4 (CH  x 2), 128.4 (CHbt), 
131.7 	140.7 (), 146.0 	148.4 () and 171.2 (C=O); mlz (ESi +ve, 45kV) 
363.9 (20%, [MNa]) 341 (40%, [NM]'); mlz (FAB, NOBA) 341 (50%, [MH]), 120 
(100%, [BtH]1); mlz (FAB, NOBA) Found 341.12442 C17H16N404 requires 341.12498. 
5.2.20 Phenyl-acetic acid 1-benzotriazol-1-yI-ethyl ester (96) 
N-. N 
The general protocol 5.2.14 was followed with 93 (1g. 4.4mmols) dissolved in 
acetonitrile (12m1). To this was added acetaldehyde (0.215g, 4.8mmols, 1.1 equiv.) and 
potassium carbonate (0.15g, 25mo1%) and the resulting mixture stirred at room 
temperature for 16hours. Column chromatography on silica gel eluting with 
EtOAc:Hexane (4:1) provided the title compound as a thick colourless oil (0.89g, 75%). 
The 2' isomer was not isolated. 
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Rf (EtOAc:Hexane, 4:1) 0.15; u .(thin film)/cm-'3052,3024 (CH), 2999, 2942 (CH), 
1747 (C=O), 1611, 1492 (C=C), 1462,1408; 6H (CDC13; 250MHz) 2.09 (3H, d, J 6.3Hz, 
Cth), 3.59 (1H, d, J 15.4Hz, CiHbC=O), 3.63 (111, d, J 15.4Hz, CHJC=O), 7.14-
7.27 (514, m, CH x 5), 7.33-7.40 (2H, m, CHbt and CHCH3 overlapping), 7.46 (1H, ddd, 
J 8.2, 6.9 and 1.2Hz, CHbt), 7.61 (11J, ddd, J 8.2, 1.0 and 1.0Hz, CHbt) and 8.05 (1H, 
ddd, J 8.2, 1.0 and 1.0Hz, CHb); 8F1 (CDC13; 63MHz) 19.2 (çH3), 40.7 (H2C=O), 77.4 
(CH), 110.1 (CHbt), 119.8 (CHbt), 124.2 (CHbt), 127.2 (CHbt), 127.8 (H), 128.5 (CH 
x 2), 129.0 (CH,,, x 2), 132.0 (), 132.6 (Cbt), 145.8 (bt) and 170.1 (C=O); nilz (ESi 
+ve, 45kV) 319.6 (10%, [MK]), 303.7 (55%, [MNa]') 281.7 (65%, [MH]'); mlz (FAB, 
NOBA) 282 (100%, [IvIH]'), 146 (65%, [MH-PhCH2CO21), 120 (100%, [BtH]4), 91 
(100%, [PhCH2]') and 77 (50%, [Ph]); mlz (FAB, 3-NOBA) Found 281.12422 
C10H12N30 requires 28 1.12425. 
5.2.21 (R/S)-2-methyl butyric acid benzotriazol-1-yl methyl ester (lilA) and 2-
methyl butyric acid benzotriazole-2-yl-methyl ester (111B) 
0 	 - 
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The general protocol 5.2.14 was followed with (R/S)-110 (0.2g, 0.98mmols) 
dissolved in acetonitrile (3m1). To this was added formaldehyde (0.031g, 1.08mmols) 
and potassium carbonate (0.03g, 25mol%) and the resulting mixture stirred at room 
temperature for 16hours after which time the reaction mixture had turned cloudy. The 
reaction was worked up as normal and the crude product pre-absorbed on silica gel. 
Column chromatography on silica gel eluting with DCM provided the desired ester 
products (R/S)-111A and (R/S)-111B as thick colourless oils (0.31g, 67%) and (0.014, 
3%), respectively. Ester (R/S)-111A was analysed by normal phase chiral HPLC eluting 
with hexane: IPA:TFA (95:5:0.1) with a column temperature of 5°C 
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(R/S)-111A 
Rf(DCM) 0.14; R(S) 12.9 minutes, (R) 14.1 minutes;u ,,,,,(thin film)/cm-1 3043 (CH), 
2971, 2937, 2878 (CH), 1748 (C=O), 1616, 1593 (C=C), 1495, 1455; 8H  (CDC13; 
250MHz) 0.75 (3H, t, J 7.5Hz, Cth), 1.08 (3H, d, J 7.0Hz, CHCth),  1.38-1.49 (1H, m, 
CHbCH'), 1.51-1.63 (111, m, CHJJJCH),  2.39 (1H, tq, J 7.0 and 7.0Hz, CHCH3), 6.58 
(2H, s, CjO), 7.39 (1H, ddd, J 8.3, 7.0 and 1.1Hz, CHbt), 7.54 (1H, ddd, J 8.3, 7.0 and 
1.1Hz, CHbt), 7.74 (1H, ddd, J 8.3, 1.0 and 1.0Hz, CHbt) and 8.05 (1H, ddd, J 8.3, 1.0 
and 1.0Hz, CHbt); S (CDC13; 63IVIHz) 11.2 (Cl3), 16.1 (CHCH3), 26.3 (H2), 40.5 
(CHC=O), 67.6 (H2O), 109.9 (CHbt), 119.9 (CHbt), 124.4 (CHbt), 128.3 (CHbt), 132.5 
(cbt), 145.9 (Gbt)  and 175.6 (C=O);nilz (ESi +ve, 45kV) 234.2 (100, [MM'); m/z (FAB, 
THIOG) 234 (90%, [MI]4), 120 (80%, [BtH]4); m/z (FAB, THIOG) Found 234.12437 
C12H16N302 requires 234. 12423. 
(R/S)-111B 
Rf (DCM) 0.36; u (thin film)/cm' 3054 (CH), 2979, 2939, 2880 (CH), 1755 (C=O), 
1616, 1593 (C=C), 1495, 1455; 6 (CDC13; 250MIETz) 0.78 (3H, t, J 7.3Hz, C), 1.10 
(3H, d, J 7.0Hz, CHCj), 1.3 8-1.50 (1H, 111, CHaHbCH), 1.49-1.62 (1H, Ifl, CHabCH), 
2.39 (11, tq, J 7.0 and 7.0Hz, CHCH3), 6.68 (2H, s, CH20), 7.39- 7.44 (2H, m, 2 X 
CHbt), 7.85-7.95 (2H, m, CHbt); & (CDC13; 63Mhz) 11.2 (CH3), 16.2 (CHCH3), 26.4 
(CH2), 40.5 (CHC=O), 70.9 (CH20), 119.6 (CHbt x 2), 127.6 (HbtX 2), 143.2 (bt  x 2) 
and 173.6 (C=O); m/z (ESi +ve, 45kV) 234.2 (100, [M}l]4); m/z (FAB, THIOG) 234 
(90%, [MiH]4), 120 (80%, [BtH]4); m/z (FAB, THIOG) Found 234.12440 C12116N302 
requires 234.12423. 
5.2.22 (S)-2-methyl butyric acid benzotriazol-1-yl methyl ester (lilA) 
138 
0 	 - 
NN 
The general protocol 5.2.14 was followed with (S)-110 (0.2g, 0.98mmols) 
dissolved in acetonitrile (3m1). To this was added formaldehyde (0.031g, 1.08mmols) 
and potassium carbonate (0.03g, 25mo1%) and the resulting mixture stirred at room 
temperature for 16hours after which time the reaction mixture had turned cloudy. The 
reaction was worked up as normal and the crude product pre-absorbed on silica gel. 
Column chromatography on silica gel eluting with DCM provided the desired ester 
product as a thick colourless oil (0.110g, 47%). Ester (S)-111A was analysed by normal 
phase chiral HPLC eluting with hexane: ]PA: TFA (95:5:0. 1) with a column temperature 
of 5°C and determined to be a 87:13 mixture of enantiomers (74% e.e.). 
(S)-111A 
All analysis comparable to (R/S)-1 11 A except mlz (FAB, THIOG) Found 234.12424 
C12H16N302 requires 234.12423; [cx]n2° +13.4 (0.972, CHC13). 
5.2.23 (R/S)-3-Phenylbutyric acid benzotriazol-1-ylmethyl ester (105) and (R/S) 3-









The general protocol 5.2.14 was followed with (R/S)-107 (1.13g, 4.26mmols) 
dissolved in acetonitrile (lOmi). To this was added formaldehyde (0.132g, 4.47mmols, 
1.05equivs) and potassium carbonate (0.088g, lSmol%) and the resulting mixture stirred 
at room temperature for lóhours. Column chromatography on silica gel eluting with 
DCM provided the ester products 105 and 108 as thick colourless oils (0.924g, 73%) and 
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(0.023g, 2%), respectively. Ester (R/S)-105 was analysed by normal phase chiral HPLC 
eluting with hexane: IPA (70:30) with a column temperature of 5°c and determined to be 
a 50:50 mixture of enantiomers. 
(R/S)-105 
Rf (DCM) 0.27; R (R) 11.9 minutes, (S) 17.5 minutes; u ,,(thin film)/cm 1 3062, 3028 
(CH), 2966, 2928, 2878 (CH), 1750 (C=O), 1616, 1593 (C=C), 1495, 1454; 6ii  (CDC13; 
250MHz) 1.21 (3H, d, J 7.0, CHCth),  2.61 (1H, dd, J 15.2 and 7.7Hz, CkkHbCH), 2.63 
(1H, dd, J 15.2 and 7.3Hz, CHdbCH), 3.21 (1H, m, CHCH3), 6.48 (1H, d, J 11.2Hz, 
CHbO), 6.51 (1H, d, J 11.2Hz, CHaHbO), 7.00-7.15 (Sn, m, AM x 5), 7.39 (1H, ddd, 
J 8.2, 6.9 and 1.2Hz, CHbt), 7.48 (1H, ddd, J 8.2, 6.9 and 1.2Hz, CHbt), 7.58 (111, ddd, J 
8.2, 1.2 and 1.1Hz, CHbt) and 8.05 (1H, ddd, J 8.3, 1.1 and 1.0Hz, CHbt); & (CDC13; 
63MHz) 21.7 (CH3), 36.2 (CH), 42.2 (CH2C=O), 67.3 (CH20), 109.9 (CHbt), 119.8 
(CHbt), 124.3 (CHbt), 126.3 (CH), 126.3 (CH), 128.2 (CH), 128.2 (CH x 2), 132.4 
144.4 (), 145.9 () and 171.2 (C=O); miz (ESi +ve, 45kV) 318.1 (100%, 
[MNa]') 296.1 (30%, [MH]); mlz (FAB, 3-NOBA) 296 (50%, [MH]+), 120 (100%, 
[BtH]) and 77 (25%, [Ph]); mlz (FAB, 3-NOBA) Found 296.13972 C17H18N302 
requires 296.13990. 
(R/S)-108 
Rf (DCM) 0.61; u ,(thin film)/cm' 3043 (CH), 2971, 2937, 2878 (CH), 1754 (C=O), 
1593 (C=C), 1495, 1455; Si (CDC13; 250MHz) 1.21 (3H, d, J 7.0, CHCH3), 2.66 (1H, 
dd, J 15.5 and 7.9Hz, CHbCH'), 2.63 (1H, dd, J 15.5 and 7.3Hz, CH&hCH), 3.21 (1H, 
m, CHCH3), 6.48 (1H, d, J 9.9Hz, CHbO), 6.51 (in, d, J 9.9Hz, CHbO), 7.00-7.29 
(5H, m, AM x 5) 7.38-7.46 (2H, m, CHbt x 2) and 7.84-7.91 (2H, m, CHbt x 2); 
6 (CDC13; 63MHz) 21.6 (CH3), 36.1 (CH),  42.2 (CH2), 74.9 (CH20),  118.5 (CHbt x 2), 
126.5 (CH x 2), 127.3 (CH x 2), 128.4 (CH x 2), 144.8 (), 144.9 (it  x 2) and 
170.4 (C=O); mlz (ESi +ve, 45kV) 318.1 (15%, [MNa]) 296.1 (30%, [MB]4); mlz 
(FAB, 3-NOBA) 296 (60%, MM'), 120 (100%, [BtFI]+) and 77 (25%, [Ph]); nilz 
(FAB, 3-NOBA) Found 296.13984 C17H18N302 requires 296.13990. 
5.2.24 (S)-3-phenylbutyric acid benzotriazol-1-yhnethyl ester (105) and (S)-3-










The general protocol 5.2.14 was followed with (S)-107 (0.569g, 2.14nimols) 
dissolved in acetonitrile (5m1). To this was added formaldehyde (0.183g, 2.25nimols, 
1 .O5equivs) and potassium carbonate (0.045g, 15mol %) and the resulting mixture 
stirred at mom temperature for 1 6hours. Column chromatography on silica gel eluting 
with DCM provided the ester products (S)-105 and (S)-108 as thick colourless oils 
(0.443g, 70%) and (0.010g, 1.6%). Ester (S)-105 was analysed by normal phase chiral 
ITPLC eluting with hexane: WA (70:30) with a column temperature of 5°C and 
determined to be a 99.6:0.4 mixture of enantiomers. (>99% e.e.) 
(S)-105 
All analysis comparable to 5.2.23 except nilz (FAB, 3-NOBA) Found 296.13972 
C17H18N302 requires 296.13990; [aID20 +29.4 (1.0, CHC13). 
(S)-108 
All analysis comparable to 5.2.23 except rnlz (FAB, 3-NOBA) Found 296.13984 
C17H18N302 requires 296.13990. 
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5.2.25 Alternative methods of preparing benzotriazol-lyl-esters from a—chiral 
acids 
5.2.26 General protocol for coupling 1-Hydroxymethylbenzotriazole with 2-
methylbutyric acid. 
l-Hydroxymethylbenzotriazole 100 (lequiv.) and (R/S)-2-methyl butyric acid 
(lequiv.) was dissolved in 'anhydrous' DCM. The appropriate coupling reagents 
(1 equiv.) and base (1 equiv.) were added. The reactions were allowed to stir overnight at 
room temperature then analysed by gradient reverse phase HPLC eluting from 5:95 




Fester (R/S)-111 20.6 
2' ester (R/S)-112 21.8 
N-acyl Bt (R/S)-110 23.1 
5.2.27 (S)-2-Methyl butyric acid benzotriazol-1-yhnethyl ester (lilA) via 
Mitsunobu reaction 
Triphenyiphosphine (1.31g, Smmols, lequiv.) and 1-hydroxymethyl 
benzotriazole, 100 (0.82g, 5.5mmols, 1.lequiv.) were dissolved in 'anhydrous' THF 
(5m1). This solution was added dropwise to a solution of DEAD (0.87g, 5mmols, 
lequiv.) and (S) 2-methyl butyric acid 102 (0.56g, Snimols, lequiv.) in 'anhydrous' THF 
(5 ml). The reaction was allowed to stir overnight at room temperature after which time 
the solution had decolourised. The solvent was removed under reduced pressure and the 
crude mixture suspended in ether. The white precipitate formed was removed by 
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filtration. The crude material was further purified by column chromatography on silica 
gel eluting with DCM: EtOAc (4:1) to provide the title compound as a colourless oil 
(0.91g, 78%). 
The same procedure was used for entries 5 and 6 Table 5) except 'anhydrous' DMF or 
resin bound PPh3 were used, respectively. 
Analysis comparable to 5.2.22 except; Ester (S)-111 was analysed by normal phase 
chiral HPLC eluting with hexane: IPA:TFA (95:5:0.1) with a column temperature of 
5°C and determined to be a 99:1 mixture of enantiomers (>98% e.e. - (S)). mlz (FAB, 
THIOG) Found 234.12437 C12H16N302 requires 234.12423; [aID2°  +17.9 (0.98, CHC13). 




Benzotriazole (6g, 0.05mols) and formaldehyde (37%, 4.32n11) were dissolved in 
a mixture of glacial acetic acid and H20 (1 5m1, 1:2) and stirred overnight at room 
temperature. A white precipitate formed which was isolated by filtration and dried to 
constant weight under reduced pressure over P205 to provide the desired product as a 
white powder (7.01g, 93%). 
Rf (DCM: Hexane) 0.28, Rf Bt = 0.28; Rf (DCM) 0.47, Rf Bt = 0.47; Mp 149-150°C, 
Lit. 139  Mp.148-149°C; u 	(nujol)/cm' 3171 (OH), 1614 (C=C), 1591 (C=C), 1494; 
8H ((CD3)2S0; 250MHz) 6.04 (211, d, J 7.3Hz, CO), 7.24 (1H, t, J 7.4Hz, CH20H), 
7.42 (1H, ddd, J 8.0, 7.0 and 0.9Hz, CHbt), 7.57 (1H, ddd, J 8.0, 7.0 and 0.9Hz, CHbt), 
7.91 (111, br d, J 8.0Hz, CHbt) and 8.06 (1H, br d, J 8.0Hz, CHbt); SH ((CD3)2S0; 
63MHz) 70.4 (CH20), 111.1 (CHbt), 119.2 (CHbt), 124.2 (CHbt), 127.5 (Hbt), 132.4 
() and 145.7 (); mlz (ESi, +ve) 120 (100%, [MH-CH20H]+); mlz (FAB, NOBA) 
120 (10%, [MH-CH20H]). 
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5.2.29 Preparation of protected amino acid containing substrates 




Carboxybenzyloxy-L-phenylalanine (3g, O.Olmols, 1 equiv.) and pyridine (1 
equiv., 0.808m1, 0.01mols) were suspended in 'anhydrous' DCM (20m1) under an inert 
atmosphere of nitrogen. The reaction mixture was cooled to —15°C in an salt/ice bath 
and cyanuric fluoride (1 equiv., 1.35g, O.Olmols) dissolved in 'anhydrous' DCM (lOml) 
was added dropwise. A white precipitate formed on addition of the cyanuric fluoride and 
the reaction mixture was stirred at —15°C for 2 hours. After this time crushed ice and 
further DCM (20m1) were added and the organic layer separated. The aqueous layer was 
re-extracted with further DCM (lOmi). The combined organic layers were washed with 
ice-cold H20, separated, dried over MgSO4, filtered and the solvent removed to provide 
the desired product as an off-white solid. The product was purified by recrystallisation 
from EtOAc to provide the product as a white powder (2.3g, 77%). 
Mp 81-82°C, Lit"' 80-83°C; u (nujol)/cm' 3324 (NH), 3029 (CH), 1832 (C=O, 
acid fluoride), 1676 (C=O, urethane), 1535 (C=O, urethane); 5n  (CDC13; 250M}Iz) 3.17 
(211, br d, J 5.5Hz, CHCf),  4.8-4.86 (1H, in, CRCH2), 5.11 (2H, s, CH2000) 5.15 
(111, obscured by CH2000, NH), 7.13 - 7.26 (2H, in, CH x 2) and 7.28-7.41 (8H, in, 
CH,); Sc (CDC13; 63MHz) 36.7 (H2), 53.1 and 54.1 (CH,  split by COF, J 60Hz), 67.3 
(CH2000), 127.7 (CH), 128.1 (CH x 2)128.3 (CH), 128.5 (H r x 2),128.9 (H x 
2), 129.0 (CHI x 2), 134.0 (Cr), 135.6 (C), 155.4 (OC=O), 158.7 and 164.6 (COF, 
split by '9F, J 370Hz); m/z (FAB, 3-NOBA) 302 (20%, [MIET]), 136 (70%, [MH- 
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PhCH20C=0]), 91(100, [PhCH2]'), 77 (60%, [Ph]); Found 302.11872 C171117NO3F 
requires 302.11925; [a]D20 -29.7 (1.0, EtOAc), Lit 113  [cx]D20 —30 (1.3, EtOAc). 
5.2.31 (S)-2-Benzotriazol-1 -yl-1 -benzyl-2-oxo-ethyl)-carbamic benzyl ester (114) 
Ph O NN 
Benzotriazole (0.40g, 3.4 mmols) was dissolved in 'anhydrous' DCM (lOud) 
under an inert nitrogen atmosphere. This solution was cooled to 0°C in an ice bath and a 
solution of triethylamine (0.56m1, 4.1 mmols, and 1.2 equiv.) in 'anhydrous 'DCM (5m1) 
was added drop wise. After complete addition of the triethylamine, a solution of (S)-113 
(1.13g, 3.7nimols, 1.1 equiv.), in 'anhydrous' DCM (5m1), was added drop wise. The 
reaction was stirred for 30mins at 0°c then a further 1 hour at room temperature. After 
this time the reaction was quenched by the addition of HC1 (1M, 5m1). The organic layer 
was separated and the aqueous layer re-extracted with further DCM (20m1). The 
combined organic layers were washed with H20 (lOmi), aqueous NaHCO3 (5%, lOmi), 
H20 (1 OmI), sat. NaCl (lOnil), dried over MgSO4, filtered and the solvent removed 
under reduced pressure to provide the desired product as a white solid (0.92g, 69%). 
Rf (DCM, 100%) 0.38; Mp 148-150°c; 1) max(1T1ujol)/cm 3311 (NH), 3029 (CH), 1743 
(C=O), 1688 (C=O, urethane), 1541 (C=O, urethane); SH (CDC13; 250MHz) 3.22 (111, 
dd, J 14 and 7.711z, CHCiaCHb), 3.48 (111, dd, J 14 and 5.1 Hz, CHCHaHb), 5.08 (2H, s, 
CJOCO) 5.54 (1H, d, J 8Hz, NH'), 6.04-6.13 (1H, m, CHCH2), 7.11-7.32 (10H, m, 
CH., x 10), 7.54 (111, ddd, J 8.2, 7.1 and 1.1, CH1),  7.68 (1H, ddd, J 8.2, 7.1 and 1.1, 
8.15 (1H, d, J 8.211z, CHbt) and 8.23 (111, d, J 8.2Hz, C,); Sc (CDC13; 63MHz) 
38.7 (Cl2), 55.5 (CI), 67.1 (CH2000), 114.2 (CHbt), 120.3 (CHbt), 126.5 (CHbt), 127.3 
(CH), 128.0 (CH), 128.2 (CH), 128.4 (CH), 128.6 (CH1  x 2), 129.1 (CHa,  x 2), 
130.7 (CH,,,), 130.9 (), 134.8  (), 135.9  (), 145.9  (), 155.6 (OC=O) and 170.7 
(COF); mlz (ESi +ve, 45kV) 423.2 (40%, [MNa]), mlz (FAB, 3-NOBA) 401 (20%, 
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[MH]), 136 (80%, [MH- PhCH20C=0]), 120 (30%, [Bt]), 91(100, [PhCH2]), 77 
(60%, [Ph]); Found 401.16089 C231121N403 requires 401.16137; [aID2°  +20.2 (1.09, 
CHC13). 
5.2.32 (S) -2-Benzyloxycarbonylamino-3-phenyl-propionic benzotiiazol-1-ylmethyl 
ester (112) 
Ph 
Ph ' 0 NH 0 
(S)-114 (0.5g, 1.3mmols) and powdered potassium carbonate (15mol%, 25.9mg, 
and 0.2mmols) were suspended in acetonitrile (50m1- large volume required due to 
insolubility of 114) and stirred vigorously. To this solution was added formaldehyde 
(1 .O5equivs, 0. 106m1, and 1 .4mmols) and the reaction was stirred at room temperature 
overnight. TLC indicated that the reaction had not gone to completion so a further 
volume of formaldehyde was added (1.05 equivs, 0.106m1, 1.4mmols) and the reaction 
mixture stirred for a further 16 hours at room temperature. The powdered potassium 
carbonate was removed by filtration and the solvent removed under reduced pressure to 
yield a yellow oil. Column chromatography on silica gel eluting with DCM:EtOAc 
(95:5) provided the desired product as a colourless glassy solid (288mg, 54%). 
The chiral purity of 114 was determined to be 90% e.e. by normal phase HPLC eluting 
with Hexane:IPA (80:20) at 1m1/min' and 5°C. 
Note: The 2' ester of 114 was not isolated but a very faint spot (Rf 0.57, DCM:EtOAc 
(95:5)) was detected. 
Rf (DCM:EtOAc, 95:5) 0.43; R (S)-enantiomer 40.9niins, (R)-enantiomer 48.1mins; Mp 
98-100°C; ii (thin film)/cm 1 3323 (NH), 3052, 3032 (CH), 2976, 2930 (CH), 1758 
(C=O), 1716 (C=O, urethane), 1615 (C=C), 1541 (C=O, urethane), 1496, 1455; 
SR (CDC13; 250MHz) 3.01 (211, d, J 5.9Hz, CHCU), 4.64-4.72 (1H, m, CHCH2), 5.06 
(2H, s, CH2000) 5.19 (1H, d, J 8.3Hz, NH), 6.51 (1H, d, J 11.1Hz, CffaHbO), 6.69- 
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6.74 (3H, m, CHaHbO + CH overlapping), 6.90-7.08 (311, m, C x 3) 7.31-7.39 (5H, 
m, CHx 10), 7.43 (1H, ddd, J 8.1, 7.0 and 1.0Hz, CHbt), 7.52 (1H, ddd, J 8.2, 7.0 and 
1.0 Hz, 	7.66 (1H, d, J 8.3Hz, CHbt) and 8.10 (1H, d, J 8.2Hz, CHbt); Sc (CDC13; 
63MiHz) 37.5 (CH),  54.5 (CH), 67.0 (CH2000), 68.1 (OH2), 109.9 (CHbt), 120.0 
(CHbt), 124.5 (CHbt), 127.0 (CH), 128.0 (H x 2), 128.1 (cH,x  2), 128.3 (CHx 2), 
128.3 (CH),128.7 (CH  x 2), 132.6 (), 134.4  (), 135.8  (), 145.9 (Ca),  155.4 
(OC=O) and 170.8 (C=O); mlz (ESi +ve, 45kV) 453.2 (100%, [MNa]'), 431.2 (60%, 
[IvIHj; mlz (FAB, 3-NOBA) 453 (10%, {MNa], 431 (100%, [MH]), 136 (30%, EMil-
PhCH20C=01), 91(60, [PhCH2]4 ), 77 (35%, [Ph]); Found 431.17187 C23H21N403  
requires 431.17193; [aID20—  6.3 (1.27, CHC13). 
5.2.33 (S)-2-Benzyloxycarbonylamino-3-phenyl-propionic benzotriazol-1 -yhnethyl 
ester (112) 
Ph 
PhO'  NH 
(S)-113 (ig, 3.3mmols, 1 equiv), EDCI (0.63g, 3.3mmols, 1 equiv.), DIPEA 
(0.42g, 3.3mmols, 1 equiv) and 1-hydroxybeuzotriazole (0.45g, 3.3mmols, 1 equiv.) 
were dissolved in 'anhydrous' DCM (50m1) and allowed to stir for 30 minutes at room 
temperature. 1-Hydroxymethylbenzotriazole 100 (0.492g, 3.3mols, 1 equiv.) was added 
and the solution stirred for a further 16 hours at room temperature. The reaction mixture 
was washed with H20 (10m]), aqueous K2CO3 (10%, lOml), H20 (lOmi) and brine. The 
organic layer was separated, dried over MgSO4, filtered and the solvent removed under 
reduced pressure to give a thick yellow oil. Column chromatography eluting with 
DCM:EtOAc (95:5) gave the desired product as a white solid (0.539g, 37%). 
The chiral purity of (S)-112 was determined to be 100% e.e. by normal phase HPLC 
eluting with Hexane: IPA (80:20) at lmlImin 1 and 5°c. 
Analysis comparable to 5.2.32 except R (S)- enantiomer 40.9mins, (R)-enantiomer not 
detected; mlz (FAB, 3-NOBA) Found 431.17295 C23H21N403 requires 431.17193; 
[aID2° - 8.9 (1.02, CHC13). 
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5.2.34 (R/S) -2-Benzyloxycarbonylamino-3-phenyl-propionic benzotriazol-1-yl 
methyl ester (112) 
Ph 
#b Ph' O' NH 	o . 
(R/S)-103 (ig, 3.3mmols, 1 equiv), EDCI (0.634, 3.3mmols, 1 equiv.), DIPEA 
(0.42g, 3.3mmols, 1 equiv) and 1-hydroxybenzotriazole (0.446g, 3.3mmols, 1 equiv.) 
were dissolved in 'anhydrous' DCM (50m1) and allowed to stir for 30 minutes at room 
temperature. 1-Hydroxymethylbeuzotriazole 100 (0.492g, 3.3mmols, 1 equiv.) was 
added and the solution stirred for a further 16 hours at room temperature. The reaction 
mixture was washed with H20 (10m]), aqueous K2CO3 (10%, lOmi), H20 (lOmi) and 
brine. The organic layer was separated, dried over MgSO4, filtered and the solvent 
removed under reduced pressure to give a thick yellow oil. Column chromatography 
eluting with DCM: EtOAc (95:5) gave the desired product as a thick oil (0.350g, 25%). 
The enantiomeric purity of (RIS)-112 was determined to be 0% e.e. by normal phase 
HPLC eluting with hexane:]PA (80:20) at lmllmiif1 and 5°C. 
Analytical data comparable to 5.2.33 except mlz (FAB, 3-NOBA) Found 431.17185 
C231121N403 requires 43 1.17193. 
5.2.35 (S)-{ 1-[(Benzotriazol-1 -ylmethyl)-aminocarbonyl]-2-phenyl-ethyl}-carbamic 
acid benzyl ester. 
C) 
%% __O' 
Commercially available Z-L-phenylalanine amide 116 (0.5g, 1.67mmols, 
lequiv.) and 1-hydroxymethylbenzotriazole 100 (0.25g, 1.67mmols, 1 equiv.) were 
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dissolved in acetic acid (4m1) and refluxed for 6 hours. The acetic acid was removed 
under reduced pressure to give a yellow oil which was dissolved in DCM (lOmi) and 
washed with Na2CO3 (10%, 6m1). The organic layer was separated, dried over MgSO4 
and the solvent removed to give a white solid. Purification by silica gel chromatography 
eluting with EtOAc:DCM (1:1) gave the desired compound as a white solid (0.237g, 
33%). 
M.P. 162°C Rf (EtOAc:DCM, 1:1) 0.53; u max(nujol)/cm'  3293 (NH), 1682 (C=O, 
urethane), 1628 (C=O, amide), 1605 (C=C) and 1537 (C=O, amide); 5H ((CD3)2S0; 
250MHz) 2.73 (1H, dd, J 13.6 and 10.0H-z, CHCHb), 2.92 (1H, dd, J 13.6 and 4.7Hz, 
CHCHaHb), 4.23.4.30 (1H, m, CHCH2), 4.95 (2H, s, CO), 6.03 (1H, dd, J 14.0 and 
6.4Hz, NIHCHb), 6.07 (1H, dd, J 14.0 and 6.5Hz, NHCH3ff13), 7.00-7.37 (11H, m, Ph 
x1  + OCONH), 7.44 (1H, ddd, J 8.2, 7.1 and 1.0Hz, CHbt), 7.57 (1H, ddd, J 8.2, 7.1 and 
1.0Hz, CHbt), 7.96 (1H, d, J 8.4Hz, CHbt), 8.07 (1H, d, J 8.4Hz, CHbt) and 9.50 (1H, t, J 
6.5Hz, CH2Nfl);  S ((CD3)2S0; 63MHz) 38.0 (CHH2), 52.0 (NCH2N), 57.1 (HCH2), 
66.2 (CH20), 112.2 (CHbt), 119.9 (CHbt), 125.0 (CHbt), 127.1 (CHbt), 128.2 (H), 
128.3 (CH x 2), 128.6 (CH), 128.8 (CHI x 2), 129.1 (CH x 2), 129.9 (CHa, x 2), 
133.0 (), 137.8  (), 138.4 (), 146.2 (Cbt), 156.7 (C=O, urethane) and 173.4 (C=O, 
amide); mlz (ESi +ve, 45kV) 468.0 (10%, [MK]), 451.9 (100%, [MNa]), 429.9 (10%, 
[MHj); mlz (FAB, 3-NOBA) 430 (20%, [MM), 120 (50%, [BtH]+), 107 (60%, 
[PhCH20]), 91(70%, [PhCH2])and 77 (60%, [Ph]); mlz (FAB, 3-NOBA) Found 
430.18775 C24H24N503 requires 430.18789; MD 2' -12.3 (1.00, CHC13) 
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5.2.36 [1-(1 -Benzotriazol-1 -yl-2-methyl-propylcarbainoyl)-2-phenyl-ethyl]-
carbamic acid benzyl ester. 
0 
K 
 N jel 
N-O 
Commercially available Z-L-phenylalanine amide 116 (2.98g, lOmmol, 1 equiv.), 
freshly distilled iso-butyraldehyde (1.02g, 14. immols, 1.4 equivs.), benzotriazole 
(1.81g, 15.2mmols, 1.5equivs.) and a catalytic amount ofp-toluenesulphonic acid (0.lg) 
were stirred in anhydrous toluene (30m1) for 30 minutes at room temperature. The 
reaction mixture was heated under reflux for 2 hours, using Dean Stark conditions to 
remove any water formed. After this time, TLC indicated that a substantial amount of 
amide remained and so further iso-butyraldehyde was added and refluxing continued for 
a further 2 hours. The solution was allowed to cool and the solvent removed under 
reduced pressure to yield a brown oil. The brown oil was dissolved in ethyl acetate 
(30m1), washed with K2CO3 (1M, lOmi x 2) and water (lOmi x 2). The organic layer was 
separated, dried over MgSO4 and the solvent removed under reduced pressure to yield 
brown oil. Further purification by column chromatography on silica gel eluting with 
Hexane:EtOAc (1:1) gave the desired product as a white foam (2.16g, 44%). The 
compound was obtained as a 50:50 mixture of diastereomers as confirmed by HPLC and 
integrals in 1H NMR. 
M.P. 183°C; R1 (Hexane:EtOAc, 1:1) 0.4; u (IR card)/cm' 3293 (NH), 1681 (C=O, 
urethane), 1668 (C=O, amide) and 1537 (C=O, amide); 6H  ((CD3)2S0; 250MHz) 0.56 
(1.51-1, d, J 61-1z, CH(CH3)3), 0.58 (1.5H, d, J 611z, CH(CH3)3), 1.00 (1.5H, d, J 6.511z, 
CH(CH3)3), 1.16 (1.511, d, J 6.5Hz, CH(Cth)3), 2.52-2.79 (3H, m, CHCH2 + CH(CH3)3 
overlapping), 4.29-4.30 (1H, m, CHCH2), 4.96 (2H, s, CjO), 6.24-6.37 (1H, m, 
NHCH(CHNbt), 7.00-7.37 (11H, m, ArH + OCONH), 7.46 (1H, ddd, J 8.2, 7.1 and 
WIC 
1.0Hz, Cj1,), 7.55 (1H, ddd, J 8.2, 7.1 and 1.0Hz, 	7.92 (1H, d, J 8.4Hz, 
8.03 (1H, d, J 8.4Hz, CHbt), 9.49 (0.5H, d, J 8.3Hz, CHNH) and 9.52 (0.5H, d, J 8.31HIz, 
CHNff); & ((CD3)2S0; 63M1EIz) 18.4 (CH(CH3)2),  18.9, 19.1 (CH(CH3)2), 31.8, 31.9 
(CH(CH3)2), 37.2, 37.8 (CHCH2), 55.9, 56.2 (HCH2), 65.3, 65.4 (çH20), 68.7, 68.9 
(NHCHN) 111.2, 111.3 (cHbt),  119.2 (CHbt), 124.2, 124.2 (CHbt), 127.1 (CHbt), 128.2 
(CH), 128.3 (CH x 2),128.6 (CH), 128.8 (CH  x 2),129.1 (CH x 2),129.9 (CH., x 
2), 132.3, 132.6 (Q), 137.0, 137.1, 137.4, 137.7 	145.1, 145.2 (cb),  155.8, 155.9 
(C=O, urethane) 172.2 and 172.3 (C=O, amide); mlz (ESi -ye, 45kV) 470.4 (100%, 
[MHfl; mlz (FAB, 3-NOBA) 472 (50%, [MH]), 120 (50%, [BtH11), 107 (30%, 
[PhCH201), 91(70%, [PhCH2]) and 77 (50%, [Ph]'); nilz (FAB, 3-NOBA) Found 
472.23442 C27H30N503 requires 472.23487; [aID2°  -17.2 (1.00, CHC13). 
5.2.37 (R/S) 3-Phenylbutyric acid methyl ester (104) 
(R/S)-3-Phenylbutyric acid (4g, 24mmols) was dissolved in methanol (30nil) and 
a catalytic amount of conc. H2SO4  was added. The resulting mixture was refluxed for 8 
hours and allowed to cool. The methanol was removed under reduced pressure and the 
crude oil dissolved in hexane (50m1). The solution was washed with NaHCO3 (5%, 20" 
x 3), H20 (30m1) and the organic layer separated. The organic layer was dried over 
MgSO4 and the solvent removed to give the desired product as a clear liquid (3.7g, 
85%). 
Chiral HPLC on a Chiracel OD-H column using an isocratic method eluting with 10% 
IPA and 90% Hexane at 20°c gave baseline separation of both enantiomers. 
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Rt (R)-enantiomer 4.3mins, (S)- enailtiomer 6.7niins;u (neat)/cm' 3084, 3062, 3029 
(CH), 2964, 2874 (CH), 1738 (CO, ester) and 1603 (C=C); 6H (CDC13; 200MIHz) 
1.39 (3H, d, J 7.0Hz, CHCITI),  2.62 (1H, dd, J 15.3 and 8.6hz, CHCHaHb), (1H, dd, J 
15.3 and 6.6Hz, CHCHjb), 3.28-3.46 (1H, m, CHCH2), 3.70 (3H, s, OCth)  and 7.25-
7.43 (5H, m, Ph); S (CDC13; 63MHz) 20.8 (CHH3), 35.5 (H), 41.8 (H2), 50.4 
(OCH3), 125.4 (CH), 125.7 (QHar x 2), 127.5 (CH x 2), 144.7 () and 171.7 (C=O). 
Note: A sample of (S)-3-Phenyl butyric acid methyl ester 104 was also prepared in a 
similar manner to use as a standard for Chiral HPLC. 
5.3.0 Enzymatic studies on benzotriazole substrates 
5.3.1 Screening of lipases for hydrolysis of 94a-e, 95d and 96. 
Hydrolysis experiments were performed in glass tubes (2m1) with plastic 
stoppers. 0.9m1 of a stock substrate solution (to give 0.003nimol per reaction e.g. for 94b 
0.8mg/mi) was added to 0.lml of a stock enzyme solution (1mg/mi). The solutions were 
rotated for three hours at room temperature on a 3600 blood rotator, after which time a 
200tl sample was taken and quenched with 200it1 of acetone. The resulting solution was 
centrifuged, to remove the precipitated enzyme, and 20041 of supernatant were diluted to 
600 pl with CH3CN:H20 (50:50) and analysed by reverse phase HPLC. Control 
experiments contained all reagents except the enzyme. 
HPLC conditions: Using equipment according to section 5.1.3 with a gradient method 
eluting with H20 (0.1% TFA) and CH3CN (0.1% TFA). 
Time (mins) %H20 (0.1%TFA) %CII3CN (0.1%TFA) 
0 70 30% 
30 10 90 
35 10 90 
35.01 95 5 
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Stock substrate solutions: Prepared to give 0.003mmols of substrate per reaction (i.e. 
for 94b concentration = 0.8mg/mi in 10% CH3CN pH7 buffer) 
Stock lipase/esterase solution: Prepared freshly prior to each hydrolysis experiment at 
a nominal concentration of 1mg/mi in p117 buffer. 
Sodium phosphate buffer solution (pH7): Prepared in accordance with Methods in 
Enzymology 161 
5.3.2 Enzymatic hydrolysis of (+1-) 3-phenylbutyric acid benzotriazol-1-ylmethyl 
ester and (+1-) 3-Phenylbutyric acid methyl ester 
Hydrolysis experiments were performed, in quadruplicate, in glass tubes (2m1) 
with plastic stoppers. 0.05m1 of a stock substrate solution (50.1mg/mi for (R/S)-105 and 
30.0mg/mi for (R/S)-104) was added to 0.45m1 of a stock enzyme solution. The 
solutions were rotated for a known time period at room temperature on a 360° blood 
rotator, after which time imil of acetonitrile was added. 2 samples were taken 
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immediately; the first a 0.5m1 aliquot diluted to imi with further acetonitrile for analysis 
by reverse phase HPLC and the second a 0.25m1 aliquot diluted to lml with IPA for 
analysis by normal phase chiral HPLC. The reverse phase HPLC method allowed 
determination of the extent of conversion (using the relative response factor (RRF) of 
the ester with respect to the 3 -phenylbutyric acid) and the chiral method determined the 
e.e. of the remaining substrate. Control experiments contained all reagents except the 
enzyme 
Reverse phase HPLC conditions: Using equipment according to section 5.1.3 with an 
isocratic method eluting with 55% H20 (0.1% TFA) and 45% CH3CN (0.1% TFA). 
Specificity of HPLC method: 
Analyte Rt(mins) RRF 
Benzotriazole 3.2 - 
3-Phenylbutyric acid 5.9 - 
104 15.3 1.01 
105 21.7 2.87 
Normal phase HPLC conditions (RIS)-105: Using equipment according to section 
5.1.3 on a Chiracel OD column using an isocratic method eluting with 55% IPA and 
45% Hexane at 20°C. 
Analyte R (mins) 
(R)-105 6.6 
(S)-105 8.6 
Normal phase IIPLC conditions for (R!S)-104: Using equipment according to section 
5.1.3 on a Chiracel OD-H column using an isocratic method eluting with 10% IPA and 
90% Hexane at 20°C. 
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Analyte R (mins) 
(R)-104 4.3 
(S)-104 6.7 
5.3.3 Initial rate determination for hydrolysis of (R/S)-104 and (RIS)-105 
Hydrolysis experiments were performed, in duplicate, using a Gilson SK233 
system. 2m1 of a stock substrate solution (1.0mg/mi for (R/S)-105 and 0.6mg/mi for 
(R/S)-104 in CH3CN) was added, followed by 15m1 of pH7 buffer. The hydrolysis was 
initiated by addition of imi of the stock enzyme solution (1mg/mi in pH 7 buffer).The 
solutions were magnetically stirred and sampled automatically after 2 minutes. 
Subsequent sampling occurred every five minutes for the first 30minutes and thereafter 
every 30minutes for 4 hours. At each sampling interval 250tl was removed, placed in a 
separate HPLC vial and quenched by the addition of 7501..xl of acetonitrile. }IPLC 
analysis using the methods documented in section 5.3.2 determined the amount of 
conversion. 
Note: For slower hydrolysis reactions sampling was performed at less frequent intervals 
over a longer analysis time. 
5.3.4 a— Chymotrypsin hydrolysis of 117 and 118. 
Hydrolysis experiments were performed in glass tubes (2m1) with plastic 
stoppers. 0.lml of a stock substrate solution (1mg/mi in CH30H'), 0.lnil of 
a—chymotrypsin solution (freshly prepared at 1mg/mi in distilled water), 0.lml of 0.1M 
Tris HCl buffer at pH 7.8 and 0.7 ml of distilled H20 were added. The solutions were 
rotated for 24 hours at room temperature on a 360° blood rotator, after which time the 
solution was analysed directly by reverse phase HPLC using a gradient method 
described in Section 5.3.1. 
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Specificity of HPLC method: 






117 - diastereomer 1 26.8 
117 —diastereomer 2 27.0 
5.4 Synthesis of SERRS active benzotriazole dyes 
5.4.1 General procedure for phenolic monoazo benzotriazole dyes 119 and 120 
5-aminobenzotriazole (1. lequiv.) was dissolved in a solution of 2m1 of 36% (v/v) 
hydrochloric acid solution and 3m1 of iced water. The resulting solution was cooled to 
0°C and a cooled aqueous solution of sodium nitrate (1.2 equiv.) was added dropwise 
until an immediate blue/black colour was observed on starch/iodine paper (A small 
volume of the reaction solution was removed and tested). The diazotised 
aminobenzotriazole solution was added dropwise over 30mins to a stirred cooled 
solution of the appropriate phenol component (1.0 equiv) dissolved in sodium hydroxide 
solution (1.OM, 15m1) with sodium acetate added (lOg) and acetone (15m1). The pH was 
monitored and maintained >7.0 by addition of further sodium hydroxide solution (1M) if 
required. The deeply coloured solution was maintained at 0°C for 30mins and allowed to 
stir at room temperature for a further ihour. The pH of the solution was adjusted to 7.0 
using 1M HC1 and the precipitate formed collected by filtration. The precipitate was 
washed with saturated KC1 (lOmi x 2), 10% aq. acetic acid (lOmI x 2) and H20. The 
crude precipitate was dissolved in DMF and precipitated by addition of water. The 
coloured product was filtered off and dried under reduced pressure over P205. The crude 
product was then purified by trituration in dichioromethane and ether (if required) to 
give the desired product as a highly coloured powder. 
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The general procedure outlined in section 5.4.1 was followed with 5-
aminobenzotriazole (ig, 7.63mmols), sodium nitrate (0.58g, 9.16minols) and 
a —Naphthol (ig, 6.94 nimols) to give the title compound as deep red powder (1.3g, 
65%). The purity of the azo dye obtained was determined by HPLC as >99% eluting on 
a gradient of 95%H20 to 95% CH3CN over 30mins. 
Rf (EtOAc:MeOH:NH3 85:15:1%) 0.22; Rt 18.2 mins; Mp 224-226°C (dec.); 
ii 	(nujol)/cm' 1612 (C=C), 1559 (C=C), 1519; SH ((CD3)2S0; 2501V11-Iz) 7.02 (1H, d, 
J 8.7Hz, CFLI), 7.59 (1H, ddd, J 8.2, 6.9 and 1.5Hz, CH), 7.73 (in, ddd, J 8.2, 6.9 and 
1.5 Hz, CH, ), 8.00 (1H, d, J 8.7Hz, CH), 8.04 (1H, dd, J 8.9 and 0.8Hz, CHi,t), 8.11 (1H, 
dd, J 8.9 and 1.3Hz, 	8.23 (11-1, d 8.4Hz, CH,,,), 8.38 (111, br s, Clli,) and 8.89 (111, 
br d, 8.4Hz, C); 8c ((CD3)2S0; 63MHz) 110.2 (CH), 112.4, 115.9 and 118.4 (3 x 
CHbt), 122.8, 122.8, 122.9 (3x CH), 125.2 (), 125.9 (CH),  128.5 (H), 129.5, 
133.2, 143.0, 143.4, 149.7, 154.2 (6 x Cr); rnlz (ESi -ye, 45Kv) 288 (100%, [MHfl; 




The general procedure outlined in section 5.4.1 was followed with 5-
aminobenzotriazole (ig, 7.63mmols), sodium nitrate (0.58g, 9.16minols). and 3,5-
dimethoxy phenol (1.07g, 6.94 mmols) to give the title compound as deep red powder 
(1.2g, 54%). The purity of the azo dye obtained was determined by HPLC as >99% 
eluting on a gradient of 95% 1420 to 95% CH3CN over 30mins. 
Rf (EtOAc:MeOH:NH3, 85:15:1%) 0.32; Rt 18.5mins; Mp 216°-219°C (dec.); 
u 	(nujol)/cm 1 1612 (C=C), 1559 (C=C), 1519; SH ((CD3)2S0; 250MHz) 3.79 (6H, s, 
(0C113)2), 6.08 (21-1, broad s, CH), 7.77 (1H, dd, J 8.9 and 1.7Hz, CHbt), 7.98 (111, dd, J 
8.9 and MHz, Cjt),  8.05 (111, dd, J 1.7 and 0.7Hz, CHb); 6c  ((CD3)2S0; 63MHz) 93.9 
(2 xCH), 111.4, 116.1, 117.0 (3xCHbt), 122.0 (C), 133.2, 143.0 (2 xCbt), 153.1 (Cr), 
157.4 (2 x C), 159.2 (Cr); mlz (ESi -ye, 45Kv) 298 (100%, [IVIHfl; mlz (FAB, 3-
THIO) 300 (25%, [MH]), Found 300.10958 C14H14N503 requires 300.10967. 
5.4.4 General procedure for preparation of N'N'-Dimethyl monoazo 
benzotriazole dyes 
5-aminobenzotriazole (1.0equiv.) was dissolved in a solution of imI of 36% (v/v) 
hydrochloric acid solution and 1 .5m1 of iced water. The resulting solution was cooled to 
0°C and a cooled aqueous solution of sodium nitrate (1.2 equiv.) was added drop wise 
until an immediate blue/black colour was observed on starch/iodine paper (A small 
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volume of the reaction solution was removed for testing). The diazotised 
aniinobenzotriazole solution was added drop wise over 30mins to a stirred cooled 
solution of the appropriate NN'-Dimethyl component (1.0-1.1 equiv) dissolved in 
sodium acetate buffer (1.OM, 20m1, pH=6.0) and acetone (25m]). The deeply coloured 
solution was maintained at 0°C for 30mins after which time 1M NaOH was added until 
the solution changed colour and stirring was continued for a further 30mins. The pH of 
the solution was adjusted to pH7.0 using 1M HO and the precipitate formed collected 
by filtration. The precipitate was washed with saturated KC1 (25m1 x 2), 10% aq. acetic 
acid (25m]. x 2) and H20. The wet cake was dried under vacuum over P205 to constant 
weight, and then purified by trituration in dichloromethane, methanol and ether to give 
the desired product as a highly coloured powder. 
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The general procedure outlined in section 5.4.4 was followed with 5-
aminobenzotriazole (0.75g, 5.6mmol), sodium nitrate (0.51g, 6.7mrnol) and N'N'-
Dimethyl aniline (0.67g, 5.6 mmol) was followed and gave the title compound as an 
orange powder (1.29g, 86%). 
Rf (EtOAc: MeOH, 99:1) 0.53; Mp 212-214°C (dec.); u (nujol)/cm 1, 1626(C=C), 
1599 (C=C); 8F1 ((CD3)2S0; 360MHIz), 3.19 (6H, s, N(Cj)2), 6.86 (211, d, J 9.2Hz, 
2xCjj), 7.86 (2H, d, J 9.2Hz, 2xC), 7.96 (111, dd, J 8.9 and 1.6Hz, CHi,t), 8.01 (1H, 
d, J 8.9Hz, 	8.23 (1H, s, CH); 5c ((CD3)2S0; 63Mhz) 40.0 (N(cH3)2), 110.7 
(CHbt), 111.7 (2xCH), 115.7 (CHbt), 118.1 (CHbt), 124.9 (2x CHar ), 140.1, 140.2, 142.6, 
150.1 and 152.6 (5 x ); mlz (ESi- 45Kv) 265.1 (100%, [MM'); mlz (FAB, THIO) 
Found 267.13583, C14H15N6 requires 267.13582. 
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The general procedure outlined in Section 5.4.4 was followed with 5-
aminobenzotriazole (1.5g, 11.2mmols), sodium nitrate (0.87g, 12.6nimols) and 3-
dimethylaminoanisole (1.539g, 11.2 mmols) was followed to give the title compound as 
deep red powder (2.4g, 78%). 
Rf (EtOAc, 100%) 0.18; Mp 116-118°C (dec.); u m (nujol)/cm 1 1601 (C=C), 1556 
(C=C); 8n ((CD3)250; 250MHz), 3.07 (6H, s, N(Cth)2), 3.97 (3H, s, OCFjj), 6.33 (1H, 
d, J 2.4Hz, CH,), 6.40 (1H, dd, J 9.2 and 2.5Hz, C), 7.69 (1H, d, J 9.2Hz, Cf), 7.86 
(1H, dd, J 8.9 and 1.6Hz, CHbt), 7.91 (1H, dd, J 8.9 and 0.8Hz, CHbt), 8.14 (1H, dd, J 1.6 
and 0.8Hz, CHbt); Sc ((CD3)2S0; 63MHz) 40.2 (N(CH3)2), 56.7 (OH3), 95.8 (H), 
105.5 (CH), 110.4 (CHbt), 116.5 (CHbt), 118.1 (CHbt), 119.2 (CH), 133.2, 140.4, 
140.9, 151.6, 155.2, 160.1 (6 xC); mlz (ESi+, 45Kv) 296.9 (100%, [IVIH]'); nilz (FAB, 
NOBA) 297 (50%, [MH]); Found 297.14648, C15H17N60 requires 297.14639. 
5.4.7 [4-(1H-Benzotriazol-6-ylazo)-naphthalen-1 -yl] -diniethyl-aniine (123) 
/ 
_.- N 52 
NN 	 H 
07 , 
 
The general procedure outlined in section 5.4.4 was followed with 5-
aminobenzotriazole (0.53g, 3.9mmols), sodium nitrate (0.32g, 4.7nimols) and N'N'- 
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Dimethyl-napthylamine (0.7mls, 4.3mmols) to give the title compound as a bright 
orange powder (0.91g, 74%). 
Rf (EtOAc: MeOH 99:1) 0.67; Mp 210-212°C (dec.); u (nujol)/cm 1 1571 (C=C), 
1507 (C=C), 1323; SH  ((CD3)2S0; 250MHz), 2.98 (6H, s, N(CH)2),  7.20 (1H, d, J 
8.4Hz, C), 7.64 (1H, ddd, J 8.1, 6.8 and 1.5Hz, C), 7.72 (1H, ddd, J 8.1, 6.8 and 
1.5Hz, CH),  7.91 (1H, d, J 8.4Hz, CH), 8.03 (1H, d, J 8.9Hz, CHbL), 8.12 (1H, dd, J 
8.9 and 1.5Hz, 	8.21 (1H, d, J 8Hz, Cjj), 8.48 (1H, distorted s, CHbt), 9.00 (1H, 
d, J 8Hz, CH,); Sc  ((CD3)2S0; 63MHz) 44.5 (N(CH3)2), 112.6 (CHbt), 113.3 (çH), 
115.7 (CHbt), 117.8 (CHbt), 123.4, 124.7, 125.7, 125.9 and 127.2 (5 x CH), 127.5, 
132.6, 140.6, 140.7, 141.5, 150.1 and 154.3 (7 x 	); mlz (ESi +ve) 317.2 (100%, 
[MH]); mlz (FAB, NOBA) Found 317.151 10 C18H17N6 requires 317.15147 
5.4.8 (1H-Benzotriazol-6-yl)-(4-pyrrolidin-1 -yl-napthalen-1 -yl)-diazene (124) 
ON 
NH 
The general procedure outlined in section 5.2.1 was followed with 5-
aminobenzotriazole (0.99g, 7.4mmols), sodium nitrate (0.61g, 8.9mmols) and 1-phenyl 
pyrollidine (1.2g, 8.lmmols) to give the title compound as a dark orange/brown powder 
(1.32g, 61%). 
Rf (EtOAc: MeOH 99:1); Mp 224-226°C(dec.); 1) max(flujol)/cm 1 1612 (C=C), 1559 
(C=C), 1519; S  ((CD3)2S0; 250MHz) 1.98 (4H, m, 2 x CCH2N), 3.42 (4H, m, 2 x 
CH2CthN), 6.67 (2H, d, J 9.1Hz, 2 x CH,,,), 7.75 (1H, dd, J 8.9 and 1.7Hz, CHbt), 7.80 
(2H, d, J 9.1Hz, 2 x CH,), 7.84 (1H, dd, J 8.9 and 0.7Hz, Cjt),  8.17 (1H, dd, J 1.6 and 
0.6Hz CHbt); 5c  ((CD3)2S0; 63M}Tz) 25.9 (2 x CH2CH2N), 48.3 (2 x CH2CH2N), 112.4 
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(2 x CH), 112.7, 116.5 and 116.7 (3 x CHbt), 125.6 (2 x 	142.9, 143.2, 143.4, 
149.7, 150.5 (5 x Cu); mlz (ESi +ve, 45Kv) 293.1 (100%, [IVll{]); mlz (FAB, 3-
NOBA) 293 (62%, [MHJ1), Found 293.15147 C16H17N6 requires 293.15142. 
5.4.9 General procedure for acylafion of N'N Dimethyl and pyroffidine monoazo 
benzotriazole dyes 
The azo dye (1.0equiv.) 121-124 was suspended in 'anhydrous' DCM (see 
individual experiments for volume used) under an inert atmosphere of nitrogen and 
cooled to 0°C in an ice bath. To this stirred suspension was added a solution of 
triethylamine (1.2equiv.) in 1-2m1 of 'anhydrous' DCM followed by the drop wise 
addition of a solution of the 'appropriate' acid chloride (1.1 equiv.) in 1 -2m1 of 
'anhydrous 'DCM. Upon addition of the acid chloride the monoazo benzotriazole dye 
dissolved in the DCM and the reaction was stirred at 0°C for an hour. After this time the 
reaction was allowed to stir for a further 30 minutes while warming to room 
temperature. The reaction was quenched by addition of 5m1 of 2M HC1, and an 
additional volume of DCM was added. The organic layer was separated, washed with 
H20, re-separated, dried over MgSO4 and filtered. The solvent was removed under 
reduced pressure and the crude mixture of regioisomers purified by column 
chromatography, HPLC or trituration as appropriate. 
5.4.10 1 -[5-(4-Dimethylamino-phenylazo)-benzotriazol-1 -yl]-3-(S)-phenyl- butan-1 - 
one (137A) and 1-[6-(4-Dimethyl aniino-phenylazo)-benzotriazol-1-yl]-3-(S)-
phenyl-butan-1- one (137B) 
N N 
	





The general procedure (5.4.9) was followed with 121 (118.4mg, 0.44nimols) in 
lOml of 'anhydrous' DCM. Triethylarnine (53.8mg, 0.53rmnols, 1.2 equiv.) and (S)-3-
Phenylbutyryl chloride 106 (89mg, 0.49 mmols, 1.1 equiv.) were added. The title 
compound was furnished as a thick dark red oil after column chromatography on silica 
eluting with DCM as a mixture of the two regioisomers (104mg, 57%) in the ratio 48:52 
(A:B, respectively by NMR). The regioisomers were separated (baseline resolution not 
achieved) by prep-HPLC using a Biotage Flex system eluting with 87% CH3CN I 13% 
H20. Crystals suitable for x-ray crystallography of 137B were grown from acetonitrile; 
the crystals grown of 137A did not diffract sufficiently to allow a crystal structure to be 
determined 
137A 
Rf (DCM) 0.58; Rt 7.3mins; Mp 153-155°C; u (thin film)/cm' 3028 (CH), 2963, 
2928, 2873 (CH), 1739 (C=O), 1606 (C=C); SIT (CDC13; 250MHz) 1.50 (3H, d, J 6.5Hz, 
CH-j), 3.15 (6H, s, N(Cth)2),  3.66-3.75 (2H, m, C1±CH),  3.80-3.87 (1H, m, CHCH2), 
6.80 (2H, d , J 9.3Hz, 2 x CH), 7.24-7.39 (5H, m, ArH), 7.95 (2H, d, J 9.2Hz, 2 x 
CH), 8.24 (1H, dd, J 8.8 and 1.7Hz, CHbt), 8.32 (1H, dd, J 8.8 and MHz, CHbt), and 
8.54 (1H, dd, 1.7 and 0.6Hz, CHbt); S (CDC13; 63MIHz) 22.0 (CH3), 36.0 (CH'),  40.2 
(N(H3)2), 43.5 (CH2), 111.4(2 xCH), 114.3, 114.3 (2 xCHbt),  124.3 (CHbt), 125.3 (2 
x CH), 126.6 (CH), 126.8 (2 x CHI), 128.6 (2 x CH), 131.2, 143.2, 144.9, 146.9, 
151.6 and 152.7 (6 x Car) 170.9 (C=O); mlz (ES1 +ve, 45Kv) 413 (100%, [MR]'); mlz 
(FAB, NOBA) Found 413.20907 C24H25N60 requires 413.20898. 
137B 
Rf (DCM) 0.58; Rt 6.5mins; Mp 161-162°C; u 	thin film)/cm' 3028 (CH), 1740 
(C=O), 1606 (C=C); SIT  (CDC13; 250M}Tz) 1.50 (3H, d, J 6.5Hz, Cth),  3.15 (6H, s, 
N(C113)2), 3.67-3.75 (2H, m, CCH), 3.81-3.88 (111, m, CHCH2), 6.80 (211, d, J 9.2Hz, 
2 x C), 7.21-7.40 (5H, m, Aril), 7.96 (211, d, J 9.2Hz, 2 x C), 8.07 (1H, dd, J 8.8 
and 1.7Hz, CHbt), 8.16 (1H, dd, J 8.8 and MHz, CHbt), 8.66 (1H, dd, 1.7 and 0.6Hz, 
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CHbt); S (CDC13; 63MHz) 22.5 (ç$), 36.5 (CH), 40.7 (N(cH3)2),  44.0 (CH2), 108.7 
(CHbt), 111.9 (2 x 	120.6 and 121.3 (2 xCHbt), 126.1 (2 x 	127.1 (CH), 
127.3 (2 x CH), 129.1 (2 x CH), 132.3, 144.0, 145.6, 146.6, 153.4 and 154.9 (6 x 
171.4 (C=O); mlz (ESi +ve, 45Kv) 413 (100%, [MH]); mlz (FAB, NOBA) Found 
413.20903 C24H25N60 requires 413.20898. 
5.4.11 1-[5-(4-Dimethyl amino-phenylazo)-benzotriazol-1 -yl]-3-(R)-phenyl-butan-1-
one (137A) and 1 -[6-(4-Dimethylaniino-phenylazo)-benzotriazol-1 -yl]-3 (R)-
phenyl-butan-1-one (137B) 
N 
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The general procedure outlined in section 5.4.9 was followed with 121 (99.3mg, 
0.37mmols) in lOmi of 'anhydrous' DCM. Triethylamine (42mg, 0.41mmols) and (R)-
3-Phenylbutyryl chloride 106 (72mg, 0.39nimols) were added. The title compound was 
furnished as a thick dark red oil after column chromatography on silica eluting with 
DCM as a mixture of the two regioisomers (104mg, 68%) in the ratio 48:52 by NIVIR of 
(A:B). The two regioisomers were not separated by HIPLC. 
Analysis identical to (5.4.10) except; 
SH (CDC13; 250MHz) 1.54 (1.5H, d, J 6.3Hz, Cth,  one regioisomer), 1.57 (1.5H, d, J 
6.3Hz, Cth,  one regioisomer), 3.19 (311, s, N(Cjj)2, one regioisomer), 3.20 (3H, s, 
N(Cth)2, one regioisomer), 3.66-3.75 (2H, m, CthCH, both regioisomers), 3.80-3.87 
(1H, m, CHCH2, both regioisomers), 6.84 (2H, d, J 8.6Hz, 2 x CH,  both regioisomers), 
7.33-7.42 (5H, m, ArH), 7.99 (2H, d, J 8.6Hz, 2 x C, both regioisomers), 8.09 (0.5H, 
dd, J 8.8 and 1.7Hz, CHbt, B), 8.19 (0.5H, dd, J 8.8 and MHz, CHbt, B), 8.27 (0.511, dd, 
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J 8.8 and 1.7Hz, CHbt, A), 8.35 (0.5H, dd, J 8.8 and 0.7Hz, CI, A), 8.58 (0.5H, dd, J 
1.7 and 0.6Hz, CHbt, A) 8.69 (0.5H, dd, J 1.7 and 0.6Hz, CH t, B); S (CDC13; 63MIHz) 
21.9, 22.0 (CH3, both regioisomers), 35.8, 36.0 (CH, both regioisomers), 40.2 (N(H3)2, 
both regioisomers), 43.4, 43.5 (CH, both regioisomers), 108.7 (CHbt, A), 111.4 (2 x 
CH, one regioisomer), 111.5 (2 x CH, one regioisomer), 114.3, 114.4 (2 x cHbt, A), 
120.7 and 121.4(2 xcHbt, B), 124.5 (CHbt, A), 125.3 (2 	126.2 (2 xH), 126.8 
(c.H, both regioisomers), 127.1 (2 x CH, both regioisomers), 128.9 (2 x CHar, both 
regioisomers), 131.1, 132.4, 143.2, 144.1, 145.0, 145.5, 146.6, 147.0, 151.6, 152.7, 
153.5 and 155.1 (12 x 	, both regioisomers), 170.9 and 171.0 (2 x C=O, both 
regioisomers); mlz (ESi+, 45kV) 413.1 (100%, [MH]); mlz (FAB, NOBA) Found 
413.20894 C24H25N60 requires 413.20898. 
5.4.12 1 -[5-(4-Dimethylamino-phenylazo)-benzotriazol-1 -yl]-butan-1 -one (130) and 







The general procedure outlined in Section 5.4.9 was followed with 121 
(136.4mg, 0.51mmols) in lOml of 'anhydrous' DCM. Triethylamine (80.i1, 0.57nimols) 
and butyryl chloride (59il, 0.56mmols) were added. The title compounds were furnished 
as a red oil after column chromatography on silica eluting with DCM (121mg, 75%). 
The ratio of the regioisomers was calculated by comparison of the integrals at 8.56 and 
8.72 p.p.m (in the crude mixture) and determined to be 52:48 (131:130). The two 
regioisomers were separated by HPLC on Biotage Flex system eluting with 75% 
CH3CN: 25% H20- 
165 
130 
Rf (DCM, 100%) 0.42; Rt 4.3mins; Mp 184-185°C; u max(thjfl film)/cm' 2963, 
2927(CH), 1740 (C=O), 1601 (C=C) and 1517 (C=C); 8H  (CDC13; 360Mhz) 1.16 (3H, t, 
J 7.4Hz, Cth),  2.00 (2H, qt overlapping, J 7.5Hz and 7.5Hz, CH3CH2C2), 3.15 (6H, s, 
N(Cth)2), 3.46 (2H, t, J 7.5Hz, CH3CH2C), 6.81 (2H, d, J 9.2Hz, 2 x C), 7.97 (2H, 
d, J 9.2Hz, 2 x CH), 8.28 (1H, dd, J 8.8 and 1.7Hz, CHbt), 8.37 (111, dd, J 8.8 and 
0.6Hz, CHbt), 8.56 (1H, dd, J 1.7 and 0.6Hz, CHbt); S (CDC13; 63MHz) 14.1 (H3), 
18.4 (CH3CH2CH2), 37.7 (CH3CH2CH2), 40.7 (N(CH3)2), 111.9 (2 x CHO, 114.9 
(CHbt), 114.9 (CHbt), 124.8 (CHbt), 125.8 (2 xCH), 13 1.8, 143.8, 147.4, 152.1, 153.2 (5 
x ), 172.9 (C=O); nilz (ESi +ve, 45Kv) 337 (100%, [MU]4); m/z (FAB, 3-NOBA) 
337 (65%, [MH]4), 307 (70%, [MH-CH2CH3]4), 267 (10%, [M}1-COCH2CH2CH3]4); 
Found (FAB) 337.17807 C18H21N601 requires 337.17768. 
131 
Rf (DCM, 100%) 0.44; Rt 4.1mins; Mp 178-179°C; u (thin film)/cm 1 2964, 2927 
(CH), 1740. (CO), 1601 (C=C) and 1517(C=C); 6H  (CDC13; 360MHz) 1.16 (3H, t, J 
7.5Hz, Cth),  2.01 (2H, tq overlapping, J 7.5Hz and 7.5Hz, CH3CCH2), 3.14 (6H, s, 
N(C)2), 3.42 (2H, t, J 7.5Hz, CH3CH2C), 6.82 (2H, d, J 9.3Hz, 2 x CH"), 7.99 (2H, 
d, J 9.3Hz, 2 x CH,,,), 8.10 (1H, dd, J 8.8 and 1.7Hz, CHbt), 8.18 (1H, dd, J 8.8 and 
0.7Hz, CHbt), 8.72 (1H, dd, J 1.7 and 0.7Hz, CHbt); 8c (CDC13; 63MHz) 14.1 (CH3), 18.3 
(CH3 H2CH2), 37.8 (CH3CH2CH2), 40.8 (N(CH3)2), 108.8 (CHbt), 112.1 (2 x CH), 
120.6 (CHbt), 121.1 (CHbt), 126.2(2 xCH),  132.4, 144.1, 146.6, 153.4, 154.9 (5 x), 
172.8 (C=O); mlz (ESi +ve, 45Kv) 337 (100%, [MH]4); mlz (FAB, 3-NOBA) 337 (65%, 
{MH]4), 307 (100%, [MH-CH2CH3]4), 267 (30%, [MH-COCH2CH2CH3]4); Found 
(FAB) 337.17802 C18H21N601 requires 337.17768. 
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5.4.13 1-[5-(4-dimethylamino-2-methoxy-phenylazo)-benzotriazol-1-yl]-(S)-3-
phenyl-butan-1-one (138A) and 1 -[6-(4-Dimethylaniino-2-methoxy-
phenylazo)-benzotriazol-1-yl]-(S)-3-phenyl- butan-1 -one (138B). 
N 
No' C 0-, N 	 N 
/ 
'N 







+ 	 N NN 	N 	Ph 
(S)-138B 
The general procedure outlined in section 5.4.9 was followed with 122 (500mg, 
1.69mmols) in 15m1 of 'anhydrous' DCM. Triethylamine (285p1, 2.03mmols) and (S)-
(+)-3-phenylbutyryl chloride (339mg, 1 .86mmols) were added. The title compounds 
were furnished as a red solid (621.5mg, 84%) after trituration with CH3CN. The ratio of 
the regioisomers was calculated by comparison of the integrals at 8.47 and 8.58 p.p.m 
and determined to be 44:56 (A:B) Separation of the regioisomers by HPLC or TLC was 
not achieved despite extensive method development. 
Rf (DCM, 100%) 0.88 and 0.90 (DCM/BtOAc, 95/5) 0.40 and 0.38; R (87% CH3CN) 
7mins; Mp 159-161°C; u 	thin film)/cm' 3029 (CH), 2964, 2926, 2871 (CH), 1742 
(C=O), 1606 (C=C); SH  (CDC13; 250MHz) 1.44 (1.5H, d, J 6.5Hz, Cth,  one 
regioisomer), 1.45 (1.511, d, J 6.5Hz, CJ1,  one regioisomer), 3.11 (3H, s, N(CH)2, one 
regioisomer), 3.11(3H, s, N(CH)2, one regioisomer), 3.61-3.69 (2H, m, CH2CO), 3.74-
3.82 (1H, m, CHCH2CO, both regioisomers overlapping), 4.03 (1.5H, s, OCth,  one 
regioisomer), 4.04 (1.5H, s, OCth,  one regioisomer), 6.19 (0.51-1, d, J 2.5Hz, C, one 
regioisomer), 6.21 (0.5H, d, J 2.5Hz, CH, one regioisomer), 6.34 (05H, d, J 9.3 and 
2.5Hz, 	one regioisomer), 6.35 (05H, d, J 9.3 and 2.5Hz, CH,  one regioisomer), 
7.18-7.35 (5H, m, ArH, both regioisomers), 7.83 (1H, dd, J 9.3 and 1.1Hz, C, both 
regioisomers), 8.00 (0.5H, dd, J 8.9 and 1.7Hz, CHbt, B), 8.08 (0.5H, dd, J 8.9 and 
0.8Hz, CHbt, B), 8.18 (0.5H, dd, J 8.9 and 1.7Hz, CHbt, A), 8.25 (0.5H, dd, J 8.9 and 
0.8Hz, CHbt, A), 8.47 (05H, dd, J 1.7 and 0.7Hz, CHbt, A), 8.58 (0.5H, dd, J 1.7 and 
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0.7Hz, CHbt, B); S (CDC13; 63MHz) 21.9, 22.0 (CHH3, both regioisomers), 35.9, 36.0 
((:H, both regioisomers), 40.2 (N(CH)2), 43.3, 43.5 (CHCH), 56.0, 56.1 (0c113, both 
regioisomers), 94.4, 94.4 (CH,,, both regioisomers), 104.8, 104.9 (c$, both 
regioisomers), 108.8 (Hbt, B), 114.1 (CHbt, A), 114.2 (CHbt, A), 118.1, 118.3 
both regioisomers), 119.9 (CHbt, B), 120.2 (CHbt, B), 124.5 (CHbt, A), 126.5 (CH, 
both regioisomers), 126.7 (2 x CH, both regioisomers), 128.5 (2 x CHar, both 
regioisomers), 130.9, 131.8, 133.2, 133.5, 145.0, 145.0, 145.8, 146.9, 152.1, 154.4, 
154.7, 155.1, 159.5, 159.9 (14 x C, both regioisomers), 170.9 and 170.9(C=O, both 
regioisomers); mlz (ESi +ve, 45kV) 443.2 (100%, [MH]); (FAB+, NOBA) 443 (100%, 
[1VIH]'), 297 (30%, [MH - COCH2CHPhCH3]; (FAB+, NOBA) Found 443.21959 
C25H26N602 requires 443 .21955. 
5.4.14 1-[5-(4-Dimethylamino-2-methoxy-phenylazo)-benzotriazol-1-yl]-(R)-3-
phenyl-butan-1 -one (138A) 1 -[6-(4-Dimethylamino-2-methoxy-phenylazo)-
benzotriazol-1 -yl]-(R)-3-phenyl- butan-1 -one (138B) 
/ 
'N 




+ 	 NN Ph 
N 
(R)-138B 
The general procedure (5.4.9) was followed with 122 (451mg, 1.52mmols) in 
15m1 of 'anhydrous' DCM. Triethylamine (25841, 1.82mrnols) and (R)-(-)-3-
phenylbutyryl chloride (306mg, 1.67mmols) were added. The title compounds were 
furnished as a red solid (557mg, 83%) after trituration with CH3CN. The ratio of the 
regioisomers was determined to be 55:45 (B:A) by comparison of the integrals at 8.51 
and 8.63 p.p.m. Separation of the regioisomers, by HPLC or TLC, was not achieved 
despite extensive method development. 
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Analysis comparable to 5.4.13 except (FAB+, NOBA) Found 443.21963 C25H26N602 
requires 443.21955. 
5.4.15 1 -[5-(4-Diniethylamino-napthalen-1  -ylazo)-benzotriazol-1 -yl]-(S)-3-phenyl-
butan-1 -one (139A) and 1 -[6-(4-dimethyl-aniinonapthalen-1 -ylazo)- 
benzotriazol-1 -yl]-(S)-3-phenyl-butan-1  -one (139B) 
NN  






+ 	 N Ph 
(S)-139B 
The general procedure (5.4.9) was followed with 123 (500mg, 1.57mmols) in 
15m1 of 'anhydrous' DCM. Triethylamine (264..tl, 1.88nimols) and (S)-3-phenylbutyryl 
chloride 106 (317mg, 1.73neimols) were added dropwise. The title compounds were 
furnished as a deep red oil (384mg, 57%) after column chromatography on silica gel 
eluting with DCM. The ratio of the regioisomers was determined to be 50:50 by 
comparison of the integrals at 8.67 and 8.79 p.p.m. Separation of the regioisomers by 
HPLC was not attempted. 
Rf (DCM) 0.66 both regioisomers, u 	(thin film)/cm' 3027 (CHar), 2941, 2871, 2836, 
2788 (CH), 1739 (C=O), 1604 (C=C), 1572(C=C), 1509(C=C). 8H  (CDC13; 250MHz) 
1.47(1.5H, d, J 6.4Hz, CH,, one regioisomer), 1.48 (1.5H, d, J 6.4Hz, Cth,  one 
regiosiomer), 3.04(3H, s, N(C)2), one regioisomer), 3.05(3H, s, N(CH)2, one 
regioisomer), 3.61-3.79 (2H, m, CCO, both regioisomers overlapping), 3.80-3.90 (1H, 
m, CHCH2CO, both regioisomers, overlapping), 7.08 (0.5H, d, J 8.4Hz, CH, one 
regioisomer), 7.09 (0.5H, d, J 8.4Hz, CH, one regioisomer), 7.18-7.28 (5H, m, ArH, 
both regioisomers), 7.57 (1H, ddd, J 8.5, 6.9 and 1.5Hz, CJ, both regioisomers), 7.66 
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(1H, ddd, J 8.5, 6.9 and 1.5Hz, C, both regioisomers), 7.94 (0.5H, d, J 8.4Hz, CH, 
one regioisomer), 7.95 (0.5H, d, J 8.4Hz, CH, one regioisomer), 8.19-8.35 (3H, m, 2 x 
CHbt and 	both regioisomers), 8.67 (0.5H, dd, J 1.3 and 1.3Hz, CHbt, A), 8.79 
(0.5H, dd, J 1.3 and 1.3Hz, CHbt, B), 8.99-9.06 (1H, m, CH., both 
regioisomers); S (CDC13; 63MHz) 22.0 (CH3, both regioisomers), 36.0 (CH, both 
regioisomers), 43.5 	both regioisomers), 44.7 (N(CH3), both regioisomers), 109.9, 
112.7, 112.9, 113.1, 113.7, 114.5, 115.2, 120.2, 120.4, 122.7, 123.6, 124.0, 124.6, 125.0, 
125.3, 125.5 and 126.6 (17 x CH, both regioisomers), 126.2 (2 x CH), 127.0, 127.8 
and 128.0 (3 x 	both regioisomers), 128.2 (), 128.5 (2 x CH), 131.6, 131.7, 
132.0, 133.1, 133.3, 142.2, 142.4, 145.0, 145.0, 146.4, 146.8, 151.6, 154.3, 154.9, 155.3 
(15 x C, both regioisomers), 170.9 (C=O, both regioisomers); mlz (ESi +ve, 45kV) 
463.2 (10%, [MH]); nilz (FAB, 3-NOBA) 463 (100%, [MH]), 317 (30%, [MI-I-
COCH2CHPhCH3]), 77 (20%, Ph); (FAB, 3-NOBA) Found 463.22500, C28H26N60 
requires 463.22463. 
5.4.16 1 -[5-(4-Dimethylawino-napthalen-1 -ylazo)-benzotriazol-1-yl]-(R)-3-phenyl-
butan-1-one (139A) and 1-[6-(4-dimethyl-aminonapthalen-1 -ylazo)- 
benzotriazol-1 -yl]-(R)-3-phenyl-butan-1-one (139B). 
N _ N 
'N 








The general procedure (5.4.9) was followed with 123 (337mg, 1 .O7mmols) in 
15m1 of 'anhydrous' DCM. Solutions of triethylamine (180tl, 1.28mmols) and (R)-3-
phenylbutyryl chloride 106 (214mg, 1.17mmols) were added drop wise. The title 
compounds were furnished as a deep red oil (420mg, 85%) after column 
chromatography on silica gel eluting with DCM. The ratio of the regioisomers was 
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determined to be 50:50 by comparison of the integrals at 8.67 and 8.79 p.p.m. Separation 
of the regioisomers by HPLC was not attempted. 
Analytical data comparable to (5.4.15) mlz (FAB, 3-NOBA) Found 463.22472, 
C28H26N60 requires 463 .22463. 
5.4.17 (S)-3-Phenyl-1 -[6-(4-pyrollidin-1-yl-phenylazo)-benzotriazol-1 -yl]-butan-1 - 











The general procedure (5.4.9) was followed with 124 (49 8mg, 1 .79mmols) in 
15m1 of 'anhydrous' DCM. Solutions of triethylamine (302..tl, 2.15mmols) and (S)-3-
phenylbutyryl chloride 106 (3 62mg, 1 .97mmols) were added drop wise. The title 
compounds were furnished as a bright red solid (373mg, 49%) after purification by 
column chromatography on silica gel eluting with DCM. The ratio of the regioisomers 
was determined to be 50:50 by comparison of the integrals at 8.48 and 8.60 p.p.m. 
Separation of the regioisomers by HPLC was not attempted. 
Rf (DCM) 0.45 both regioisomers, U max(thi1T1 film)/cm-1 3027 (CH), 2923, 2836 (CH), 
1736 (C=O), 1602 (C=C), 1518(C=C); 6ii  (CDC13; 250MHz) 1.46 (3H, d, J 6.4Hz, Cu3, 
both regioisomers), 1.99-2.09 (4H, in, 2 x NCH2Cff2, both regioisomers), 3.37-3.42 (2H, 
in, CHCH2, both regioisomers), 3.69-3.83 (1H, in, CHCH2, both regioisomers), 6.60 
(2H, d, J 8.4Hz, 2 x C, both regioisomers), 7.16-7.35 (5H, in, ArH,  7.90 (2H, d, 
8.4Hz, 2 x CH, both regioisomers), 8.02 (0.5H, dd, J 8.8 and 1.7Hz, CHbt, B), 8.11 
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(0.5H, d, J 8.8, CHbt, B), 8.19 (0.511, dd, J 8.8 and 1.7Hz, CHbt, A), 8.27 (0.5H, d, J 8.8, 
CHbt, A), 8.48 (0.511, dd, J 1.7Hz, CHbt, A) and 8.60 (0.5H, d, J 1.7Hz, CHbt, 
B); S (CDC13; 63MHz) 21.9 (H3, both regioisomers), 25.3 (2 x NCHH2, both 
regioisomers), 35.9 (CH, both regioisomers), 43.4 (CHH, both regioisomers), 47.6 (2 x 
NCH2CH2, both regioisomers), 108.0 (CHbt, B), 111.4 (2 x CH,, one regioisomer), 
111.4 (2 x cH, one regioisomer), 114.0, 114.2 (2 x cHbt, A), 120.0 (HM, B), 120.7 
(Hbt, B), 124.3 (CHbt, A), 125.5 (2 x Mar  one regioisomer), 125.8 	both 
regioisomers), 126.5 (CH x 2, one regioisomer), 126.7 (H x 2, both regioisomers), 
128.5 (CH x 2, both regioisomers), 131.0, 131.8, 142.9, 143.2, 145.0, 145.0, 145.9, 
146.9, 150.3, 150.5, 151.6 and 154.5 (12 x C, both regioisomers), 170.8 (C=O); mlz 
(ESi+, 45kV) 439.3 (80%, [MH]); mlz (FAB, 3-NOBA), 439 (40%, [MH]+) Found 
439.22525 C26H26N60 requires 439.22463. 
5.4.18 General procedure for preparation of ester 'blocked'SERRS dyes 
The acylated monoazo benzotriazole dyes 137-140(A+B) were dissolved in the 
appropriate volume (depending on solubility) of CH3CN:DCM (10:1) at room 
temperature and stirred vigornusly. To this was added crushed K2CO3 (15 to 25 mol% - 
with respect to acylated monoazo beuzotriazole dye) and formaldehyde (1.05 equiv, 
37% aqueous solution). The resulting solution was stirred overnight at room temperature 
and monitored by TLC to ensure the reaction had gone to completion. The K2CO3 was 
removed by filtration, and then the solvent removed under reduced pressure to give the 
desired products as a highly coloured oil. The desired 'ester' compounds were obtained 
by column chromatography on silica gel. This provided the C ester as a single 
regioisomer and the A and B esters as a mixture of both regioisomers. A known weight 
of the A + B ester mixture was dissolved in the minimum volume of CH3CN (with a few 
drops of DMSO added to aid solubility) to give a typical concentration of 5-10mg/mi. 
The mixture was purified by prep-HPLC on a Biotage Flex system eluting with the 
appropriate mobile phase. The individual fractions of each regioisomer were pooled, the 
organic solvent removed under reduced pressure and the ester compound isolated from 
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the remaining aqueous solution by extraction with DCM. The organic layer was 
separated, dried over MgSO4, filtered and evaporated under reduced pressure to yield a 
single regioisomer of the ester compound as a highly coloured oil. This oil was re-
purified by small-scale column chromatography on silica gel (to remove any 
underivatised monoazo dye which may have been carried through the purification 
procedure) to yield the desired ester product as a highly coloured oil. 
Note: The chiral integrity of the ester compounds was established by cleavage of =lmg 
dissolved in 2m1 of 1M NaOH / acetone (50:50). The solvent was removed under 
reduced pressure and the residue resuspended in WA / Hexane (50:50), filtered through a 
0.22..tm filter and the iesulting solution analysed by normal phase chiral HPLC using a 
Chiracel OD column eluting with Hexane / WA (98:2, 0.1%TFA) at 5°C. 
Rt of (R)-3 phenylbutyric acid = 8.0mins 
Rt of (S)-3 phenylbutyric acid = 17.8mins 
The enantiomeric excess determined was compared with that for the starting 3-
phenylbutyric acid as determined by the same method. 
Starting (S)-3-Phenylbutyric acid = >99% e.e. 
Starting (R)-3-Phenylbutyric acid = 100% e.e. 
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5.4.19 (S)-3-Phenyl-butyric acid 5-(4-dimethyaniino-phenylazo)-benzotriazol-1 - 
yhnethyl ester (141A) and (S)-3-Phenyl-butyric acid 6-(4-dimethylamino-
phenylazo)-benzotriazol-1 -yhnethyl ester (141B) and (S)-3-Phenyl-butyric 
acid 5-(4-diinethylamino-phenylazo)-benzotriazol-2-yl methyl ester (141C). 






II0 N 	- + 	 C N Ph 
(S)-141B 
+ N 	




The general protocol outlined in section 5.4.18 was followed with (S)-137A+B 
(55.4mg, 0.134mmols) dissolved in lOmi of CH3CN:DCM (9:1). Crushed K2CO3 
(4.6mg, 0.033mmols, 25 mol %) and formaldehyde (10.5j..tl, 0.141mmols, 1.05 equiv.) 
were added and the reaction stirred vigorously overnight at room temperature. Column 
chromatography eluting with DCM, furnished the desired products as dark red oils; 
A+B(19.8mg, 33%) as a mixture of the regioisomers in the ratio (52 B: 48 A) and C 
(1.9mg, 3.2%). A+B were separated using the Biotage Flex system running a gradient 
from 75:25 to 95:5 over 20mins (CH3CN:H20) to give 141B as a red oil (7.0mg, 11.7%) 
and 141A as a red oil (6.6mg, 11%). 
(S)-141A 
Rf (DCM) 0.16; Rt 11.6mins; u (thin film)/cm 1 3054 (CH), 2963 (CH), 1753 (C=O), 
1602 (C=C) and 1519 (C=C); 6 (CDC13; 600Pvll{z) 1.26 (3H, d, J 7.1Hz, Cth), 2.66 
(1H, dd, J 15.2 and 7.6Hz, CjHbCO), 2.69 (1H, dd, J 15.2 and 7.8Hz, CH,EjbCO), 3.15 
(6H, s, N(CH3)2), 3.26 (1H, m, CH, 6.53 (1H, d, J 11.1Hz, CjHbO), 6.56 (1H, d, J 
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11.2Hz, CHjbO), 6.82 (2H, d, J 9.2Hz, CH x 2), 7.07-7.18 (5H, m, ArH),  7.64 (1H, 
dd, J 8.9 and 0.6Hz, CHbt) 7.96 (2H, d, J 9.3Hz, CH x 2), 8.14 (1H, dd, J 8.9 and 
1.6Hz, CHbt) and 8.52 (1H, dd, J 1.6 and 0.6Hz, CHbt); 1H NUE (CDC13; 360MHz) 
irradiation at 7.64 p.p.m gave 2% enhancement at 6.53-6.56 p.p.m and 17% 
enhancement at 8.14 p.p.m and irradiation at 6.56-6.59 p.p.m gave 10% enhancement at 
7.64 p.p.m); S (CDC13; 63M11{z) 22.7 (çH3), 36.5 (H), 40.3 (N(CH3)2), 42.3 (CH2CO), 
67.6 (CH20), 110.1 (CHbt), 111.5 (,CH,,, x 2), 115.3 (CHbt), 125.2 (cH  x 2), 125.3 
(CHbt), 126.4 (CH x 2), 126.6 (CH), 128.4 (CH  x 2), 133.1, 143.4, 144.5, 146.8, 
150.7, 152.6 ( x 6) and 171.4 (C=O); m/z (ESi-i-, 45kV) 443.4 (100%, [MH]), 267 
(50%, [MH - CH2000CH2CHPhCH3]); mlz (FAB, NOBA) 443 (100%, [MH]), 289 
(50%, [MNa - CH2000CH2CHPhCH3]), 267 (30%, [MH - CH2000CH2CHPhCH3I); 
(FAB, NOBA) Found 443.21950 C25H27N602 requires 443.21955. 
(S)-141B 
Rf (DCM) 0.16; Rt 11.3mins; u (thin film)/cm' 3053 (CH), 2963 (CH), 1752 (C=O), 
1602 (C=C), 1519 (C=C); 5j (CDC13; 600MHz) 1.27 (3H, d, J 7Hz, CH3), 2.66 (1H, dd, 
J 15.2 and 7.6Hz, CHbCO), 2.71 (1H, dd, J 15.2 and 7.8Hz, CHaHbCO), 3.16 (6H, S, 
N(CH3)2), 3.26 (1H, m, CH),  6.56 (1H, d, J 11.2Hz, CHbO), 6.59 (1H, d, J 11.2Hz, 
CHjjbO), 6.82 (2H, d, J 9.3Hz, 2 x C), 7.01-7.16 (5H, m, AriD,  7.98 (2H, d, J 9.3Hz, 
2 x CH), 8.02 (1H, dd, J 9.3 and 1.6Hz, CHbt) overlapping with 8.03 (1H, d, 1.6Hz, 
Ca,) and 8.12 (1H, d, J 9.3Hz, Cjji,); 'H NOE (CDC13; 360MHz) irradiation at 8.03 
p.p.m gave 2% enhancement at 6.56-6.59 p.p.m and irradiation at 6.56-6.59  p.p.m gave 
7% enhancement at 8.03 p.p.m; 6, (CDC13; 63MIHz) 21.9 (H3), 36.4 (CH), 40.3 
(N(CH3)2), 42.4 (CH2CO), 67.8 (CH20), 104.2 (Hbt), 111.5 (CH x 2), 119.1 (CHbt), 
120.1 (CHbt), 125.5 (CH x 2), 126.5 (CH x 2), 126.5 (CH), 128.4 (CH,,, x 2), 133.4, 
143.5, 144.6, 146.2, 152.9, 153.1 ( 	x 6) and 171.2 (C=O); mlz (ESi+, 45kV) 443.4 
(100%, [MHIF'), 267 (50%, [MR - CH2000CH2CHPhCH3]'); nilz (FAB, NOBA) 443 
(100%, [MH]4), 289 (50%, [MNa - CH2000CH2CHPhCH3]), 267 (30%, [MH - 
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CH2000CH2CHPhCH311); (FAB, NOBA) Found 443.2 1947 C251127N602 requires 
443.21955. 
(S)-141C 
Rf (DCM) 0.41; t ,(thin film)/cm' 3054 (CH), 2987 (CH), 1757 (C=O), 1602 (C=C); 
H (CDC13; 360MHz) 1.32 (3H, d, J 7.1Hz, Cth),  2.72 (111, dd, J 15.4 and 7.8Hz, 
CHbCO), 2.76 (1H, dd, J 15.4 and 7.411z, CHaHI)CO), 3.15 (61-1, S, N(CH3)2), 3.33 
(1H, m, CH), 6.53 (1H, d, J 10.0Hz, CHaHbO), 6.56 (1H, d, J 10.0Hz, CHaBbO), 6.82 
(2H, d, J 9.2Hz, CH x 2), 7.02-7.25 (51-1, m, ArH),  7.93 (1H, dd, J 9.3 and 0.7Hz, CHbt) 
7.97 (2H, d, J 9.3Hz, CH, x 2), 8.14 (1H, dd, J 9.3 and 1.7Hz, CHbt) and 8.35 (1H, dd, J 
1.7 and MHz, CHbt); 'H NOE (CDC13; 360MHz) irradiation at 6.56 p.p.m gave no 
enhancement at any of the benzotriazole signals; S (CDC13; 63MHz) 22.2 (H3), 36.7 
(CH), 40.7 (N(CH3)2), 42.8 (CH2CO), 75.4 (CHO), 111.9 (CHa, x 2), 116.1 (CHbt), 
119.3 (CHbt), 121.3 (CHbt), 126.9 (H), 127.0 (CHI x 2), 127.0 (CH x 2), 128.9 
(H x 2), 143.9, 145.3, 146.0, 146.1, 152.9, 153.1 (C., x 6) and 171.0 (C=O); mlz 
(ESi+, 45kV) 443.4 (100%, [M1H]), 267 (50%, [NM - CH2000CH2CHPhCH3]); mlz 
(FAB, NOBA) 443 (100%, [MH]), 289 (50%, [MNa - CH2000CH2CHPhCH3]), 267 
(30%, [MH - CH2000CH2CHPhCH3]); (FAB, NOBA) Found 443.2 1959 C25H27N602 
requires 443.21955. 
A, B and C were all cleaved and the resulting (S)-3 phenylbutyric acid released was 
determined by chiral HPLC (according to protocol 5.4.18) to be >99% e.e. This is in 
excellent agreement with the starting acid. 
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5.4.20 (R)-3-Phenyl-butyric acid 5-(4-dimethyamino-phenylazo)-benzotriazol-1-
yhnethyl ester (141A), (R)-3-Phenyl-butyric acid 6-(4-dhnethylamino-
phenylazo)-benzotriazol-1-ylmethyl ester (141B) and (R)-3-Phenyl-butyric 
acid 5-(4-dimethylainino-phenylazo)-benzotriazol-2-yl methyl ester (141C). 
N 









The general protocol outlined in section 5.4.18 was followed with (R).-137A+B 
(108.3mg, 0.262mmols) dissolved in 20ml of CH3CN:DCM (9:1). Crushed K2CO3 
(9.02mg, 0.065nimols, 25 mol %) and formaldehyde (39.3tl, 0.524rnmols, 2 equiv.) 
were added and the reaction stirred vigorously overnight at room temperature. Column 
chromatography eluting with DCM, furnished the desired products as dark red oils; 
A+B(35.7mg, 31%) as a mixture of the iegioisomers in the ratio 50:50 as determined by 
NMR and C (3.4mg, 2.9%). A+B were separated using the Biotage Flex system running 
a gradient from 75:25 to 95:5 over 20mins (CH3CN:H20) to give 141B as a red oil 
(9.7mg, 8.4%) and 141A as a red oil (8.8mg, 7.6%). 
Analytical data for (R)-141A, (R)-141B and (R)-141C were all comparable to the 
appropriate (S)-enantiomers in 5.2.19. 
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A, B and C were all cleaved and the resulting (R) —3 phenylbutyric acid was determined 
according to protocol 5.4.18 to be >99% e.e. - which is in excellent agreement with the 
starting acid. 
5.4.21 (S)-3-Phenyl-butyric 	acid 	5-(4-dimethylamino-2-methoxy-phenylazo)- 
benzotriazol-1-yl methyl ester (142A), (S)-3-phenyl-butyric acid 6-(4-
dimethylainino-2-methoxy-phenylazo)-benzotriazol-1 -ylmethyl ester (142B) 
and (S)-3-phenyl-butyric acid 5-(4-dimethylamino-2-methoxy-phenylazo)-















The general protocol 5.4.18 was followed with (S)-138 A+B (56.9mg, 
0.129mmols) dissolved in lOmi of CH3CN: DCM (9:1). Crushed K2CO3 (3.6mg, 
0.035mols, 15 mol %) and formaldehyde (19.341, 0.135mmols, 1.05 equiv.) were added 
and the reaction stirred vigorously overnight at room temperature. Column 
chromatography eluting with DCM, furnished the desired products as 2 dark red oils; 
A+B (30.5mg, 50.8%) as a mixture of the regioisomers in the ratio 56:44 (ratio 
determined by integral of methyl peaks at 1.25 and 1.27 p.p.m) and C (4.6mg, 7.5%). 
A+B could not be separated by prep scale HPLC despite extensive method development. 
178 
142A+B 
Rf (DCM/BtOAc, 9:1) 0.44 and 0.44; u ,(tbin film)/cm' 3053, 3029 (CH), 2962, 
2926 (CH), 1750 (C=O), 1602 (C=C) and 1559; SH (CDC13; 250MIHz) 1.25 (1.5H, d, J 
7.0Hz, Cft3,  one regioisomer), 1.27 (1.5H, d, J 7.0Hz, CH 3, one regioisomer), 2.67 (111, 
dd, J 15.2 and 7.7Hz, CHaHbCO, both regioisomers), 2.68 (1H, dd, J 15.2 and 7.7Hz, 
CLHbCO, both regioisomers), 3.15 (31-1, s, N(Cij3)2,  one regioisomer), 3.17 (3H, s, 
N(CH3)2, one regioisomer), 3.23-3.28 (1H, m, CH, both regioisomers), 4.09 (3H, s, 
OCH3, both regioisomers), 6.25 (0.511, d, J 2.6Hz, CH,  one regioisomer), 6.26 (0.5H, d, 
J 2.611z, CH, one regioisomer), 6.41 (0.5H, dd, J 9.3 and 2.6Hz, CH,  one 
regioisomer), 6.41 (0.5H, dd, J 9.3 and 2.6Hz, C, one regioisomer), 6.41 (0.5H, dd, J 
9.3 and 2.6Hz, CH, one regioisomer), 6.50 (0.5H, d, J 11.2Hz, CHaHbO, one 
regioisomer), 6.52 (0.5H, d, J 11.211z, CHaHbO, one regioisomer), 6.56 (0.5H, d, J 
11.2Hz, CHJjI,O,  one regioisomer), 6.59 (0.511, d, J 11.21-tz, CHJJbO, one regioisomer), 
7.06-7.20 (5H, m, ArH, both regioisomers), 7.63 (0.51-1, d, J 8.914z, CHbt, A), 7.91 (0.5H, 
d, J 9.3Hz, C, one regioisomer), 7.92 (0.5H, d, J 9.3Hz, C, one regioisomer), 
7.99-8.03 (1H, m, overlapping signals from 2 x 	8.09 (0.5H, dd, J 8.6 and 1.0Hz, 
CHbt, B), 8.14 (0.511, dd, J 9 and 1.61-1z, CHbt, A) and 8.50 (0.5H, dd, J 1.6 and 1.0Hz, 
CHbt, A); 6 (CDC13; 63MHz) 22.3 (H3, both regioisomers), 36.8 (H, both 
regioisomers), 40.8 (N(CH3)2), 42.8 (CH2CO), 56.6 (OH3, both regioisomers), 68.0, 
68.4 (CH20, both regioisomers), 94.9, 95.1 (CH, both regioisomers) 104.2 (CHbt, B) 
105.7 (CH, both regioisomers), 110.5 (CHbt, A), 115.3 (cHbt, A), 118.9, 119.2 (CH, 
both regioisomers), 119.8 (CHbt)  B), 120.5 (CHbt, B), 122.8 (CHbt,  A), 126.4 	both 
regioisomers) 126.9 (CH x 2, both regioisomers), 128.9 (H x 2, both regioisomers), 
132.7, 133.0, 133.3, 133.4, 144.5, 145.8, 146.6, 150.8, 153.2, 154.4, 154.7, 159.4 and 
159.8 (Ca, x 13), 171.0 and 171.2 (C=O, both regioisomers); mlz (ESi+, 45kV) 473.2 
(100%, [MHI), 297 (10%, {MH - CH2000CH2CHPhCH3]'); mlz (FAB, NOBA) 473 
(100%, [MHJ'), 297 (30%, [MEl - CH2000CH2CHPhCH3]4); (FAB, THIO) Found 
473.23011 C261-128N603 requires 473.23011. 
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142C 
Rf (DCM/EtOAc, 9:1) 0.63; u (thin film)/cm-1 3053, 3029 (CH), 2962, 2926 (CH), 
1756 (C=O), 1602 (C=C) and 1559; SH (CDC13; 250MIHz) 1.31 (3H, d, J 7.0Hz, Cl3), 
2.71 (1H, dd, J 15.4 and 7.8Hz, CHaHbCO), 2.74 (111, dd, J 15.4 and 7.611z, CI.iaHbCO), 
3.16 (6H, s, N(CH3)2), 3.28-3.36 (1H, m, CH,), 4.09 (3H, s, OC3),  6.27 (1H, d, J 
2.6Hz, CH,), 6.40 (in, dd, J 9.2 and 2.6Hz, CH.,), 6.51 (1H, d, J 9.91-1z, CHaFIbO), 6.51 
(111, d, J 9.911z, CHaHbO),  7.11-7.25 (5H, m, Arl3, 7.90 (0.5H, d, J 9.2Hz, CH",), 7.90 
(1H, dd, J 9.4 and 0.811z, CHat),  8.13 (1H, dd, J 9.3 and 1.7Hz, Cjijbt) and 8.30 (1H, dd, 
J 1.6 and 0.8Hz, CHat);  8v (CDC13; 63 MHz) 21.7 (H3), 36.2 (çH),  40.3 (N(CH3)2), 42.2 
(H2), 56.2 (OCH3), 74.9 (CH20), 94.6 (CH), 104.9 (CH), 115.0 (CHbt), 118.1 
(CH), 118.7 (Hbt), 121.3 (CHbt), 126.4 (CH),  126.5 (2 x CH),  128.4 (2 x CH), 
133.3, 144.8, 145.4, 145.5, 152.9, 154.4, 159.7 (7 x 	) and 170.5 (C=O); mlz (ESi+, 
45kV) 473.2 (100%, [MH]), 297 (25%, [MH - CH2000CH2CHPhCH3]); mlz (FAB, 
3-NOBA) 473 (100%, [MH]'), 297 (30%, [MH - CH2000CH2CHPhCH3]); (FAB, 3-
NOBA) Found 473.23057 C26H28N603 requires 473.23011. 
A, B and C were all cleaved and the resulting (S)-3 phenylbutyric acid released was 
determined by chiral HPLC (according to protocol 5.4.18) to be >99% e.e. This is in 
excellent agreement with the starting acid. 
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5.4.22 (R)-3-Phenyl-butyric 	acid 	5-(4-dimethylainino-2-methoxy-phenylazo)- 
benzotriazol-1-yl methyl ester (142A), (R).3-phenyl-butyric acid 6-(4-
dimethylamino-2-methoxy-phenylazo)-benzotriazol-1 -yhuethyl ester (142B) 
and (R)-3-phenyl-butyric acid 5-(4-dimethykunino-2-methoxy-phenylazo)-
benzotriazol-2y1 methyl ester (142C). 
/ 
C 
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The general protocol outlined in section 5.4.18 was followed with (R)-138(A+B) 
(102.8mg, 0.232mmols) dissolved in 15nil of CH3CN: DCM (9:1). Crushed K2CO3 
(4.8mg, 0.035mols, 15 mol %) and formaldehyde (35.3l, 0.244mrnols, 1.05 equiv.) 
were added and the reaction stirred vigorously overnight at room temperature. Column 
chromatography eluting with DCM, furnished the desired products as dark red oils; A+B 
(52.9mg, 48%) as a mixture of the regioisomers in the ratio 55:45 (as determined by 
integral of methyl peaks at 1.25 and 1.27 p.p.m) and C (4.6mg, 4.2%). A+B could not be 
separated by prep scale HPLC despite extensive method development. 
Analytical data for (R)-142A, (R)-142B and (R)-142C were all comparable to the 
appropriate (S)-enantiomers in 5.4.21. 
A, B and C were all cleaved and the resulting (R)-3 phenylbutyric acid released 
determined, according to protocol 5.4.18, to be >99% e.e. - which is in excellent 
agreement with starting acid. 
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5.4.23 (S)-3-Phenyl-butyric 	acid 	5-(4-dimethylamino-napthalen-1 -ylazo)- 
benzotriazol-1-ylmethyl ester (143A), (S)-3-Phenyl-butyric acid 6-(4-
dimethylamino-napthalen-1-ylazo)-benzotriazol-1 -yi methyl ester (143B) 
and 	(S)-3-Phenyl-butyric acid 5-(4-dhnethylamino-napthalen-1 -ylazo)- 
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The general protocol (5.4.18) was followed with (S)-139A+B (241.9mg, 0.524mmols) 
dissolved in 40" of CH3CN: DCM (9:1). Crushed K2CO3 (10.8mg, 0.0786nimols, 15 
mol%) and formaldehyde (42.51..tl, 0.549mrnols, 1.05 equiv.) were added and the 
reaction stirred vigorously overnight at room temperature. Column chromatography 
eluting with DCM, furnished the desired products as dark red oils; A+B (2 12.2mg, 82%) 
as a mixture of both regioisomers in the ratio 48:52 (as determined by integral of peaks 
at 2.96, 6.45 and 9.0p.p.m) and C (19.7 mg, 7.6%). A+B (72.5mg) were taken and 
separated on a Biotage Flex system eluting at 50:50 (CH3CN:H20) to provide B as a 
deep red oil (12. 1mg) and A as an orange/red oil (25mg). 
(S)-143A 
Rf (DCM/Et20, 99:1) 0.31; Rt 25-29 mins (broad peak); Vrnax (thin film)/cm-1 3024 
(CH), 2964, 2924, 2825 (CH), 1750 (C=O), 1603 (C=C), 1574 (C=C), 1509 (C=C) 
1393 and 1136; 8H (CDC13; 600MHz, COSY) 1.24 (3H, d, J 7Hz, C), 2.66 (11-1, dd, J 
15.2 and 7.7Hz, CjHbCO), 2.67 (1H, dd, J 15.2 and 7.7Hz, CHaffl)CO), 3.20-3.29 (1H, 
IMA 
m, CH), 6.50 (111, d, J 11.1Hz, CHbO), 6.56 (1H, d, J 11.1Hz, CHbO), 7.02-7.14 
(6H, m, AM (x5) + CH,,, naphthalene, overlapping), 7.58 (1H, ddd, J 8.4, 6.9 and 1.5Hz, 
C), 7.65 (1H, dd, J 8.9 and MHz, CHbt) overlapping with 7.68 (1H, ddd, J 8.4, 6.9 
and 1.5Hz, C), 7.95 (1H, d, J 8.3Hz, C), 8.23 (1H, ddd, J 8.3, 1.5 and 0.914z, 
8.25 (1H, dd, J 8.9 and 1.7Hz, CHbt), 8.65 (1H, dd, J 1.7 and 0.7Hz, CHbt) and 
9.05 (1H, ddd, J 8.4, 1.5 and 0.9Hz, CH);  1H NOE irradiation at 6.50-6.56 p.p.m gave 
3.5% enhancement at 7.7p.p.m.; S  (CDC13; 631V11{z) 21.9 (H3), 36.4 (CH), 42.2 
(CH2CO), 44.8 (2 x N(CH3)2), 67.4 (CH20), 110.2 (CHbt), 112.5 (CH), 113.1 (CH), 
116.3 (Hbt), 123.6, 123.6, 124.5 (CH  x 3), 125.3 (CHbt), 126.3 (CH  x 2), 126.4, 
126.8 (CH), 128.1 (), 128.3 (CH x 2), 133.1, 133.4, 142.4, 144.3, 146.6, 150.8, 
154.7 (C, x 7) and 171.3 (C=O); mlz (ESi+, 45kV) 493.2 (100%, [MH]'); mlz (FAB, 3-
NOBA) 493 (80%, [MH]), (FAB, 3-NOBA) Found 493.23554 C29H28N602 requires 
493.23519. 
(S)-143B 
Rf (DCM/Et20, 99:1) 0.31; R20-25mins (broad peak); 	(thin film)/cm' 3053, 3024 
(CH), 2964, 2922, 2825 (CH), 1752 (C=O), 1603 (C=C), 1573 (C=C), 1509(C=C) 
1393 and 1136; 6H  CDC13; 250MHz) 1.24 (3H, d, J 7Hz, CH-A), 2.63 (1H, dd, J 15.4 and 
7.7Hz, Cj1HbCO), 2.68 (1H, dd, J 15.4 and 7.8Hz, CHJ3bCO),  3.26 (1H, m, C, 6.55 
(1H, d, J 11.1Hz, CHaHbO), 6.61 (1H, d, J 11.1Hz, CHa}jbO), 6.99-7.19 (6H, m, AIH 
(x5) + CH naphthalene, overlapping), 7.58 (1H, ddd, J 8.4,6.9 and MHz, CH) 7.68 
(111, ddd, J 8.3,6.9 and 1.5Hz, CH),  7.97 (111, d, J 8.4Hz , Cj) 8.14-8.17 (3H, m, 
Cj1,x 3 overlapping), 8.24(1H, dd, J 8.1 and 0.9Hz, CH,) and 9.05 (1H, dd, J 8.1 and 
0.9Hz, CH); 8CDC13; 63M1-lz) 21.9 (çH3),  36.4  (CH),  42.2 (H2CO), 44.8 (2 x 
N(H3)2), 67.6 (QH20), 106.1 (CHbt), 112.8 (CH), 112.9 (CH) 118.7 (CHb), 120.2 
(CHbt), 123.7, 124.6, 125.4 (CH x 3), 126.4 (CH x 2), 126.4, 126.9 (CH x 2), 126.5 
(CH x 2), 128.3 (CH x 2), 128.0, 133.3, 133.3, 142.4, 144.4, 146.5, 153.0, 155.1 (C 
x 8) and 171.2 (C=O); m/z (BSi+, 45kV) 493.2 (100%, [NM); mlz (FAB, 3-NOBA) 
493 (80%, [MIH]), (FAB, 3-NOBA) Found 493.23656 C29H28N602 requires 493.235197 
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(S)-143C 
Rf (DCM/Et20, 99:1) 0.40; p,, (thin film)/cm' 3054, 3024 (CH), 2964, 2923, 2825 
(CH), 1757 (C=O), 1607 (C=C), 1574 (C=C), 1509 (C=C) 1393 and 1136; SH (CDC13; 
250MHz) 1.29 (311, d, J 7Hz, Cth), 2.67 (11-1, dd, J 15.4 and 7.8Hz, CjHbCO), 2.74 
(1H, dd, J 15.4 and 7.3Hz, CH0ffi,CO), 3.23-3.37 (111, m, CH), 6.51 (111, d, J 10.0Hz, 
CHbO), 6.58 (1H, d, J 10.0Hz, CHJO),  7.07-7.23 (6H, m, ArH (x5) + CH.,  
naphthalene overlapping), 7.57 (1H, ddd, J 8.3, 6.9 and 1.5Hz, C), 7.65 (1H, ddd, J 
8.3, 6.9 and 1.514z, CH.,), 7.95 (11-1, d, J 8.311z, C) overlapping with 7.98 (1H, CHbt), 
8.23 (111, dd, J 8.9 and 1.41-1z, CH,), 8.25 (1H, dd, J 9.3 and 1.7Hz, C) 8.49 (1H, d, J 
1Hz, Ci,) and 9.02 (111, dd, J 8.4 and 1.5, C); 6(CDC13; 63MHz) 22.2 (çH3),  36.7 
(CH), 42.7 (CH2CO), 45.3 (2 x N(H3)2), 75.4 (dHO), 113.1 (CH), 113.6 (H), 
117.8 (CHbt), 119.6 (CHbt), 121.2 (Hbt), 124.2, 125.1, 125.9, 127.0 (CH,,, x 4), 127.0 
(CH x 2), 127.3 (CH), 128.6 (), 128.9 (CU,,. x 2), 133.7, 143.0, 145.3, 145.9, 146.4, 
153.1, 155.3 (C x 7) and 171.0 (C=O); mlz (ESi+, 45kV) 493.2 (100%, [Mill1); nilz 
(FAB, 3-NOBA) 493 (90%, [MHJ4), (FAB, 3-NOBA) Found 493.23550 C29H28N602 
requires 493.23519. 
A, B and C were all cleaved and the resulting (S)-3 phenylbutyric acid determined 
according to protocol 5.4.18 to be >99% e.e. - which is in excellent agreement with 
starting acid. 
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5.4.24. (R)-3-Phenyl-butyric 	acid 	5-(4-dimethylamino-napthalen-1 -ylazo)- 
benzotriazol-1-ylmethyl ester (143A), (R)-3-Phenyl-butyric acid 6-(4-
dimethylawino-napthalen-1 -ylazo)-benzotriazol-1 -yi methyl ester (143B) 
and 	(R)-3-Phenyl-butyric acid 5-(4-dimethylamino-napthalen-1 -ylazo)- 
benzotriazol-2-yl methyl ester (143C). 
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The general protocol 5.4.18 was followed with (R)-139A+B (191.3mg, 
0.414mmols) dissolved in 25m1 of CH3CN: DCM (9:1). Crushed K2CO3 (8.6mg, 
0.062mols, 15mol %) and formaldehyde (371il, 0.435mmols, 1.05 equiv.) were added 
and the reaction stirred vigorously overnight at room temperature. Column 
chromatography eluting with DCM, furnished the desired products as dark red oils; A+B 
(136mg, 66.7%) as a mixture of both regioisorners in the ratio 48:52 (as determined by 
the integral of peaks at 2.96, 6.45 and 9.0p.p.m) and C (13.7 mg, 6.7%). A+B (40mg) 
were taken and separated on a Biotage Flex system eluting at 50:50 (CH3CN: 1120) to 
provide B as a deep red oil (5.2mg) and A as an orange/red oil (8.7mg). 
Analytical data for (R)-143A, (R)-143B and (R)-143C were all comparable to the 
appropriate (S)-enantiomers in 5.4.23 
A, B and C were all cleaved and the resulting (R)-3 phenylbutyric acid determined 
according to protocol 5.4.18 to be >99% e.e.— which is in excellent agreement with 
starting acid. 
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5.4.25 (S)-3-Phenyl-butyric acid 5-(4-pyrolidin-1 -yl-phenylazo)-benzotriazol-1 -yl 
methyl ester (144A), (S)-3-phenyl-butyric acid 6-(4-pyrolidin-1 -yl-
phenylazo)-benzotriazol-1 -yl methyl ester (144B) and (S)-3-phenyl-butyric 
acid 5-(4-pyrolidin-1-yl-phenylazo)-benzotriazol-2-yl methyl ester (144C). 
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The general protocol 5.4.18 was followed with (S)-140(A+B) (195.6mg, 
0.45mmols) dissolved in 60m1 of CH3CN: DCM (9:1). Crashed K2CO3 (9.6mg, 
0.108mols, 24 mol%) and formaldehyde (40jii, 0.473mmols, 1.05 equiv.) were added 
and the reaction stirred vigorously overnight at room temperature. Column 
chromatography eluting with DCM, furnished the desired products as dark red oils; A+B 
(138mg, 65%) as a mixture of the regioisomers in the ratio 50:50 (as determined by 
integral of methyl peaks at 1.31 and 1.32 p.p.m) and C (21.4 mg, 10%). A+B could not 
be separated by prep scale HPLC despite extensive method development. 
(S)-144A+B 
Rf (DCM/Et20, 99:1) 0.25; ii mac(t11ifl film)/cm' 3055 (CHM), 2966, 2874 (CH), 1751 
(C=O), 1603 (C=C), 1517 (CC), 1384, 1144; 6H (CDC13; 250MHz) 1.31 (1.5H, d, J 
7.0Hz, C, one iegioisomer), 1.32 (1.5H, d, J 7.0Hz,one regioisomer), 2.12-2.14 
(4H, m, NCH2C, both regioisomers), 2.67 (1H, dd, J 15.4 and 7.9Hz, CHbCO, both 
FIV  
regioisomers), 2.73 (1H, dd, J 15.2 and 7.3Hz, CHaHbCO, both regioisomers), 3.25-3.38 
(1H, m, CH, both regioisomers), 3.46-3.49 (411, m, NCH2Cth,  both regioisomers), 6.54 
(0.5H, d, J 11Hz, CliaHbO, one regioisomer), 6.57 (0.5H, d, J 11.1Hz, CHaHbO, one 
regioisomer), 6.61 (0.5H, d, J 11Hz, CHaH1,O, one regioisomer), 6.65 (0.5H, d, J 11.1Hz, 
CHbO, one regioisomer), 6.71 (2H, d, J 9Hz, CH x 2, both regioisomers), 7.09-7.19 
(5H, m, AM, both regioisomers), 7.67 (0.5H, d, J 9Hz, CHbt, A), 8.00 (1H, d, J 9Hz, 2 
x C, one regioisomer), 8.01 (111, d, J 9Hz, 2 x CH,, one regioisomer), 8.03-8.09 
(1.5H, m, overlapping signals from 3 x 	8.16 (0.5H, d, J 9.4, CHbt, B), 8.18 (0.5H, 
dd, J 9 and 1.6Hz, CHbt, A) and 8.55 (0.5H, dd, J 1.6 and 0.8Hz, CHbt, A); 8 (CDC13; 
63MHz) 22.3, 23.4 (H3, both regioisomers), 25.9 (NCH2 FT2, both regioisomers), 36.9 
(CH, both regioisomers), 42.8 (CH2CO), 48.2 (NCH2CH2, both regioisomers), 68.0, 68.3 
(CH20, both regioisomers), 104.5 (CHbt, B), 110.5 (CHbt, A), 111.9, 112.0 (QHa, x 2, 
both regioisomers) 115.5 (CHb, A), 119.6 (CHbt, B), 120.5 (CHbt, B), 125.9 (CHbt, A), 
126.3 (CH, both regioisomers), 126.9 (CH.,, x 2, both regioisomers), 127.0 (CH,,, x 2, 
both regioisomers), 128.9 (QHa, x 2, both regioisomers), 133.2, 133.9, 143.5, 143.7, 
144.9, 145.0, 146.7, 147.0, 150.7, 150.9, 151.2 and 153.7 (C x 12, both regioisomers), 
171.7 and 171.8 (C=O, both regioisomers); nilz (ESi+, 45kV) 469.4 (100%, {MH]'), 293 
(10%, [Mli—CH2000CH2CHPhCH3]'); mlz (FAB, NOBA) 469 (10%, [MH]), 293 
(30%, [MH—CH2000CH2CHPhCH3]); (FAB, 3 -NOBA) Found 469.23523 C27H28N602 
requires 469.23520. 
(S)-144C 
Rf (DCMIEt20, 99:1) 0.44; u m,,,(thin film)/cm' 3029 (CH), 2924, 2825 (CH), 1755 
(C=O), 1603 (C=C), 1384 and 1135; Su (CDC13; 250MHz) 1.27 (3H, d, J 7Hz, CIj), 
2.03-2.09 (4H, m, NCH2C), 2.67 (1H, dd, J 15.4 and 7.9Hz, CHaHbCO), 2.73 (1H, dd, 
J 15.4 and 7.3Hz, CHJCO),  3.27-3.32 (1H, m, CH), 3.39-3.45 (4H, m, NCHCH2), 
6.48 (11-1, d, J 10.0Hz, CHaHbO), 6.55 (111, d, J 10.0Hz, CHa jbO), 6.63 (2H, d, J 9.2Hz, 
CH x 2), 7.09-7.22 (5H, m, ArH), 7.86 (111, d, J MHz, CHbt, obscured by signal at 
7.92 p.p.m), 7.92 (2H, d, J 9.1Hz, CH., x 2), 8.09 (1H, dd, J 9.3 and 1.7Hz, CH t) and 
8.28 (111, dd, J 1.6 and 0.8Hz, CHbt); Sc (CDC13; 63M}Iz) 21.7 (CH3), 25.4 (2 x 
187 
NCH2CH2), 36.7 (CH), 42.2 (CH2CO), 47.7 (2 x NCH2CH2), 74.9 (çH20), 111.4 (H 
x 2), 115.1 (CHbt), 118.7 (CHbt), 120.9 (cHbt), 125.5 (CH,,, x 2), 126.4 (CH,,,), 126.5 
(H x 2), 128.4 (H x 2), 143.1, 144.8, 145.5, 150.2, 152.4, 153.1 ( 	x 6) and 
170.5 (C=O); mlz (ESi+, 45kV) 491.3 (100%, [MNa]), 469.4 (50%, [.MHfl, 293 (10%, 
[MI-I - CH2000CH2CHPhCH3]); mlz (FAB, 3-NOBA) 469 (10%, [MH]), (FAB, 3-
NOBA) Found 469.23512 C27H28N602 requires 469.235199. 







(S)-137B (5mg, 1.2xlO 5mols) was dissolved in CH3CN: DCM (9:1, 2m1). To 
this was added potassium carbonate (0.1mg) and the mixture stirred for sixteen hours at 
room temperature. At various time points the solvent was removed under reduced 
pressure and the crude mixture analysed by NMR in CDC13. After NMR analysis the 
deuterated solvent was removed under reduced pressure and the crude mixture 
resuspended in CH3CN: DCM (9:1, 2m1). After sixteen hours the solvent was removed 
under reduced pressure and the crude mixture purified by column chromatography 













611 (CDC13; 200 MHz) (only benzotriazole signals reported.) 
Initial - 6 (CDC13; 200 MHz) 7.94 (1H, dd, J 9.0 and 0.8Hz, 	8.07 (1H, d, J 
9.0Hz, CHbt) and 8.56 (1H, d, J 0.8Hz, CHbt). 
After 1 hour— SH (CDC13; 200 MHz) 7.94 (1H, dd, J 9.0 and 0.811z, 	8.07 (1H, d, J 
9.0Hz, CHbt) and 8.56 (1H, d, J 0.8Hz, CHbt). 
After 16 hours - 611 (CDC13; 200 MHz) 7.97 (0.57H, d, J 8.2Hz, 	8.06 (0.57H, d, J 
8.2Hz, CHbt), 8.17 (0.4311, dd, J 8.2Hz, CHbt), 8.21 (0.43H, d, J 8.2Hz, CHbt), 8.42 
(0.43H, s, CHbt) and 8.59 (0.57H, s, CHbt). 
The ratio of regioisomers, after 16 hours incubation with K2CO3, was calculated as 43:57 
(A: B) by integration of peaks at 8.42 and 8.59 p.p.m respectively. 
5.4.27 Attempted synthesis of 4-(1 -Hydroxymethyl-1H-benzotriazol-5-ylazo-)-
naphthalen-1-ol (130) and 4-(1 -Hydroxymethyl-1H-6-ylazo)-napthalen-1-ol 
(131) 
HO,.... 
Ô N f  
130 	 OH 
HO 
+ 	oj N .N'CCN 
N OH 
131 
120 (250mg, 0.87minols) was suspended in glacial acetic acid (2m1) with 1120 
(2m1) and acetone (2m1). The reaction was heated to 70°C and formaldehyde (64.9j.il, 
1 .74mmols, 2 equiv.) was added. The reaction was heated for a further 30mins then 
allowed to cool. On cooling a dark brown precipitate was formed which was collected 
and dried under high vacuum to give a dark brown powder (0.201g, 72%). The crude 
product was analysed by reverse phase HPLC eluting with 85% MeOH/15% H20 (no 
TFA added). Under these conditions the R of the parent dye was 3.Omins. The product 
was used without further purification 
5.4.28 Attempted synthesis of 4-(1-Hydroxymethyl-1H-benzotriazol-5-ylazo)-3,5-
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119 (0.165g, 0.55mmols) was dissolved in the minimum amount of acetic acid: 
H20 (2:1, approx 20m1). To this was added formaldehyde (0.041m1, 0.55mmols, 1 
equiv) and the reaction mixture was allowed to stir for three hours at room temperature. 
The red precipitate formed was filtered off, washed with cold ether (lOmi) and dried in a 
vacuum dessicator over P205 under reduced pressure. Further purification was 
unsuccessful. 
Mø 
5.4.29 Attempted synthesis of 1-[6-(4-Hydroxy-naphthalen-1 -ylazo)-benzotriazol-1- 
yl]-2-methyl-butan-1-one 	(126) 	and 	1-[5-(4-hydroxy-naphthalen-1 -ylazo)- 
benzotriazol-1 -yl]-2-methyl-butan-1-one (127). 
HO 	 o,—&___ 
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127 
120 (200mg, 0.692mmols) was dissolved in 'anhydrous' DCM under an inert 
atmosphere of nitrogen and cooled to 0°C. To this was added triethylaniine (0.115m1, 
1.2equiv) followed by (R/S)-2-methyl butyiyl chloride 109 (0.129m1, 1.5equiv.) and the 
reaction mixture was stirred for ihour. HPLC analysis indicated that the azo dye (eluting 
at 6mins) had been converted to less polar components at 25, 28, 42 and 47minutes. The 
reaction was quenched by addition of HCl (2M, lOml) and further DCM (50ml) was 
added. The organic layer was separated, washed with H20 (20m1), dried over MgSO4, 
filtered and the solvent removed under reduced pressure to give a deep red oil. The 
crude mixture was dissolved in CH3CN (5nil) and purified by Prep scale I{PLC 
collecting 4 fractions at 25, 28, 42 and 47 minutes respectively. The organic solvent was 
removed from each fraction and the product extracted with DCM, dried over MgSO4, 
filtered and the solvent removed in vacuo to give the four fractions as red oils; 25mins 















Time (mins) % HO % CH3CN 
0 50 50 
20 20 80 
40 20 80 
60 5 95 
5.4.30 Isolation of (R/S)-2-methylbutyric acid 4-(1H-benzotriazol-6-ylazo)-
napthalen-1-yl ester (129) 
0-~~( 
129 
R 25 mins; u (thin film)/cm 1 3054 (CH), 2986, 2936, 2878 (CH), 1752 
(C=O), 1635 (C=C), 1574 (C=C), 1507, 1265; 61-1 (CDC13; 250MHz) 1.15 (311, t, J 
7.4Hz, CH2Cjf), 1.48 (31-1, d, J 6.91-1z, CHCth), 1.72-1.86 (1H, m, CjHbCH), 1.97- 
2.11 (1H, m, CH,fjbCH), 2.89 (11-1, tq, J 6.9 and 6.911z, CHCH3) 7.31 (1H, d, J 8.4Hz, 
CH), 7.56 - 7.63 (2H, m, CHIT x 2), 7.73 (1H, d, J 8.9, CH), 7.82 (111, d, J 8.4Hz, 
CH,), 7.92 (11-1, br d, J 9.2Hz, 	8.09 (111, br d, J 9.214z, 	8.46 (111, br s, 
CHbt) and 8.87 (11-1, br d, 8.8Hz, CH); Sc (CDC13; 63MHz) 12.2 (CH2CH3), 17.2 
(CH3), 27.3 (cH2CH3), 42.0 (CH) 112.3 (CHbt), 113.8 (CH), 115.3 and 118.5 (cHbt), 
120.3 (CH,, ), 121.6 (CH), 124.1 (CH), 127.6 (CH), 127.8 (), 127.9 (CH), 129.5, 
133.0, 143.0, 145.5, 149.8, 151.5 (Cx 6); mlz (ESi -ye, 45Kv) 372.0 (100%, [M-H]; 
rnlz (FAB+ve, 3-NOBA) 374 (70%, [MH]), 290 (60%, [M-(CH3CH2CHCH3C=O)], 
192 
120 (40%, [BtH]+) and 77 (60%, [Ph]+); mlz (FAB+ve, 3-NOBA) Found 374.16284 
C211-120N502 requires 374.16398 
Fraction at 28 mins - Weak NIVIR due to lack of material; mlz (ESi -ye, 45Kv) 372.1 
(100%, [M-H]). 
Fraction at 42 mins - impure NMIR; mlz (ESi -ye, 45Kv) 372.1 (100%, EM-H]) 
5.4.31 Isolation of (R/S)-2-methylbutyric acid 4-[3-(2-methyl-butyryl)-1H-
benzotriazol-6-ylazo]-naphthalen-1 -yl ester (128a) and (R/S)-2-methyl-
butyric acid 4-[1 -(2-methyl-butyryl)-1H-benzotriazol-5-ylazo]-naphthalen-1-
yl ester (128b). 
oy( 
0 













Rt 47 mins; u (thin film)/cm-1 3054 (CH), 2969, 2936, 2877 (CH), 1758 (C=O), 
1738(C=O), 1589(C=C), 1574 (C=C), 1508,1461; 811 (CDC13; 250MBz) 1.01, 1.04 and 
1.17 (611, t, J 7.41-1z, CH2CI x 3 overlapping), 1.44 (4.5H, d, J 6.9171z, CHCH3 x 2 
overlapping) 1.45 (1.51-1, d, J 6.911z, CHCH3) 1.64-1.88 (21-1, m, CHaHbCH X 2 
overlapping), 1.92-2.12 (2H, m, CH,CH x 2 overlapping), 2.84 (1H, tq, J 6.9 and 
6.9Hz, OC=OCHCH3), 4.05 and 4.07 (1H, tq, J 6.9 and 6.9 Hz, NC=OCHCH3, 
overlapping) 7.34 (1H, d, J 8.411z, CH.,), 7.56 - 7.70 (2H, ddd, J 8.3, 6.8 and 1.0Hz, 
CH x 2 overlapping), 7.91-7.97 (214, m, CH x 2), 8.19 (11-1, 2 x d overlapping, J 
8.9Hz, CHbt), 8.38 (11-1, m, CHbt x 2), 8.70 (0.5H, br s, CHbt, one regioisomer), 8.86 
(0.511, br s, CHbt, one regioisomer) and 8.98 (11-1, 2 x d overlapping, CH ); Sc (CDC13; 
63MHz) 12.0, 12.2 (CH2CH3), 17.1, 17.2, 17.2 (H3), 27.2, 27.3 (CH2CH3), 41.0, 42.0 
(CH), 110. 9, 112.6, 112.7, 115.3, 116.6, 118.5, 118.6, 120.9, 121.3, 121.7, 121.7, 124. 1, 
124.1, 125.0, 127.5, 127.5 (CH + QHbt x 16), 127.9, 127.9 (2 x 	) 128.0, 128.1 
193 
(CH), 132.4, 132.9, 133.1, 133.2, 145.4, 145.5, 147.3, 150.2, 150.5, 151.7, 152.0, 154.3 
(Cx 12), 175.1, 175.2 (C=O, N-acyl) and 176.6 (C=O, ester); mlz (FAB +ve, 3-NOBA) 
458.0 (55%, [M-H]+); 374 (10%, [MH-(CH3CH2CHCH3C=O)]+, 290.0 (30%, [M-
(CH3CH2CHCH3C=O)x 2]), 120 (25%, [BtH]) and 77 (60%,[Ph]);  mlz (FAB, 
NOBA) Found 458.21927 C261128N503 requires 458.21933. 
5.5 	Measurment of SERRS spectra of dyes (121-123) 
SERRS spectra were measured at an excitation wavelength of 5 i4nm. Silver 
colloid (0.5nil) was added to the cuvette followed by monoazo-beuzotriazole dye (e.g. 
121, 0.lml, 1 x 10 5M in pH 8 HEPES buffer). The resulting solution was stirred and 
analysed immediately. Spectra were acquired for is accumulation time every 5 seconds. 
Measurement of SERRS spectra of blocked ester dye (S)-141A 
SERRS spectra were measured at an excitation wavelength of 514nm. Silver 
colloid (0.5m1) was added to the cuvette followed by the appropriate enzyme solution 
(e.g. PCL, 0.5m1, 1mg/nil in pH 8 HEPES buffer). To this suspension was added (S)-
141A (0.1ml, 1 x 10 5M in pH 8 HEPES buffer) and the resulting solution analysed 
immediately. Spectra were acquired for is accumulation time every 5 seconds for the 
duration of the hydrolysis reaction. 
194 
6.0 Bibliography 
1 	K. M. Koeller and C-H. Wong, Nature, 2001, 409, 232. 
2 G. M. Whitesides and C-H. Wong, 'Enzymes in Synthetic Organic Chemistry', 
Pergamon, 1994. 
3 	D. C. Demirjian, P. C. Shah and F. Moris-.Varas, Top. Curr. Chem., 1999,200, 1. 
P. Berglund, Biomol. Eng., 2001, 18, 13. 
P. Villeneuve, J. M. Muderhwa, J. Graille and M. J. Haas, J. Mol. Catal. B: 
Enzymatic, 2000, 113. 
6 	w Tischer and F. Wedekind, Top. Curr Chem., 1999, 200, 95. 
F. H. Arnold, Chem. Eng. Sci., 1996, 51, 5091. 
8 	F. H. Arnold, Acc. Chem. Res., 1998, 31, 125. 
J. C. Moore and F. H. Arnold, Nat. Biotechnology, 1996, 14, 458. 
10 	K. Chen and F. H. Arnold, Proc. Natl. Acad. Sci. USA, 1993, 90, 5618. 
11 	J-H. Zhang, G. Dawes and W. P. C. Stemmer, 1997, 1997, 94, 4504. 
12 W. P. C. Stemmer, Nature, 1994, 370, 389. 
13 	W. P. C. Stemmer, Proc. Natl. Acad. Sci U.S-A, 1994, 91, 10747. 
14 H. Zhao, L. Giver, Z. Shao, J. A. Afffiolter and F. H. Arnold, Nat. Biotechnology, 
1998, 16, 258. 
15 	M. T. Reetz and K-E. Jaeger, Top. Curr. Chem., 1999, 32. 
16 J. B. Jones and G. Desantis, Acc. Chem. Res., 1999, 32, 99. 
17 	K. K. Y. Hirose, Y. Nakanishi, Y. Kurono and K. Achiwa, Tetrahedron. Lett., 
1995, 36, 1063. 
18 	D. Rotticci, J. C. Rotticci-Mulder, S. Denman, T. Norin and K. Hult, Chem. 
BioChem., 2001,2,766. 
19 	M. T. Reetz, Angew. Chem. mt. Ed., 284,40,284. 
20 M. Olsen, B. Iverson and G. Georgiou, Curr. Opin. Biotech., 2000, 11, 331. 
21 	S. A. Sundberg, Curr. Opin. Biotech., 2000, 11, 47. 
22 D. Wahier and J-L. Reymond, Curr. Opin. Chem. Biol., 2001, 5,152. 
23 	R. D. Schmid and R. Verger, Angew. Chem. mt. Ed., 1998, 37, 1608. 
195 
24  L. Sarda and P. Desnuelle, Biochim. Biophys. Acta, 1958, 30, 513. 
25 	L. Brady, A. M. Brozozowski, Z. S. Derewanda, B. Dodson, G. Dodson, S. 
Tolley, J. P. Turkenburg, L. Christiansen, B. Huge-Jensen, L. Norscov, L. Thim 
and U. Menge, Nature, 1990, 343, 676. 
26 	F. K. Winkler, A. D'arcy and W. Hunziker, Nature, 1990, 343, 771. 
27 K. Faber, 'Biotransformations in Organic Chemistry - A Textbook', Springer, 
1997. 
28 	H. G. Davies, R. H. Green, D. R. Kelly and S. M. Roberts, 'Biotransformations in 
Preparative Organic Chemistry: The Use of Isolated Enzymes and Whole Cell 
Systems in Synthesis', Academic Press, 1989. 
29 	F. Theil, Chem. Rev., 1995, 95, 2203. 
30 B. Santaniello, P. Fenaboschi, P. Grisenti and A. Manzocchi, Chem. Rev., 1992, 
92, 1017. 
31 	B. Schoffers, A. Golebiowski and C. R. Johnson, Tetrahedron., 1996, 52, 3769. 
32 M. L. E. Gihani and J. M. J. Williams, Curr. Opin. Chem. Biol., 1999, 3, 11. 
33 	S. Caddick and K. Jenkins, Chem. Soc. Rev., 1996,447. 
34 P-J. Um and D. G. Dmeckhammer, J. Am. Chem. Soc., 1998, 120, 6505. 
35 	P. M. Dinh, J. A. Howarth, A. R. Hudnott and J. M. J. Williams, Tetrahedron. 
Lett., 1996,7623. 
36 	B. A. Persson, A. L. E. Larsson, M. LeRay and J-E. Backvall, J. Am. Chem. Soc., 
1999, 121, 1645. 
37 	M. T. Reetz and K. Schimossek, Chimia, 1996, 668. 
38 T. Pathek and H. Waidmami, Curr. Opin. Chem. Biol., 1998, 112. 
39 	A. M. Klibanov, Nature, 2001, 409, 24 1. 
4° 	T. Okamoto and S. Ueji, J. Chem. Soc., Chem.Commun., 1999,939. 
41 Y-Y. Liu, J-H. Xu and Y. Hu, J. Mol. Catal. B: Enzymatic, 2000, 10, 523. 
42 	D. Lee, Y.K. Choi and M-J. Kim, Org. Lett., 2000,2,2553. 
43 M. T. Reetz, Curr. Opin. Chem. Biol., 2002,6, 145. 
44 	B. Cambou and A. M. Klibanov, J. Am. Chem. Soc, 1984, 106, 2687. 
196 
45  J. J. Lalonde, C. Gorvardhan, N. Khadaf, A. U. Martinez, K. Visuri and A. L. 
Margolin, J. Am. Chem. Soc., 1995, 117, 6845. 
46 	I. J. Colton, S. N. Ahmed and R. J. Kazlauskas, J. Org. Chem., 1995, 60, 212. 
47 M. T. Reetz, A. Zonta, J. Simpelkamp and W. Könen, J. Chem. Soc., Chem. 
Commun., 1996, 1397. 
48 	W. V. Tuomi and R. J. Kazlauskas, J. Org. Chem., 1999,64,2638. 
49 F. H. Arnold, Nature, 2001, 409, 253. 
50 	R. J. Kazlauskas, Curr. Opin. Chem. Biol., 2000, 4, 81. 
51 L. E. Janes, A. Cimpoia and R. J. Kazlauskas, J. Org. Chem., 1999, 64, 9019. 
52 	M. Hoiquist and P. Berglund, Org. Lett., 1999, 1, 763., 
53 M. Holmquist, F. Hffner, T. Norin and K. Hult, Protein. Sci.,1996, 5, 83. 
54 	D. Rotticci, J. C. Rotticci-Mulder, S. Denman, T. Norin and K. Hult, Chem. 
BioChem., 2001,2,766. 
55 	S. Patkar, J. Vind, E. Kelstmp, M. W. Christensen, A Svendsen, K. Borch and 0. 
Kirk, Chemistry and Physics of Lipids, 1998, 93, 95. 
56 	A. Magnusson, K. Hult and M. Holmquist, J. Am. Chem. Soc, 2001, 123, 4354. 
57 A. Svendsen, Biochim. Biophys. Acta., 2000, 1543, 223. 
58 	C. Schmidt-Dannert, Biorg. and Med. Chem., 1999, 7, 2123. 
59 L.Giver, A. Gershenson, P. 0. Freskgard and F. H. Arnold, Proc. Natl. Acad. Sci. 
U.S.A, 1998, 12809. 
60 	M. T. Reetz, S. Wilensek, D. Zha and K-B. Jaeger, Angew. Chem. mt. Ed, 2001, 
40, 3589. 
61 	K. Liebeton, A. Zonta, K. Schimossek, M. Nardini, D. Lang, B. W. Dijkstra, M. 
T. Reetz and K-B. Jaeger., Chem. and Biol., 2000, 7,709. 
62 	K-E. Jaeger and M. T. Reetz, Curr. Opin. Chem. Biol., 2000, 4, 68. 
63 M. T. Reetz and K-B. Jaeger, Chem. Eur. J., 2000, 6, 407. 
64 	D. Zha, S. Wilensek, M. Hermes, K-B. Jaeger and M.T. Reetz, J. Chem. Soc. 
Chem. Commun., 2001, 2664. 
65 	M. T. Reetz, A. Zonta, K. Schimossek, K. Liebeton and K-B. Jaeger, Angew. 
Chem. mt. Ed., 1997, 36, 2830. 
197 
66  U. T. Bomscheuer, J. Altenbuchner and H. H. Meyer, Biorg. and Med. Chem., 
1999, 7, 2169. 
67 	E. Henke and U. T. Bomscheuer, Biol. Chem., 1999, 380, 1029. 
68 S. Fong, T. D. Machajewski, C. C. Mak and C-H. Wong, Chem. Biol., 2000, 7, 
873. 
69 	0. May, P. T. Nguyen and F. H. Arnold, Nat. Biotechnology, 2000, 18, 317. 
70 	J. Kauffman and C. Schmidt-Dannert, Protein. Eng., 2001, 14, 919. 
71 K. A. Powell, S. W. Ramer, S. B. Del Cardayi, W. P. C. Stemmer, M. B. Tobin, 
P. F. Longchamp and G .W. Huisman, Angew. Chem. mt. Ed, 2001, 40. 
72 	U. T. Bornscheuer and M. Pohl, Curr. Opin. Chem. Biol., 2001, 5, 137. 
73 	P. Souniillion and J. Fastrez, Curr. Opin. Biotech., 2001, 12,387. 
74 	S. Danielsen, M. Eklund, H-J. Deussen, T. Graslund, P-A. Nygren and T. V. 
Borchert, Gene, 2001, 267. 
75 	F. Beisson, A. Tiss, C. Riviere and R. Verger, Eur. J. Lipid. Sd. Technol., 2000, 
133. 
76 	F. Cardenas, E. Alvarez, M-S. de Castro-Alvarez, J-M. Sanchez-Montero, M. 
Valmased, S.W. Elson and J-V. Sinisterra, J. Mol. Catal. B: Enzymatic, 2001, 14, 
111. 
77 	S. J. C. Taylor, R. C. Brown, P. A. Keene and I. N. Taylor, Biorg. and Med. 
Chem., 1999, 7, 2163. 
78 	F. Zocher, M. M. Euzelberger, U. T. Bomscheuer, B. Hauer and R. D. Schmid, 
Anal. Chim. Acta, 1999, 391, 345. 
79 	I. P. Petrounia and F. H. Arnold, Curr. Opin. Biotech., 2000, 11, 325. 
80 	H. Joo, A. Arisawa, Z. Lm and F. H. Arnold, Chem. and Biol., 1999, 6, 699. 
81 	A. Y. Fu, C. Spence, A. Scherer and F. H. Arnold, Nat. Biotechnology, 1999, 17, 
1109. 
82 	L. E. Janes, C. Lowendahi and R. J. Kazlauskas, Chem. Eur. J., 1998, 4, 2324. 
83 A. M. F. Liu, N. A. Somers, R. J. Kazlauskas, T. S. Brush, F. Zocher, M. M. 
Enzelberger, U. T. Bomscheuer, G. P. Horsman, A. Mezzetti, C. Schmidt-
Dannert and R.D. Schmid, Tetrahedron: Asymmetry, 2001, 12, 545. 
198 
84  F. Moris-Varas, A. Shah, J. Aikens, N. P. Nadkarni, J. D. Rozzell and D.C. 
Demhjian, Biorg. and Med. Chem., 1999,7,2183. 
85 	M. Baumann, B. Hauer and U. T. Bomscheuer, Tetrahedron: Asymmetry, 2000, 
11, 4781. 
86 	L. E. Janes and R. J. Kazlauskas, J. Org. Chem., 1997, 62, 4560. 
87 J. D. De Caro, P. Rouimi and M. Rovery, Eur. J. Biochem., 1986, 158, 601. 
88 	T. L. de Monpezat, B. de Jeso, J-.L. Butour, L. Chavant and M. Sancholle, Lipids, 
1990, 25, 661. 
89 	G. Klein and J-L. Reymond, Helv. Chim. Acta., 1999, 82, 400. 
90 R. P. Carlon, N. Jourdain and J-L. Reymond, Chem. Eur, J., 2000, 6, 4154. 
91 	F. Badalassi, D. Waliler, G. Klein, P. Crotti and J-L. Reymond, Angew. Chem. 
mt. Ed., 2000, 39, 4067. 
92 	P.Geymayer, N. Bahr and J-L. Reymond, Chem. Eur. J., 1999, 5, 1006. 
93 D. S. Tawfick, B. S. Green, R. Chap, M. Sela and Z. Eshhar, Proc. Natl. Acad. 
Sci. U.S.A, 1993,90, 373. 
94 	G. MacBeath and D. Hilvert, .1. Am. Chem. Soc., 1994, 116, 6101. 
95 G. Klein and J-L. Reymond, Angew. Chem. mt. Ed., 2001, 40,1771. 
96 	A. Jenne, W. Gmelin, N. Raffler and M. Famulok, Angew. Chem. mt. Ed., 1999, 
38, 1300. 
97 	G. Rosse, E. Kueng, M. G. P. Page, V. Schauer-Vukasinovic, T. Giller, H-W. 
Lahm, P.Hunziker and D. Schiatter, J. Comb. Chem., 2000,2,461. 
98 	S. A. Farber, M. Pack, S. Y. Ho, I. D. Johnson, D.S. Wagner, R. Dosch, M. C. 
Mullins, H. S. Hendrickson, E. K. Hendrickson and M. B. Halpern, Science, 
2001, 292, 1385. 
99 	M. T. Reetz, K. M. Kuhling, S. Wilensek, H. Husmaiin, U. W. Hausig and M. 
Hermes, Catalysis Today, 2001, 67, 389. 
100 	M. T. Reetz, K. M. Kuhling, A. Deege, H. Hinrichs and D. Belder, Angew. 
Chem. mt. Ed., 2000, 39, 3 89 1. 
101 	L. D. Hutt, D. P. Glavin, J. L. Bada and R. A. Mathies, Anal. Chem., 1999, 71, 
4000. 
199 
102 	• Rodriguez, L. J. Jm and S. F. Y. Li, Electrophoresis, 2000, 21, 211. 
103 	M. T. Reetz, M. H. Becker, H-W. Klein and D. Stockigt, Angew. Chem. mt. Ed., 
1999, 38, 1758. 
104 	J. Guo, J. Wu, G. Siuzdak and M.G. Finn, Angew. Chem. mt. Ed., 1999, 38, 
1755. 
105 	A. Horeau, Tetrahedron. Lett., 1962, 2, 506. 
106 	A. Horeau, Tetrahedron. Lett., 1962, 3, 965. 
107 	A. Horeau and A. Schoofs, Tetrahedron. Lett., 1977, 18, 3259. 
108 	A. Horeau and A. Nouaille, Tetrahedron. Lett., 1990, 31, 2707. 
109 	C. Presig and G. Byng, J. Mol. Catal. B: Enzymatic, 2001, 11,733. 
110 	M. T. Reetz, M. H. Becker, K. M. Kuhling and A. Holwarth, Angew. Chem. mt. 
Ed., 1998, 37,2647. 
A. R. Connoly and J. D. Sutherland, Angew. Chem. mt. Ed., 2000, 39, 4268. 
112 	M. T. Reetz, K. M. Kubling and H. Hinrichs, Chiraliy, 2000, 12, 479. 
113 	M. T. Reetz, Angew. Chem. mt. Ed., 2001, 40, 284. 
114 	G. A. Korbel, G. Lalic and M. D. Shair, J. Am. Chem. Soc., 2001, 123,361. 
115 	F. Taran, P. Y. Renard, C. Creminion, A. Valleix, Y. Frobrt, P. Pradelles, J. 
Grassi and C. Mioskowski, Tetrahedron. Lett., 1999, 40, 1887. 
116 	F. Taran, P. Y. Renard, C. Creminion, A. Valleix, Y. Frobrt, P. Pradelles, J. 
Grassi and C. Mioskowski, Tetrahedron. Lett., 1999,40, 1891. 
117 	F. Taran, C. Gauchet, B. Mohar, S. Meunier, A. Valleix, P.Y. Renard, C. 
Creminon, J. Grassi, A. Wagner and C. Miokowski, Angew. Chem. mt. Ed., 
2002, 41, 124. 
118 	S. M. Firestine, F. Salinas, A. E. Nixon, S. J. Baker and S. J. Benkovic, Nat. 
Biotechnology, 2000, 18, 544. 
119 	M. Baumann, R. Stunner and U. T. Bomscheuer, Angew. Chem. mt. Ed., 2001, 
40,4201. 
120 	J. C. Jones, C. McLaughlin, D. Littlejohn, D. A. Sadler, D. Graham and W. E. 
Smith, Anal. Chem., 1999, 71, 596. 
200 
121 	D. Graham, C. McLaughlin, G. McAnally, J. C. Jones, P. C. White and W. B. 
Smith, J. Chem. Soc. Chem. Coinmun., 1998, 1187. 
122 	D. Graham, W. B. Smith, A. T. Linacre, C. H. Munro, N. D. Watson and P.C. 
White, Anal. Chem., 1997,69,4703. 
123 	C. Rodger, W. E. Smith, G. Dent and M. Edmondson, J. Chem. Soc. Dalton 
Trans., 1996, 791. 
124 	C. H. Munro, W. E. Smith and P.C. White, Analyst, 1995, 120, 993. 
125 	M. Campbell, S. Leconte and W.E. Smith, J. Raman Spectrosc., 1999, 30, 37. 
126 	Mobil. Oil. Corporation, in 'Fuel and Lubricant compositions', United Kingdom, 
1972 ,No. 1,387,134 
127 	H. Nickel and F. Suckfull, in 'Azo dyestuffs containing a triazole group', United 
States, 1970, No. 3,501,454 
128 	S. Narita and T. Kitagwa, in 'Benzotriazole derivatives and chiral derivatisation 
reagents for carboxylic acids', Europe, 1989, No. 0363964. 
129 	A. R. Katritzky, X. Lan, J. Yang and 0. Denisko, Chem. Rev., 1998, 98, 409. 
130 	D. Graham, R. Brown and W. E. Smith, J. Chem. Soc. Chem. Commun., 2001, 
1002. 
131 	D. Graham, B. J. Mallinder and W. E. Smith, Angew. Chem. mt. Ed., 2000, 39, 
1061. 
132 	C. G. Mowat, C. S. Miles, A. W. Munro, M. R. Cheesman, L. G. Quaroni, G. A. 
Reid and S. K. Chapman, J. Biol. Inorg. Chem., 2000, 5, 584. 
133 	R. M. Seifar, M. A. F. Alteaar, R. J. Dijkstra, F. Ariese, U. A. Th. Brinkman and 
C. Gooijer, Anal. Chem., 2000, 72, 5718. 
134 	N. G. Gaylord and J. M. Naughton, J. Org. Chem., 1957, 6, 1022. 
135 	M. Ono and I. Itoh, Chem. Letts., 1988, 585. 
136 	A. R. Katritzky, S. Rachwal and B. Rachwal, Synthesis, 1991, 69. 
137 	A. R. Katritzky, A. Pastor and M. V. Voronkov, J. Het. Chem., 1999, 36, 777. 
138 	A. R. Katritzky, S. Rachwal and B. Rachwal, J. Chem. Soc. Perkin Trans. 1, 
1987, 791. 
201 
139 	J. H. Burckhalter, V. C. Stephens and L. A. R. Hall, J. Am. Chem. Soc., 1955, 77, 
3868. 
140 	G. Varadharaj, K. Hazell and C. D. Reeve, Tetrahedron. Asymmetry, 1998, 9, 
1191. 
141 	M. J. Begley, L. Crombie, R. C. F. Jones and C. J. Palmer, J. Chem. Soc. Perkin 
Trans. 1, 1987, 353. 
142 	j Jones, 'Amino Acid and Peptide Synthesis', Oxford Science Publications, 
1997. 
143 	J-N. Bertho, A. Loffer, C. Pinel, F. Reuther and G. Semiyey, Tetrahedron. Lett., 
1991, 32, 1303. 
144 	D. M. Blow, Acc. Chem. Res., 1976, 9, 145. 
145 	A. R. Katritzky, N. Shobana, P. A. Harris, J. B. Hill and D. J. Ager, Org. Prep. 
and Proc. mt., 1992, 24, 121. 
146 	A. R. Katritzky, J. Pemak, W-Q. Fan and F. Saczewski, J. Org. Chem., 1991, 56, 
4439. 
147 	A. R. Katritzky and M. Drewniak, J. Chem. Soc. Perkin Trans. 1, 1988, 2339. 
148 	A. R. Katritzky and L. Urogdi, J. Chem. Soc. Perkin Trans. 1, 1990, 1853. 
149 	j Dowden, Unpublished results. 
150 	R. Reents, D. A. Jeyaraj and H. Waldmann, Adv. Synth. Catal., 2001, 6-7, 343. 
151 	A. Paio, A. Zaramella, R. Femtto, N. Conti, C. Marchiom and P. Seneci, J. 
Comb. Chem., 1999, 1. 
152 	A. R. Katritzky, A. Pastor, M. Voronkov and D. Tymoshenko, J. Comb. Chem., 
2001, 3, 167. 
153 	A. R. Katritzky, S. A. Belyakov and D. Tymoshenko, J. Comb. Chem., 1999, 1, 
173. 
154 	D. McIntyre, Unpublished results. 
155 	G. D. Bohm, J. Dowden, D. C. Rice, I. Burgess, J. F. Pilard, B. Guilbert, A. 
Haxton, R. C. Hunter, N. J Turner and S. L. Flitsch, Tetrahedron. Letts, 1998, 
39, 3819. 
202 
156 	C-S. Chen, Y. Fujimoto, G. Girdaukas and C. J. Sih, J. Am. Chem. Soc., 1982, 
104,7294. 
157 	A.R. Katritzky, S. Perumal and G. P. Savage, J. Chem. Soc. Perkin Trans. 2, 
1990, 921. 
158 	A. R. Katritzky and K.Yannakopoulou, Heterocycles, 1989, 28, 1121. 
159 	D. Graham, ersonal communication, 2002. 
160 	D. Graham, A. R. Kennedy and S. J. Teat, Journal of Heterocyclic chemistry, 
2000, 37, 1555. 
161 	A. R. Katritzky, W. Kuzmierkiewicz, B. Rachwal, S.Rachwal and J. Thomson, J. 
Chem. Soc., Perkin Trans 1, 1987, 811. 
162 	J. D. Dmliner, J. Am. Chem. Soc., 1968, 90, 6879. 
163 	M. P. Deutscher, Methods In Enzymology', Academic Press, 1990. 
164 	L. Konopski and A. Kielczewska, Chem. Anal. (Warsaw), 1995, 40, 887 
165 	B. Bachman, J. Org. Chem. 1970,35,4229. 
203 
7.Appendices 
7.1. X-ray crystal structure for [4-(1 H-benzotriazol-6-ylazo)-3-methoxy-phenyl]-
diinethyl-amine (122). 
204 
Tablel Crystal data and structure refinement for/disk2/texsau/extras/ciftab. 
Identification code 	 dglo 
Empirical formula 	 C15 H18 N6 02 
Formula weight 	 314.35 
Temperature 	 123(2) K 
Wavelength 	 0.71073 A 
Crystal system, space group 	 triclinic PT 
Unit cell dimensions 	a = 7.1142(2) A alpha = 90.4490 (10) dec. 
Volume 
Z, Calculated density 
Absorption coefficient 
Crystal size 
b = 10.3909(3) A beta = 104.6160(10) deg. 
c = 10.7890(3) A gamma = 99.1340(10) deg. 
761.00(4) A"3 
2, 1.372 Mg/mA3 
0.096 rran' 
0.20 x 0.10 x 0.10 mm 
Theta range for data collection 
Index ranges 
Reflections collected / unique 
Completeness to 2theta = 27.03 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F"2 
Final R indices [I>2sigma(I)] 
R indices (all data) 
Largest diff. peak and hole  
3.00 to 27.03 deg. 
-9<=h<=8, -12<=k<=13, l3<=l<=13 
5941 / 3317 [R(int) = 0.01691 
99.5% 
Full-matrix least-squares on F2 
3317 / 0 / 223 
1.035 
Rl = 0.0408, wR2 = 0.1007 
Rl = 0.0549, wR2 = 0.1088 
0.233 and -0.199 e.A'-3 
205 
Table 2. Atomic coordinates ( x 104) and equivalent isotropic 
displacement parameters (A2 x 1031? to /dizk2/texzan/extra/ciftab 
J(q) iz defined as one third of the trace of the oithoona1ized 
U.ij teosor. 
U ( eg) 
0(1) 1762(1) -2515(1) -633.3(1) 27(1) 
0(2W) -76(2) 1795(1) -11100(1) 29(1) 
N(l) -5926(2) 2241(1) -9905(1) 22(1) 
N(2) -4569(2) 2367(1) -10544(1) 24(1) 
XU3) -3116(2) 1723(1) -9952(1) 22(1) 
N(4) -2695(2) -826(1) -6024(1) 23 (1) 
'IT (5) -1292() -1368(1) -6199(1) 22(1) 
N. 1935(2) -4510(1) -2289(1) 30(1) 
Cli) -3525(2) 1154(1) -8897(1) 19(1) 
 -5344(2) 1491(1) -8877(1) 19(1) 
 -6278(2) 1056(1) -7917(1) 23(1) 
 -5308(2) 317(1) -6997(1) 23(1) 
C(S) -3461(2) -25(1) -7034(1) 21(1) 
C(6) -2531(2) .389(1) -7977(1) 20(1) 
C(7) -566(2) -2169(1) -5205(1) 21(1) 
 1057(2) -2759(1) -5276(1) 21(1) 
 1879(2) -3530(1) -4315(1) 23(1) 
CIlO) 1086(2) -3776(1) -32.51(1) 23(1) 
Clii) -603(2) -3231(1) -3210(1) 23(1) 
 -1374(2) -2447(1) -4161(1) 22(1) 
 3357(2) -3143(1) -6466(1) 27(1) 
 3615(2) -5103(2) -2383(2) 34(1) 
 1067(2) -4842(1) -1231(1) 30(1) 
206 













































































































Symmetry transformations used to generate equivalent atoms:  
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Table 4.. ...nisotrpic thsp1aenet pareauetevs (A2 x 1013) 	r !3ik2ietexrIextxi 
The 3aiotropic displacement factor exponent takes the form:  
-2 pi'2 ( h'2 t'2 ull 	- ' h 	* b U12 3 
1311 1122 	1333 	3123 	1313 	3312 
o(L) 25(1) 35(l) 27(1) 11 	1 ) 1-L (1) 14 (1) 
0 1 2W% 20(L) 43(1) 27(1) 9 6 (l) 9(1) 
N(1) 21(1) 26W 21(1) 3W SW 
N(2) 22W 26(1) 24(1) 5(1) 5(1) 7(1) 
N(3) 21 (IL) 23(1) 230 
N(4) 
 6(1) 5(1) 7(1)
22 ( 1  24(l) 24 (1) 4(1) 5 (1) 9(1) 
k4 	5) 20 (1) 22(1) 22 (1) 4(1) 4(1) 7(1) 
N() 36 (1) 33(1) 26(1) 13(1) 10 (1) 17 (1) 
 19(1) 18(l) 21 C-3 ) 0(1) 5(1) 3(1) 
 1(1) 20(1) 20(1) 0(1) 3(1) €(1) 
20(1) 27(1) 24(1) 1(1) 9(1) 
C(4) 23(1) 27(1) 22(1) 3(1) 9(1-) 7(1) 
(,(S) 22(1) 20 (1) 20(1) 2(1) 3(1) 6(1) 
C(S) 17 (1) 20 (1) 24(1) 1(i) 4(1) 5(1) 
C(7) 20(1) 21(1) 20(1) 3(1) 3(1) 5(1) 
CO) 21(1) 22(1) 21(1) 2 (U 5(1) 3(l) 
CO 1  20(1) 24(1) 25 (1) 4(1) 5(1) 8W 
 25(1) .15(1) 22(1) 3(1) 3(1) 5(1) 
 26(1) 24(1) 21W 3(1)  
C(.1.2.) 21(1) 23 U) 22(1) 1(1) 4(1) 6(1) 
 22(1) 34(1) 30(1) 7(1) IC) (1) 11 (1) 
 39(1) 35(1) 32(1) 12(1) 7(1) 20(1) 
C(iS} 36(1) 28(1) 25(1) 8(1) 6 	1) 6(1) 
Table 5. Hydrogen coordinates ( x 10"4) and isotropic 
displacement parameters (W'2 x 10"3) for /disk2/texsan/extras/cif tab. 
Y z 13(eq) 
H(1W) -260(3) 1870(2) -11930(2) 62(6) 
1-1(2W) 1190(3) 1990(2) -10750(2) 59(6) 
HM -2060(3) 1704(17) -10325(17) 42(5) 
H(3) -7528 1264 -7907 27 
H(4) -5880 29 -5321 28 
H(6) -1294 168 -7997 24 
H(9) 2994 -3899 -4374 27 
H(11) -1204 -3409 -2523 28 
H(12) -2494 -2081 -4109 27 
H(13A) 4523 -2833 -5764 40 
H(13B) 3655 -2936 -7288 40 
H(13C) 2985 -4090 -6439 40 
H(14A) 3253 -5679 -3160 51 
H(14) 4013 -5613 -1629 51 
H(14C) 4713 -4418 -2424 51 
H(15A) 795 -4049 --861 45 
H(15B) 1985 -5244 -574 45 
H(15C) -165 -5458 -1542 45 
209 











































Symmetry transformations used to generate equivalent atoms: 
Hydrogen bonds with H. .A < r(A) i- 2.000 Angstroms and <DHA > 110 deg. 
]DH dW-Ifl d(}i. 	A) <DHA cI(D. .A) A 
02W-H1W 0.876 2,085 151.00 2.882 01 ( -x, 	-y 	-z-2 
02W-B1W 0.876 2.620 140.77 3.344 N5 	[ -x -ye -z-2 
02W-H2W 0.872 1.999 174.11 2.868 Ni 	( x+1, 	y, 	z 
N3-H3 0.940 1.805 175.13 2.742 02W 
211 
$463 
7.2 	X-ray crystal structural data for (S)-1-[6-(4-Dimethylamino-phenylazo)- 
benzotriazol-1 -yl]-3-phenyl-butan-1 -one (137B) 
212 
Table 1. Crystal data and structure refinement for a1w307. 
Contact Andy Parkin, a.parkinCded.ac.uk 
A. CRYSTAL DATA 
Empirical formula 	 C24 H24 N6 0 
N3C6H3 1-(CO CH2 CHPh CH3) 4-(N2 C6H4 NMe2) 
Formula weight 412.49 
Wavelength 0.71073 A 
Temperature 150(2) 	K 
Crystal system Monoclinic 
Space group P2(1) 
Unit cell dimensions a = 	9.152(8) 	A alpha = 	90 deg. 
b = 6.931(6) 
A beta 	104.286(14)deg. 
c = 16.919(15) A gamma = 	90 deg. 
Volume 1040.0(16) 	A3 
Number of reflections for cell 361 	(2 < theta < 16 deg.) 
Z 2 
Density (calculated) 1.317 Mg/m'3 










0.44 x 0.03 x 0.02 mm 
1.24 to 26.44 deg. 
-11<=h<=ll, -8<=k<=8, -21<=l<=21 
6854 
4097 {R (int) = 0.16191 
213 
Scan type 	 phi and omega scans 
Absorption correction 
	
Sadabs (Tmin= 0.730, Tmax=0.962) 
C. SOLUTION AND REFINEMENT. 
solution 
Refinement type 
Program used for refinement 
Hydrogen atom placement 
Hydrogen atom treatment 
Data / restraints / parameters 
Goodness-of-fit on F'2 
Conventional R [F>4sigma(F)] 
Weighted R (FA2 and all data) 
Absolute structure parameter 
undetermined) 
Extinction coefficient 
Final maximum delta/sigma 
direct (SHELXS-97 (Sheldrick, 1990>> 
Full-matrix least-squares on FA2 
SHELXL- 97 
geometric 
rotating and riding 
4097/1/284 
0.798 
Rl = 0.0882 [1150 data] 
wR2 = 0.2238 




calc w=l/[\sA2A(FoA2A)+(0.0756P)A2A+0.0000P] where P=(FoA2A+2FcA2A)/3 
Largest diff. peak and hole 	 0.229 and -0.247 e.A"-3 
214 
2 	Atn 	 141'41 and oquivalout ip 
W2 x 1".31 for 	 i 
4# ipue thii 	 tbC 	 $ 
7.410) t1} 232(4) 
H3 CU) 42(3) 
94ssM 341%3(3) 47(2) 
12) -733S:141 332(. 
ply's  35U) 48( 43(3) 
(;34) .3444() 57000 47 0) 
7704(lo) -4973 M.51 044M 42(3) 
a:264 (1O) -5s5*043) 5637(5) 
C(14) .9(3_4) 47( 
-k 050 till -3(3) 34(3) 
5547 (11 15(i 39(3) 
5631 (10) 15U4) 1513 (6) 36(3) 
N41) 97040) 1429 (1.3) 1152.(4) 47(a) 
16(9) 2665 W) 3234(s) 450) 
c(43) 144110) 4:51(.15) 34216 (3) 
73(33) 53 (6) 
56240) 7146i) 56(5) 42(3) 
:1733(6) 40(3) 
c (47) 1206 (M 6045(141 2.34CO 44(3) 
1(11) 414) 2221(6) 41 (1) 
13516 ~ 5 49117(is) 45(3) 
01462) 14024 (30) :5t35 (1 3544 (5) 60(4) 
C-14634 1105(il) 429(15) (6) 
CM 7.53.9(1*) -229 MO 37 P) 
0(6) 6592 till -1710(34) 509(5) 37 M 
017) 759(10) 3254{34) 31,73(7) 35(3) 
8575(5) -4938(12) 1155(4) :35(2) 
35) '6473(5) -559(13) (S) 41 (2) 
215 
Table 3. 	Bond lengthB (A) and angles (dog) for a1w307. 
1.378(9) 
N(1)-C(2) 1.404(11) 

















N(41) -N(42) 1.20(9) 
N(42)-C(43) 1.435(11) 
















































-C(46) -C(47) 11810(9) 
C(49) 	C(47) -C(46) 120.3(9) 
C(47)-C(48)-C(43) 1195(9) 










symmetry transformations used to generate equivalent atorna: 
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Table 4. Aiotropte diplaemant paralnetara (A2 x 10A3)  for a1w307. 
'rhe aniaotropio diap1aceent factor eqoient taken the forms  
.2 p2 ( h2 a*2 VII + • 	+ 3 h k &* * U12 ] 
rJ11 U22 U33 Ma U13 U12 
NM 37(5) 32(5) 29(4) -10(4) :8(4) 
C(II) 42(7) 53(8) 28(6) -5(6) 5(5) -1(6) 
0(11) 91(5) 62(5) 25(4) 8(4) 5(3) -10(4) 
 65(8) 43(7) 18(5) 1(5) 5(9) -4(6) 
 33(6) 46(7) 33(5) -1(5) 5) 1(5) 
 26(6) 50(7) 33(6) 1(5) 14(5) -5(5) 
 35(6) 32(6) 38(6) -4(5) -1(5) 6(5) 
 45(7) 32(7) 61(7) 18(6) 28(6) 7(5) 
 37(7) 67(9) 40(6) 6(6) 13(5) 3(6) 
 44(7) 43(7) 35(6) -2(6) 3(5) 13(6) 
 39(6) 42(6) 25(5) ..8(5) 1(5) 8(5) 
0(14) 50(6) 37(6) 29(5) -3(6) 3(5) 1(5) 
0(2) 65(7) 26(6) 19(5) -3(5) 26(5) 0(5) 
0(3) 54(8) 29(6) 33(6) -9(5) 8(5) -14(6) 
0(4) 26(6) 33(7) 51(7) -12(6) 13(5) -7(5) 
 48(6) 68(7) 24(5) 21(5) 11(4) 19(5) 
 51(7) 71(7) 22(5) -3(5) 14(4) 11(5) 
0(43) 28(6) 43(7) 36(6) -3(6) 14(5) -7(6) 
0(44) 56(7) 31(7) 30(6) 7(6) -5(5) -6(6) 
C(45) 53(7) 57(8) 16(5) -4(5) 9(5) 0(6) 
0(46) 55(8) 46(7) 26(6) -14(6) 20 (5) 2(6) 
0(47) 43(7) 54(8) 35(6) 16(6) 7(5) 
0(48) 51(1) 47(8) 43(7) 21(6) 15(8) -5(6) 
5(461) 56(6) 50(6) 32(5) 1(5) 16(5) -8(5) 
0(462) 51(7) 103(10) 236 -(i) 3(5) -15(7) 
0(463) 66(a) 56(8) 54(7) 11(7) 14(6) -3(7) 
C(S) 35(7) 53(8) 29(5) 9(5) 13(9) 9(6) 
C(6) 54(7) 40(7) 16(5) -5(5) 7(5) -5(6) 
0(7) 58(7) 36(8) 12 (5) -3(5) 10(5) -1746} 
5(8) 38(5) 53(7) 19(4) -4(5) 1(4) -9(5) 
5(9) 36(5) 47(6) 37(5) -11(5) 2(4) -8(5) 
Table 5. Hydrogen coordinates ( x 10A4) and isotropic 
displacement praeter (A2 x 103) for a1w307. 
x y z U(.q) 
H(12A) 8333 -8408 3132 51 
H(125) 6794 -7402 3199 52. 
H(13) 9486 -7537 4514 45 
 6034 -4985 3840 44 
 5059 -2738 4610 52 
H(134) 6132 -2564 6027 57 
R(135) 8151 -4447 6631 50 
H(136) 9062 -6715 5884 44 
83.88 -9844 5105 60 
}I(148) 8293 -10581 4225 60 
R(14C) 6753. -9686 4345 60 
11(3) 9614 -1539 2620 47 
11(44) 3905 5416 343 50 
11(45) 11516 8022 518 50 
11(47) 13367 623.7 2858 53 
11(48) 1160 3623 2648 56 
R(46A) 14441 9532 3012 90 
11(469) 15541. 10105 2446 90 
H(46C) 2.5331 7887 2658 90 
N(46D) 13712 946 73.0 88 
11(46E) 14156 11487 1392 88 
11(46F) 12423 10930 1028 88 
11(5) 7433 83.9 445 44 
11(6) 5854 -1818 104 44 
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7.3. SERRS Spectra of dyes 121-123 
Appendix 7.3.1: 	Spectrum of mono-azo benzotriazole dye 121 
Appendix 7.3.2: 	Spectrum of mono-azo benzotriazole dye 122 
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Appendix 7.3.3 	Spectrum of mono-azo benzotriazole dye 123 
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